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1..  INTRODUCTION 
The objective of this Commission Working Paper is  to report on the evaluation of 
the operation  of  · 
•  Council  Directive  67/548/EEC
1  on the  approximation of laws,  regulations  and 
administrative provisions relating to the classificatiOf\, packaging and labelling of 
dangerous substanc_es, _as amended; 
•  .Directive  88/379/EEC
2  on  the  approximation  of the  laws,  regulations  and 
administrative provisions relating to the classification, packaging and labelling of · 
dangerous preparations; 
•  Council Regulation (EEC) 79_3/93
3  on the evaluation and control of the risks of 
existing substances; 
•  Directive  76/769/EEC
4  on  the  approximation  of the. laws,  regulations  and 
ad~inistrative provisions of the. Member  States  relating  to  restrictions  on the 
marketing and use of certain dangerous substances and preparations. These four 
legal instruments govern industrial chemicals in the Community. 
~·  Legislation has been in existence since 1967 when it was tecognised that provisions 
relStting to the classification, ·packaging and labelling of substances on the market, in 
particular  dangerous  industrial  chemicals,  should , be  harmonised  throughout  the 
Community in order to eliminate the barriers to trade that national provisions in the 
Member States could represep.t.  Since then,  a range of legislative instruments- have 
been established in the Community, which seek to achieve and maintain a high level 
of protection of human health and the  environment in the  context of the Internal 
Market. 
It was only in 1979 that the environmental protection requirement was introduced 
into the then existing 1egislation
5
• At the same .tirrie,  in order to ensure a control of 
4 
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notification system for "new" substances as from 1981. 
Currently there  is  wide-spread  public  concern ;:tbout •the  effects  of chemicals  on 
human health and "the environment as well as the fear about new potential threats as 
in  the  case of endocrine disrupters.  This  concern is  exacerbated  by  the  so-called 
"burden of the.past". Since the notification procedure has only been in place since 
1981, all chemicals marketed prior to that date. have never been scrutinised according 
to this procedure. Thus, for the majority of these chemicals few data are available. 
The immediate concern is therefore that man and the environment are  potentially 
exposed to a large number of  chemical substances for which the hazardous properties 
have not been identified and/or the risks have not been assessed.  · 
The recent follow-up Report to the 1995 ''Debris assessment"
6 on the changes in the 
pan-European  environment  highlights  the  concern  about  toxicity  and  bio-
accumulatiort aspects of chemicals, in particular pesticides, as well as  the need for 
appropriate policy responses to the possible human and ecological impacts caused by 
chemicals. 
2.  THE EVALUATION 
The evaluation of  these instruments covers their effectiveness and efficiency in terms 
of their specific  objectives,  which cover  the  protection of human  health  and  the 
environment as well as the elimination of  barriers to trade. It provides an assessment 
of  their operational weaknesses and identifies issues -for further consideration in view 
ofimprovement. The findings also refer to the link-up with existing risk management 
measures. The detailed findings on the implementation of  Directive 67/548, Directive 
88/379, Regulation 793/93 and Directive 761769 are attached as Annexes 1, 2, 3 and 
4 respectively.  ·  ' 
For the  purpos·e  of the evaluation it is  essential to  clarify the  distinction between 
"new" and "existing"  chemicals,  since  they  are  governed  in  the  Community  by 
different legal instruments. 
According to Regulation 793/93 "existing" substances means chemical substances in 
use within the EU before September 1981  and listed in the European Inventory of 
Existing  Commercial  Chemical  Substances  (EINECS).  EINECS  contains  100,106 
entries including: industrial chemicals, substances produced from natural products by 
chemical modification or purification, such as metals, minerals, cement, refined oil 
and  gas;  substances  produced  from  animals  and  plants;  active  substances  of 
pesticides,  medicaments,  fertilisers  and  cosmetic  products;  food  additives;  a  few 
natural  polymers;  and,  some  waste  and  by-products.  They  can  be  mixtures  of 
different chemicals occurring naturally or as a result of  the production process. 
"New" substances are· industrial chemicals which are  not listed in EINECS.  They 
have  to  be  notified  prior  to  being  placed  on  the  market,  after  which  they  are 
registered in the European List ofNotified Chemical Substances (ELINCS). 
6  European Environment Agency (1998) Dobris +3, Report on the State of  the Environment. 
2 Directive 76/769/EEC in  its  introduction of restrictions  on marketing and  uses  of 
certain dangerous substances is unique in that in its management of  the restrictions it 
·may target articles or products. A case in  poin~ is the ban on the use of wood treated 
with pentachlorophenol or creosote in children's playgrounds. 
Directive 67/548/EEC 
Directive 67/548 was adopted in 1967 in order to approximate the national provisions 
· relating to dangerous substances and preparations. Since then the Directive has been 
amended eight times and adapted to technical progress 23 times. These modifications 
reflect  the  continuous .  adaptation  of the  Directive  to  the .  permanent  increase  in 
technical and scientific kilowledge in the field of  dangerous substances. 
Today the Directive aims at achieving a high level of protection of  human health and 
the  environment  from  the  hazard  that  dangerous  induitrial  chemicals  may  cause 
when placed on the market and used. 
The key elements are 
· (i) classification and labelling of  chemicals according to their intrinsic dangerous 
properties 
.  '  -
The  placing· on  the  market  of an  industrial  chemical  which  the  manufacturer,  -
importer or distributor knows or suspe~ts is "dangerous" requires them to examine its 
intrinsic properties  in  order to  assess  whethe~ it  is  "dangerous" according  to  the 
Directive. If the chemical is qualified as "dangerous", it has to be placed into one or 
several  classes· of danger,  such  as  "flammable",  "toxic"  or  "dangerous  to  the 
environment". The Directive currently covers 15 classes of  danger. 
Classification  of a  chemical  as  "dangerous" requires  appropriate  labelling  on  the 
package.  The  label  includes a  danger  symbol,  standard ·phrases  on  the  nature  of 
special risks from the chemical (R-phrases) and standard safety precaution phrases 
(S-phrases) relating to the use.  · 
"Harmonised"  classification  and  labelling  is  undertaken by  a  working  group  of 
Commission  and  Member  State  experts,  with  the  participation  of industry,  trade 
unions arid. EEA-EFTA representatives. The industrial chemicals for  discussion are 
proposed by Memb~r  States arid, to a lesser extent, by Industry. Chemicals for which 
a  "harmonised"  classification  and  labelling  has  been  agreed  by  the  Commission 
services and Member States as dangerous are listed in Annex I to the Directive.· 
Classification  according  to  the  Directive  67/548  may have  repercussions  on  the 
marketing and use of a chemical. Directive 76/769/EEC on the approximation of  the 
laws,  regulations  and  administrative  provisions  of the  Member  States  relating  to 
restrictions  on  the  marketing  and  use  of  certain  dangerous  substances  and 
preparations
7  may, after an assessment including economic and social implications, 
ban  the  marketing  to  and  use  by  the  general  public  of chemicals  which  are  m 
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3 category  1  or 2  of the  danger  classes  "carcinogenic",  "mutagenic"  or "toxic  to 
reproduction", and Directive 90/394/EEC controls the presence of carcinogens at the. 
workplace when they fulfil the criteria for "carcinogenic" category 1 or 2. 
' 
(ii)  notification of  "new" chemicals prior to marketing 
Since  19  September  1981  any  manufacturer wishing  to  place  a  chemical  on the 
~arket has to notify this  to  th(!  national Competent  Authority (CA),  provided the 
chemical has not been on the market before that date. 
The  notification  of a. "new"  chemical  requires  detailed  information  about  its 
production, use and its intrinsie properties to  be  submitted to  the  CA,  including a 
proposal for classification and labelling. On acceptance of the dossier by the CA the 
chemical may be  marketed throughout the European  Union.  Subject to  increasing 
tonnage  limits .  the  manufacture:r  has  to  provide  additional  data to  the  CA.  These 
additional data may require a modification of classification and labelling or of the 
risk assessment. 
(iii) risk assessment of  "new" cftemicals 
Since 1993
8 the notificatioi1 of a "new'' substance requires a risk assessment which 
evaluates· the  danger  to  human  health  and  the  environment  upon  exposure.  The 
conclusions of the risk assessment may have an impact on the production, handling, 
classification, labelling, marketing or use of  the substance, or induce other protective 
·measures. 
Directive 88/379/EEC 
Directive 88/379, known as th~: "Preparations Directive" sets out harmonised rules 
for the classification, packaging and labelling of dangerous ·preparations (mixtures) 
so as to 
optimise the functioning of the Internal M~ket  by reducing the obstacles to 
trade  arising  from  difft:rent  classification  and  labelling  of preparations  in 
Member States; 
give· at  the  same  time  a  high  level  of protection  t~ persons  coming  into 
contact with preparations, either at work or in private by providing a .label 
giving essential information on the hazards  involved and precautions to  be 
taken and adequate packaging requirements and by introducing a safety data 
sheet for industrial users. 
A dangerous preparation is a mixture of substances (of which at least one substance 
is classified as dangerous) which in accordance with the provisions of  the Directive is 
classified as dangerous.  It is estimated that there may be one million preparations on 
the EU market. Once a preparation has been classified, packaged and labelled by the 
producer or importer according to  the rules of Directive 88/379 it can be marketed 
throughout the EU  without any  obligation to ·supply prior information  to  national 
authorities.  ·  · 
8  Council  Directive 92/32/EEC  (7th  Amendment of Council  Directive  67/548/EEC),  OJ  L  154, 
5.6.1992, p.  1. 
4 .  .  . 
It was decided from the beginning that classification of preparations would not be 
routinely  done  on  the  basis  of laboratory  tests,  as  is  the  case  with  dangerous 
substances. · The sheer number of dangerous preparations on the market would make 
such a  procedure .  impractical  but tests  were  also  considered  generally  unsuitable 
because of the costs to industry, especially SMEs  and because the number of test 
animals needed \-Y'OUld not be compatible with 'animal welfare.  Instead of routine use 
of  tests a calculation method of classification called the "Conventional Method" was 
developed.  A<;cording  ·to  the  "Conventional . Method"  the  classification  of a 
preparation can be calculated from. kilowledge of  the classifications of  the component 
substances and their concentrations· on the  basis  of the  formulae  provided in the 
Directive. 
Clearly there is a  very close link between the Dangerous Preparations Directive and· 
the  Dangerous  Substances  Directive.  Not  only  does  Directive  88/379  use  the 
substance  classifications of Directive  67/548,  it  also  uses  the  same  categories  of · 
· danger,  the  same  criteria for  labelling,  the  same labelling  scheme,  the  same  test 
methods (where needed) and the same packaging rules.  A  consequence of this close 
link is that modifications to Directive 67/548  inevitably have consequences for the 
classification o_f Preparations.  ·  · 
The Preparations Directive has been continuously developed over the past ten years. 
In  addition ·to  changes  arising  from  the . Substances ·Directive,  rules  have  been 
introduced for gaseous preparations Regulation (EEC)  793/93.  Safety Data Sheets, 
additional safety information for industrial users (e.g.  first aid· measures in case of 
fire, ·handling precautions etc.)  for  Child Resistant· Fastenings (to  protect children 
against using dangerous preparations) have also been introduced. 
Regulatio~ (EEC) 793/93 
Council  Regulation  (EEC). 793/93  on the  evaluation  and  control  of the  risks  of· · 
existing substances was adopted on 23 March 1993 and entered into force on 4 June 
1993.This Regulation i~ based on Article lOOA ofthe Treaty and is generally known 
as the "Existing Substances Regulation"  .. The Regulation was developed in response  · 
·to the. Fourth  CommunitY. Action  Progratrune  on  the  Environment  (1987;.1992),  · 
which ·underlined  the  need  for  a  legislative  instrument,  which  would  provide  a 
comprehensive structure for the evaluation of  the risks posed by "existing" industrial 
chemicals. 
In  order  to ·make  the  Regulation  fully. applicable,  a  number  of steps  had  to  be 
completed, including the adoption of  Commission Regulation (EC) No 1488/94 of  28 
June  1994,  which  lays  down  the  principles  for  the  assessment  of risks,  and  the 
production of the  Technical  Guidance  Documents on Risk  Assessment  and  Risk 
Reduction Strategies, which were published in 1996 and 1998 respectively. 
.  . 
Regulatio~ 793/93. aims to identify and reduce the risks related to theiproduction and 
distribution of "existing" industrial chemica.ls.  In principle, the Regulation seeks to 
protect man and the environment from exposure to dangerous industrial chemicals 
· via all possible routes. "Man" comprises in this cmitext "worker, cons41ner and man 
via the  environment".  The  basic  principle  of the Regulation  is  that  controls ·on 
hazardous chemicals should be based on an assessment of the actual risk to. human 
5 health and the  environment,  rather than the hazardous  properties of the  substance 
only. This approach, based on sound science, is strongly supported by Industry. 
One of the purposes of the Re:gulation was to ensure that each chemical is assessed 
· on the basis of the same  criteria~ The Regulation was also designed to ensure that a 
Member State would not notify its intention to restrict the marketing and use of a 
chemical without carrying out a risk assessment according to principles agreed by all 
Member States. Thus, the Regulation introduced a coherent and consistent system for 
evaluating the  risks related to "existing" industrial  chemicals, which is  applicable· · 
throughout the Community and at the .same time avoids fragmentation of the Internal 
Market. 
Manufacturers  or  importers.  were  required  to  provide  specific  information  on 
EINECS-listed chemicals produced or imported into the Community in volumes in 
excess of 10 tonnes per year. The most recent data provided by industry shows that 
of  the 100, 106 chemicals listed on EINECS, on the market there are approximately 
•  2,500 High Production: Vo1ume chemicals (1,000 tonnes or more per year); and, 
•  between 15,000 to 20,000 Low Production Volume chemicals (10 to 1000 tonnes 
per year). 
The remaining 80,000 or so chemicals are produced or imported in quantities of less 
than 10 tonnes per year or are: not traded at all. 
Of the  100,106  EINECS  chemicals,  approximately  3,000  have  been classified  as 
dangerous in Annex I of  Directive 67/548. 
Some EINECS chemicals which meet tht volume criteria of  Regulation 793/93 may 
have  undergone  an  equivalent  assessment  under  other  EC  legislation.  They  will 
therefore  not  be  assessed  again  under .  Regulation  793/93.  These  chemicals  are 
essentially of  occupational concern or used mainly as pesticides. 
For  practical  reasons,. a  priority  setting  approach  for  Regulation  793/93  was 
introduced  to  determine  which chemicals  should be· assessed  first.  Three  priority 
lists,  totalling  110  chemicals, were adopted by a regulatory committee of national 
representatives and set out in three Co~ission  Regulations between 1994 and 1997. 
In  these _Regulations,  each  substance  is  formally  assigned  to  a  Member· State 
"Rapporteur"  on  a  voluntary  basis,  for  evaluation  and  presentation  of a·  risk 
assessment report for consideration by the Member States. This procedure places the 
burden of' proof with the Public Authorities. If the conclusion of the risk assessment 
is  that  the  risks  are  not  adequately  managed,  the  Regulation  requires  the. 
determination of  a strategy to reduce those risks. 
Risk reduction measures may subsequently be considered within the framework  of 
other  relevant  legislative  instruments,  such  as  Directive. 76/769/EEC  relating  to 
restrictions  on  the  marketing  and  use  of  certain  dangerous  substances  and 
preparations, or worker and consumer protection legislation. Such measures can also 
include the use of  voluntary (environmental) agreements.  · 
.6 Overall, the Regulation 
•  provides a comprehensive system to determine possible risks _to  human health and 
the environment from  "existing"  chemicals and  related  measures  for  reducing 
· those risks; 
•  is  not intended to  rapidly manage  urgent or emerging new problems for  those 
"existing" chemicals which are not already on the priority lists; 
•  is not intended to cover the risk assessment and the corresponding risk reduction 
measures of harmful "existing" chemicals which are not industrial chemicals and 
are controlled by other legislative instruments. 
DIRECTIVE 761769/EEC 
Directive 76/769/EEC, known as the "Limitations Directive" establishes harmonized· 
rules  to  remove  obs~aclt~s to  intra-EU trade arising  from  restrictions  in ·Member 
States applying to· dangerous substances, preparations and. articles associated within 
these.· It also establishes harmonized rules where there is a consensus that these are· 
needed to protect human health, the environment and the interests of consumers.  In 
all cases, the Directive·sets out to assure. a high level of protection of  ·public health 
arid the environment. 
Initiatives to harmonize may· arise from many sources.  The main source so far is the 
notification  by  Member ·states  under  Directive  83/189  of new  technical  rules. 
However, this could change in the future as an increasing number of risk reduction 
measures may arise from Regulation 793/93. 
Where initiatives entail restrictions for a substance not yet included in Annex I of  the 
Directive 761769, these must be introduced through Council and Parliament by Co-
Decision Procedure.  However, a modification of restrictions of a substance already 
included can be introduced more quickly through the Technical Progress Committee. 
In all instances time is of  the essence as there is an immediate threat to human health 
and/or the environment and to the Internal Market. The risks posed by the substance 
in  question  must  be . quickly  evaluated  as  must  all  the  economic  and  social 
implication,s of  restricting the substance in order to manage the risks.  Targeted risk 
assessments, concentrating on the dangerous effect(  s) of concern and using available 
data, are performed and are followed by an analysis of  the· advantages and drawbacks 
of  possible control measures. 
:Restrictions under Directive 761769 generally take the form ofcontrolled use i.e. they 
restrict the substance for particular uses only. In a minority of cases they take the 
form of a  ban with exemptions or even a total ban on marketing as in the case of 
PCBs.  Up  to  date,  the  Directive . has  been  amended  18  ·times  providing  for 
restrictions on 42 substances or groups of substances, covering about 900 individual 
substances in total, of  which the majority are cancer causing $Ubstances banned for 
· consumer use. · These restrictions for the most part seek to protect human health, 
a~though a  good  ~any also  protect  the  environ!nent  and  some  are  specifically · 
intended to protect consumer interests. 
7 3.  FINDINGS 
In  general  the  findings ·highlight  the  need  to  l.lSe  the  current  instruments  more 
efficiently and implement as well. as enforce them more rigorously and consistently, 
the need to streamline the instruments and develop them in order to take account cf 
new emerging problems. They also recognise the role of  sound science arid highlight 
the  need to  meet  more  fully  the  concerns  of the  outside  world  by  giving  full 
consideration to the precautionary principle. They point at the need to give emphasis 
to the co-operation in the frame of  international organisations such as the OECD and 
the UN, with a view to achieve internationally agreed harmomsed rules and to benefit 
fully from the worldwide available scientific expertise.  -
More_ specifically the findings highlight the importance of 
.  . 
·  •  hazard identification as the initial key step in protecting both human health and 
the environ,ment from the potential harmful effects of  industrial chemicals; 
•  the  distinction  bet\\feen  hazard  identification,  risk  assessment  and  risk 
management; · 
•  the concept of  the  "bu~~en of proof' in relation. to the different instruments of 
hazard identification, risk asse~;sment and risk  management;  · 
•  ascertainipg ·the  number of 
11existing
11  industrial  chemicals  which constitute the 
"burden of  the past
11  and of  drawing up a clear strategy for assessing _these for their 
harmful effects in order to address the public concern. 
Directive 67/548/EEC 
In  gener~l the  provisions-of Directive  67/548  have  proven satisfactory,  although 
~ertain criticisms have been made of the system for notifying new substances. The 
· classification and labelling of some 4,500 dangerous industrial chemical substances 
has  been  agreed Community-wide.  2,100  "new"  industrial  chemicals  have;:  been 
notified and  registered  in ELINCS.  Since  1993. 400  "new" chemicals  have  been 
subject of  a risk assessment in accordance With Directive92/32. 
The review has highlighted a number of findings concerning the practical operation 
of the  Directive,  which  need  to  be  addressed.  A  number  of weaknesses  in  the 
practical operation are due to a lac:k of  resources. 
(i) classification and labelling 
•  the time period of one to two  years to  agree on· a harrnonised classification and 
labelling and its publication is 1too long; 
•  the system ofR-phrases and S-phrases has become too complex; 
•  .classification and labelling provisions are not sufficiently applied and enforced in 
the Member States;  ·  . 
•  it is difficult to trace the chemicals which have not been classified as "dangerous" 
under the Directive; 
8 •  there  is  no  adequate  follow-up  for  substances  classified . in  Annex  1  as 
carcinogenic, mutagenic or toxic to  reproduction (category 1 or 2), even though 
the effects of  such substances are of  major concern.  .  · 
(ii)  notification of  "new" cJiemicals and risk assessment 
•  industry claims that innovation and competitiveness of the chemicals industry are 
hampered by the existing provisions for polymers, intermediates and exemptions 
for research arid development; 
•  "new" industrial  chemical  substances  are  known  to  b~ marketed  without prior 
notification;  · 
•  circulation of the confidential notification dossiers among Competent Authorities 
is too long (50% of  the dossiers take 4 months, 10% take longer than one year);-
•  despite the requirement for annual publication
9
,  due to  delays in data processing 
ELINC,S has not been published since 1994; 
•  risk assessment requires inordinate effort in terms of  staff resources and time. 
(iii) structure of  f!te Directive 
•  eight  amendments  and  twenty-three  Adaptations  to  Technical  Progress  have 
dispersed the provisions of the Directive among different pieces of legislation. In 
addition the text of  the Directive has become confusing, and important provisions 
such as the principles of  risk assessment are contained in other directives.  · 
Directive 88/379/EEC 
Directive 88/379 has  generally proven effective in eliminating technical barriers to 
the free circulation of  dangerous preparations and, as a result of  constant adaptation, 
has provided a high level of  health protection. 
There have,  however,  been a  number of problems  related  to, implementation and 
enforcement. Some preparations on the market have not been classified and some are 
classified differently by  different  m~ufacturers.  .  This  occurs  because  of lack  of 
understa.Iiding or lack of expertise, especially in· smaller companies and because of 
different interpretations of certain rules. There is also evidence that the requirement 
in the Directive of having the same labels for all users may not be ideal in terms of 
costs for the manufacturer and comprehensibility for the user.  The Directive is also 
deficient in the sense that it does not cover pesticide preparations, does not deal With 
the. dangers that  d~gerous preparations present to the environment nor does it deal 
· systematically with  non-classified  preparations  which  may  nevertheless  present  a 
danger for users.  .  . 
It thus became urgent to  find solutions to these problems in order to  safeguard the 
cohesion of  the Internal Market and to preserve a high level of  protection for· human 
9  Commission Decision of 21  December 1984 concerning the list of chemical substances notified 
pursuant  to  Council  Directive  67/548/EEC  on  the  approximation  of Jaws,  regulations  and 
administrative  provisions  relating  to  the  classjflcation,  packaging  and  labeiling of  dangerous 
. substances, OJ L 30, 2.2.1985, p. 33. 
9 ·health and the environment. The solutions to these problems are  also important for 
Austria; Finland and Sweden in the framework of the Accesston Treaties. To that 
effect  on  18  July  1996  the  Commission  presented  a  Proposal  to  Council  and 
'  . 
Parliament for a new Directive on Dangerous Preparations. This Proposal seeks to 
bring together in one  legal instrument all the legislation to date on preparations and 
to  remedy the above-mentioned deficiencies with regard to pesticides, dangers to the 
environment and the dangers from non-classified preparations. 
The  proposed new ·Preparations  Directive includes  in  its  scope  the  classification, 
packaging  and  labelling  of pesticides.  This  should  eliminate  barriers  to  trade 
associated with different systems in Member States for classifying and labelling of 
p~sticides, for  safety  data sheets  and for  packaging  of pesticides.  It should also 
improve the level of protection of human health and the environment as  it includes 
stricter  rules  than  those  applicable  to  pesticides  at  present  under  Directive 
78/631/EEC. 
The proposed new· Preparations  Directive also  covers dangers to the  environment 
posed by dangerous preparations.  The new harmonised approach should remove the 
trade  barriers  linked  to  national  systems  and  provide  new  protection  to  the 
environment. 
Also included in the proposed m:w Directive are rules for preparations not classified · 
but which may nevertheless be  dangerous.  Those marketing such preparations will 
be required to compile a special Safety Data Sheet and make it available on request." 
The  proposed new Directive,  for  which  a  Common Position  was  adopted  in the 
Council in 'september 1998, will thus solve many problems related to  'Dangerous 
Preparations'. However, one of the remaining key problems  lies with enforcement 
· where Member States'should ide:ntify possible ways to improve their monitoring and 
control mechanisms. 
Practical problems relate to 
•  the  operation of the  Directive  (technical  issues  which need  to  be addressed  in 
·<>rder to guarantee the functioning of the Internal Market and to solve any legal 
uncertainty which may derive from their implementation); . 
- . 
•  the comprehensibility of labels which needs to  be analysed in-depth 1n  order to 
find  whether  the  information · on  the  label  reaches  all  users·  (consumers, 
professional users, manufacturers, authorities and medical staff); 
•  the improvement, if  necessary, ofthe current situation in terms ofthe international· 
harrnonisa~ion of rules on Dangerous Preparations which should be given high 
priority in view of  its potential trade implications and safety benefits. 
Regulation (EEC) 793/93 
So  far  11 0  "existing"  industrial  chemical  substances  have  been  selected  as 
I  .  . 
"substances requirin_g  immedi~te attention because of  their potential effect on ma:n on 
the  environmen~" in the 3 priority lists published in 1994, 1995 and 1997. However, 
the complexity of the risk assessment process  n~cessitated a lengthy lead-in time 
10 before technical work on individual chemicals could commence because of the need 
for technical guidance. 
Out of the  total of 110  priority  chemicals,  3  8 have  been· or .are  be,ing  discussed. 
19 risk assessment reports  have  been completed.  For  14  chemicals  risk ·reduction 
measures  are  recommended;  for  3  chemicals  further  testing  is  required  and  for  · 
.2 chemicals there is no need for risk reduction measures.  · 
To date, the time necessary from the publication of a priority list to the circulation of 
the  first  draft of the  risk  assessment  report  at  the  Technical  Meeting  appears  to  · 
average between 18 and 29 months. In general, a'further 9 to 25  months are needed 
from  the  circulation of the  first  draft  until  an  agreement  is  reached  on  the  risk 
assessment report. During 1998 the 'pace of completion has increased. It is currently 
taking 9 months to finalise the assessment discussions. This improvement comes as a 
result of  the increased technical competence of  those national experts working on the 
risk assessment process. 
A Commission Recommendation concerning the results of the risk evaluation for 4 
chemicals and strategies for reducing the risks for 3 ofthem should in principle be 
published before the end of 1998. This means that, since 1994, only 4 ~hemicals have 
gone through the whole process foreseen in the Regulatiqn. 
The operational experien~e gained so far highlights the following issues: 
•  there is a lack ofcommitrrient from both Member States and Industry; 
•. there is a lack of  resources in Member States and the Commission to carry out the 
necessary activities; 
•  the  priority  setting  approach  was  not  applied  successfully  for  the  first  three 
priority lists in identifYing the chemicals of  greatest concern; 
•  the  nature,  scope  and  amount  of. data  to .  be  assessed  for  the  in-depth  risk 
assessment necessitate a lengthy process;  .. 
•  the burden,ofproofis placed on Public Authorities rather than on Industry. 
DIRECTIVE 761769/EEC 
In general Directive 761769 has been successful in preserving the Internal Market and 
· in protecting human health and the environment. 
•  Over the past 20 or so years, the Directive has been amended 18 times providing 
for  restrictions  on  42  s'ubstances/groups  of substances· covering  about  900 
individual  substances.  Furthermore,  the  provisions  on  substances  included  in 
Annex I have been adapted to tecluiical progress on four occasions. 
•  In all cases, except asbestos,  i~ has  been possible to introduce Community-wide 
restrictions when Member States have planned to, unilaterally, introduce national 
restrictions  and  in  most  cases  Member  States,  have· refrained  from  derogating 
from the harmonized rules.  There are nevertheless derogations on the grounds of 
Article 100A(4) from the harmonized rules for pentachlorophenol, cadmium_ and 
creosote. The situation \vould seem to have improved, however, in recent times as 
derogations  have  not  been  requested  since  the  creosote  Directive  of 1994. 
11 Another sign  of improvement  is  that  no  Member  State  has  voted  against  any  .  ,. 
amendment or adaptation of  Directive 76/769 since that time. 
•  ·However,  whil~t in  most cases  agreement  on  harn:i.onized  restrictions  has  been-
found and sustained, there have been delays in implementing some of these.  For 
. example, the amendment on nickel in jewellery under Directive 94/27 is  not yet 
operational as  CEN has  not yet adopted the test methods needed for  entry into 
force.  Delays are also experienced in introducing bans on substances classified as 
carcinogenic, mutagenic and toxic for reproduction (categories 1 and 2) as it may 
happen  under  ..  certain  circumstances  .  the  quicker  Committee  Procedure  is 
relinquished for  reasons of political sensitivity in favour of the  full  co-decision 
procedure involving the European Parliament.  In addition, in. the case of  asbestos, 
ongoing  discussions  on th·e  safety  of the  substitutes  and  on  the  economic 
consequences of a ban, have. contributed to  further delays.  The  Directive in  its 
present form,  after 20 years  of operation,  has become  rather complex  and  not 
always easy to  interpret and use.  It has also become somewhat outdated in  its 
legislative  approach  .. For  example,  it  lacJcs  a  well-defined  scope,  prectse 
definitions and a safeguard clause. 
4.  ISSUES 
The  assessment  and  evaluation  of the  operation  of the  legal  instruments 
concerned need to be further developed in the light of comments to this Report 
from  the  Member  States  and  interested  parties.  A  number  of issues  to  be 
considered are presented below. 
Directive 67/548/EEC and Regulation 793/93 
The findings  of the evaluation of the  operation  of the .  two  legal  instruments 
highlight a  number of issues  which will  need to  be  addressed  in the  future. 
These issues concern the need to 
•  address  operational  W€~aknesses in the ·implementation of and. compliance 
with both Regulation 793/93  and Directive 67/548, in particular the review 
should focus  on the risk assessment and risk reduction strategy procedures 
_under Regulation 793/93; 
•  restructure and rationalise  Directive 67/548  to  give it the  necessary  clarity 
and transparency in order to  make  it more user friendly  and streamline its 
provisions to ensure that Industry is not unnecessarily hampered in terms of 
innovation and competitiveness;  · 
•  clarify  the  commitment  of Member  States  in  order  to  ensure  effective 
implementation of Regulation ·793/93; this should be determined in terms of 
political support for completing work on "existing" chemicals in future  and 
in terms of  actual resources; 
•  ascertain the number of  "existing" chemicals which constitute the "burden of 
the  past" and review them  to  see  if their hazardous  properties have  been 
12 identified since this will make it possible to  develop guidelines and criteria 
for the appropriate assessment and management of  any risks; 
• . address the "burden of proof' in relation to  hazard identification· and risk 
assessment of  "existing" chemicals; 
•  ·consider  the  appropriate  consultation  of  the  Scientific  Committee  for 
Toxicity, Eco-toxicity and Environment in line with the general approach of 
the Commission
10 to scientific advice;  · 
•  ensure .that  Member  States  consider  liability  as  well  as  withdrawal  of 
substances as a means to improve compliance; 
•  achieve better co-ordination in order to improv·e efficiency, effectiveness and 
consistency of approach. in both the processing of hazard identification and 
risk assessments and the definition of  risk reduction strategies for chemicals; 
•  address international co-:operation and co-ordination in order to make optimal· 
use of  existing 'expertise and resources;  . 
•  ensure that the insiruments keep up With new scientific developments, such 
as the potential threat of  endocrine disrupters. 
Directive 88/379/EE,C 
The findings of  the evaluation of  the operation of  this instrument have identified 
the need to 
•  assess  the  comprehension  of the  information  on  the  label  of dangerous 
preparations by all target groups; 
•  identify the  causes  of delays  and  non-compliance  by  Member States  and 
where necessary ensure that Member States t~e  the appropriate me.asures to 
remedy the situation and consider withdrawal of preparations as a means to 
improve compliance; 
•  address those technical issues which are important for the practical operation 
of  the Directive; 
•  develop a system for the compilation of safety data she'ets  for preparations 
not classified as dangerous; 
•  address the issue of  international classification and labelling of  preparations. 
'  .  .  . 
Directive 761769/EEC 
The findings have highlighted the need to 
1()  COM(97) 183 fin. of30 April 1997 
.  13 •  resolve the outstanding c:ases  of Article  lOOA  (4)  for  PCP,  Cadmium and 
Creosote in such a way as to respect internal market principles as well as a 
high level of  protection for human health and eqvironment; 
•  accelerate  the  adoption of new restrictions  under  the  Directive  by  giving 
preference to the Committee Procedure wherever possible; 
•  accelerate the adoption of restrictions characterised by scientific uncertainty 
or  high  economic  costs  as  in  the  current  case  of asbestos,  by  further 
improving risk assessment procedures; 
•  address  the  delays  in  the'  practical  implementation  of new  restrictions 
introduced under the Directive as those caused by difficulty in adopting test 
methods; 
•  ensure the appropriate consultation of the Scientific Committee for Toxicity, 
Eco-toxicity and Environment in order to  ensure the  sound scientific basis 
and independence of  the risk assessments under Directive 76/769; 
•  update and rationalise Directive 76/769!EEC by means of  a recast; 
•  ensure  that  the  precauti:onary  principle  is  given  full  consideration  in  the 
introduction of marketing and use restrictions of dangerous substances and 
preparations. 
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Directive 67/548/EEC
1 was adopted in 1967 to approximate the national provisions 
relating  to  dangerous  substances  and  preparations.  The  then  existing _  national 
provisions  of the  six  Member  States  differed  widely  and  thus  hindered  the 
Community trade of chemicals. In addition to  the  trade aspects, it was recognised 
that there was  a need -to  ensure  the protection of public  health,  in  particular the. 
health of  workers handling dangerous substances.  · 
This !esulted in the intn)duction of  common provi~ions on the 
- classification of dangerous  substances,  since  placing  a  substance  into  one  or · 
several  defined  classes  of -danger  characterises  the  type  and ·severity  of the 
adverse effects that the substance can cause;  , 
- packaging of dangerous substances, since adequate packaging protects from the 
known danger(s) of  a substance; 
- · labelling ofdangerous substances, since the label on the packaging informs about 
the nature of the danger(s) ofthe substance.,inside and about the safety measures 
to apply during han.dling and use.  -
The . combined  standardised  provisions  should  ensure  the.  establishnient  of  a 
common market in the field of dangerous chemical substances and a high level of 
protection of human health. Protecting the environment from the dangerous effects 
of  substances was not considered in.1967. 
tt.  ·  Classification, packaging and labelling ofdangerous substa.nces 
· The  Directive  initially  inCluded  eight  cl~sses of danger,  such  as  "explosive"  or 
"toxic", a list of  substances classified as dangerous in Annex I, danger symbols such 
as a scull with crossed bones underneath in Annex II, standard phrases on the nature 
of special risks (R-phrases) in Annex III and the wording of safety precautions (S-
phrases) relating to the handling and use of  dangerous substances in Annex IV. This 
initial structure developed over time to  take account of the continuous increase in 
scientific and technical knowledge. 
· Annex V  now contains  testing  methods  to  determine  the  potentially  dangerous 
properties of  substances, Annex VI provides detailed criteria on the proper choice of 
the class of danger and on how tp assign the danger symbols, R-·and S-phrases to a 
tested substance. -Annexes VII arid VIII do not relate to the classification or labelling 
of substances,  but to the  notification  of "new"  substances.  Annex  IX  includes 
provisions  on  child-proof  fastenings  and  tactile  warning  devices  as  special 
packaging and labelling elements. 
I OJ 196, 16.8.1967, p.  I. Currently there are fifteen classes of  danger which, in addition to the initial classes, 
include extremely strong effects, such as  "extremely flammable"  or "very toxic", 
and less  immediate effects,  which only become  appa,rent  in the  long  run,  such as 
"carcinogenic", "mutagenic" or "toxic to reproduction" effects (CMR effects). Also 
"dangerous for the environment" is an integral part of the system. 
It is important to note that all the categories of danger refer to both substances and 
preparations.  Preparations  are  mixtures  of two  or  several  substances.  Details  on 
preparations are, however, included in Directive 88/379/EEC
2 on the classification, 
packaging and  labelling of dangerous preparations.  A proposal  for  a replacement 
Directive is at present under consideration in the European Parliament and Council. 
In order to classify a substance it  is  necessary to  determine  its  intrinsic physico-
chemical and toxicological properties according to the testing methods in Annex V 
of the Directive (or equivalent if deemed acceptable by expert advice), to place the 
substance into one or several classes of  dapger according to the provisions of  Annex 
VI  and  to  assign  proper  R-phrases  or  combinations  of R-phrases  to  it,  also  in 
accordance with Annex VI. 
The outcome of  the classification determines the labelling which has to be placed on 
the package containing the substance. The danger symbol(s) for the label are taken 
from  Annex  II  and the  R-phrases  are  the  ones  assigned  during  classification.  In 
addition, S-phrases pave to be selected according to Annex VI. 
The obligation to  label  a dangerous  substance according to the provisions of the 
Directive rests with the manufacturer, distributor or importer of such a substance, in 
short with the person responsible for placing the substance  on the market This is 
laid  down  in  Article  6  of the  Directive  with  reference  to  "existing"  substances, 
which are the substances that were on the market on or before  18 September 1981. 
However, "existing" substances only need to  be classified and labelled when they 
are known or suspected to be dangerous. 
For  "new"  substances  - substances  marketed  only  after  the  target-date  of  18 
September 1981  - the manufacturer or anyone else placing it on the market has to 
include  information  about  possible  dangerous  properties  of  the  substance, 
accompanied  by  the  appropriate  classification  and  labelling,  in  a  so-called 
notificatio.n  dossier  to  be  submitted  to  the  Competent  Authority  for  acceptance. 
Thus "new" substances have to be examined whether they are potentially dangerous. 
For  some  4500  "existing"· and  "new"  dangerous  substances  classification  and 
labelling have been harmonised in the Community and published in Annex I to the 
Directive  according  to  Article  4  (3).  To  agree  on classification  and  labelli.ng  of 
. "existing" substances  the  Commission regularly  convenes  a number  of Working 
Groups.  They  are  compo:sed  of experts  from  the  Member  States  and  normally 
consider 
the  effects  ori  human health,  in particular CMR effects,  in  the  CMR Working 
·Group.  Where  more  in-depth,  scientific· advice  is  required-in  order  to  reach 
2 OJ L 187, 16.7.1988, p.  14. 
2 agreement on-classification  and  labelling,  the  additional  ''Specialized  Experts 
Group" has to provide information; 
the effects on the environment in the Environment Working Group; 
the effects as  active  ingredients of pesticides in the  Pesticide Wo.rking  Group. 
Also  '.'new"  substances  are  considered  if they  exclusively  serve  as  active 
ingredients of  pesticides. 
The meetings of these four Working Groups are hosted by  the European Chemicals 
Bureau (ECB) of  the Joint Research Centre, totalling ~.bout ten meetings per year. 
For "new" substances,  except those  serving  exclu.sively  as  pesticides,  Competent 
Authorities  in  charge  of the  notification  system  agree  o~ the  classification  and 
labelling. Their meetings are  equally convened by the  ECB, about two  times  per 
year. 
A further obligation of  the Directive concerns the safety data sheet (SDS) according 
to Directive 91/155/EEC
3
, adopted in 1991  and modified by Directive 93/112/EEC
4
• 
Any person responsible  for  placing  a  dangerous  substance  on  the  market  has  to 
supply the. industrial user' with a sheet containing information relating to  the safe 
handling ofthe substance during storage, transport and disposal, such as infommtion 
abou~  hazards,  first-aid,  fire-fighting  and  accidental  release  measures,  and 
toxicol.ogical and eco-toxicological properties. 
1.2.  Notification of "new" substances· 
The distinction between "existing" and "new" substances was introduced by the  6th 
amendment of the Directive
5
,  adopted in  1979 and in force  in the Member States 
. since  1981.  Since  theh,  any  substance  to  be  placed  on  the  market,  whether 
dangerous or not, but not on the market on or before the target-date of 18 September 
1981, has to be notified by the manufacturer, distributor or importer to the national 
Competent Authority {CA). "Notification" includes the submission of detailed data 
about  the  production,  use ·and  intrinsic  properties  of the  substance,  including  a 
proposal  for  classification,  packaging  and  labelling.  Only  on  approval  of the 
notification dossier by the CA may the substance be marketed. 
Notification of a substance requires a considerable effort on the part of the nbtifier. 
The quantity of information to be  submitted depends on the  amount of substance 
which is placed on the market. If the yearly amount is  1  -ton to less than 10 tons, a 
"base set" of notification data have  to  be  submitted to  the  CA,  as  laid  down  in 
Annex VII  A to  the Directive.  The  base  set includes data  on the  identity of the 
substance,  such  as  the  molecular  formula,  production  figures,  proposed  uses 
including  exposure  estimates,  safety  measures  concerning  handling,  storage  and 
transport;  emergency  measures,  data  about  the  physico-chemical  properties,  th~ 
3 OJ L 76, 22.3.1991, p. 35. 
4 OJ L 314, 16.12.1993, p.  38. 
5 0JL259, 15.10.1979,p.10. 
3 
M toxicology and eco-toxicology of  the substance, information about the possibility to 
render it harmless and about  packaging.  In addition,  the notifier has  to  submit a 
· proposal for classification and labelling. 
For smaller amounts, fewer data have to be submitted, in accordance with Annexes 
VII  B  and  C  of the  Directive,.  but  for  higher  tonnages  more  in-depth  data  are 
required,  as  laid-down  in  Annex  VIII ·(level  1  and  level  2).  Limits  for  data 
requirements are at 10 kg,  100 kg,  1 ton ("base set" notification), 10 tons, 100 tons, 
and 1000 tons per year and manufacturer. In addition, the data pertaining to the next 
higher tonnage level have to be provided if  the total amount on the market exceeds 5 
times the yearly amount.  ' 
To allow for exceptions in special cases the introductory clause of Articles VII A, B, 
C  and  VIII  state  that "If it  is  not technically  possible  or if it  does  not  appear 
scientifically necessary to give information," the CA may agree that fewer data are 
sufficient for the notification at a certain tonnage leveL The "reasons shall be clearly 
stated and be subject to acceptance by the competent authority." 
In conclusion,  the  effort  prior  to  placing  a  "new"  substance  on  the  market  is 
cop.siderable. The  invaluable benefit of  the notification system is, however, that the 
approval by the CA of  one Member State makes the notification valid in ·au Member 
States. The notified substance may be marketed throughout the Community, without 
any further marketing hurdles. 
It is important to note that any placing of  a "new" substance on the market has to be 
notified,  whether  or  not  it  has  been  notified  earlier  by  another  manufacturer, 
importer or distributor. In this w:ay control is kept of  .  .  · 
the slight difference in composition or impurities that the same substance may 
have when synthesised by different manufacturers following different chemical 
pathways; 
- all  importers  who  place  the  same  sub$tance  from  the  same  third  country 
manufacturer on the market. 
Furthermore, a  manufacturer outside the European Union wishing  to  export to  a 
series of European Union importers may designate a "sole representative" according 
to  Article'  2  (1)  (d)  of the  Directive.  This  person  must  be  established  in  the 
Community and acts as  the notifier for. either all or some of the  importers of the 
specific  substance.  This  procedure  eliminates  or  reduces  unnecessary  multiple 
notifications and reduces the administration costs both for CAs and industry  .  . 
1.3.  EINECS and ELINCS 
In order to distinguish between  the  large  number of "existing" supstances  which 
were already ·on the market at the time of  the entry into force of the 6
1
h amendment 
to the Directive, on 18 September 1981, and the "new" substances ~hich would be 
placed on the market for the first time after this date, the 6th amendment required the 
Commission to compile the list. of "existing" substances, called European Inventory 
.4 of  Existing  Commercial  Chemical .Substances  (EINECSt  This  inve;ntory  was 
publishedin-1990 and collected over 100,000 entries. 
"New"· substances  have  to  be  listed  in the  European  List of Notified  Chemic~l 
Substances (ELrNCS), according to a Commission Decision of 1984
7
• This list shall 
be updated before 31  December of each year. by publishing the "new" substances 
notified before 1 July of  the same year. It currently comprises over 2,100 entries. 
1.4.  Risk assessment 
The 7
1
h  amendment
8 to  Directive 67/548/EEC, adopted in  1992 and in force  since 
'1993, added the risk assessment for "new" substances to the notification scheme. 
The  principles  of  risk  assessment  are  laid  down  in  Commission  Directive  . · 
93/67/EEC
9 of  1993~ iri force since that year. Risk assessment evaluates and weighs 
the danger that human health and environment face when exposed to the substance 
of concern. If exposure is high,  protective measures will have to  be  taken or the 
substance may even have to  be banned.  On the other hand, if the  e1.1vironment or 
parts of  the environment are not at all exposed to the dangerous substance, there is . 
no risk. In this sense risk assessment completes the information necessary for a high 
level of  protecti~n for human health and the environment. 
. The risk assessment of  a ''new" substance is prepared in three steps: 
- assessment  of the  toxic  effects  and  of the  dose-response  relation,  where 
appr.opriate; 
- assessment of the exposure to  workers,  consumers and man indirectly exposed 
vht the environment; 
-·description of  the risk for human health and for the environment. 
The description of  the risk ends up in one of  four conclusions to be drawn according 
to  Directive . 93/67/EEC.  They  reach  from  "no  concern"  to  "immediate 
· recommendations  for  risk  reduction".  Risk  management  puts  these 
recommendations into practice. 
According  to  Article  7  (1)  of Directive  67/548/EEC  the  notifier  of a  "new", 
substance. may  provide  a  preliminary  risk  assess.ment  when . submitting  the 
· . notification dossier to theCA, but the definitive assessment is prepared by the CA. 
It is important to note that for "existing;, substances the risk' assessment principles 
are contained in Commission Regulation (EC) 1488/94 of 1994
10
,  as a·consequence 
6 OJ C 146 A, 15.6.1990, p.  1. 
7 OJ L 30, 2.2.1985, p. 33. 
8 OJ t 154, 5.6.1992, p.  1. 
9 OJ L 227, 8.9.1993, p. 9. 
10 OJ L 161, 29.6.1994, p. 3. 
5 
1-{ of Council Regulation (EEC) 793/93
11  on the evaluation and control of the risks of 
"existing"  substances.  Howeve:r,  the  principles  on  how  to  prepare  the  risk 
assessment are virtually the same as for "new" substan<;es. 
.  . 
To  support  the  preparation  of risk  assessments  a  four  part  Technical  Guidance 
Document of over 700 pages has been published by the  Commission
12  in  1996. It 
provides scientific and technical details concerning the risk assessment preparation, 
such as  algorithms to  assess  consumer eposure,  guidance  on the use  of structure 
activity  relationships and  the  d·escription  of the  risk  assessment report  format.  It 
takes due account ofthe differences between "new" and "existing" substances. 
· 1.5.  Risk management 
Risk management issues are covered by Directive 67/548/EEC only marginally. If 
the risk assessment of  a "new" substance leads to the conclusion that "The substance 
is of  concern and the competent authority shall immediately ~ake  recommendations 
· for risk reduction" such recommendations may entail 
modifications to the classification, packaging or labelling; 
modifications  to  the·· Safety  Data  Sheet  prepared  according  to  Directive · 
91/155/EEC; 
modifications  to  the  recommended  methods  and  precautions  or  emergency 
measures, as delivered in the notification dossier; 
advice to the relevant control authorities  that they should consider appropriate 
measures for the protection of  man or the environment. 
True restrictions on the  marketing and use of dangerous  substances, however, are 
included in Directive 76/769/EEC
13  adopted in 1976 and in force  since  1978. The 
l4
1
h amendment
14  of  this Directive, adopted end of 1994 and applicable as from mid 
1995, stipulates that all substances of Annex Ito Directive 67/548/EEC classified in 
category  1  or  2  ,  of  the  classes  "carcinogenic",  "mutagenic"  or  "toxic  for 
reproduction" have to be assessed for their risks and advantages in order to propose 
restrictions  where  necessary.  Since  then  over  850  such  substances  have  been 
restricted and may therefore not be  used as  such or in preparations for the general 
public. They are listed in the annex to that Directive. 
Exemption is only made if such a substance is present at a very low concentration. 
This concentration limit is  laid  down in  Annex I to  Directive 67/548/EEC, and is 
11  OJ L 84, 5.4.1993, p. 1. 
12 Technical Guidance Document in support of Commission Directive 93/67/EEC on Risk Assessments for 
New Notified Substances and  Commission  Regulation  (EC)  No.  1488/94  on  Risk Assessment for 
Existing  Substances.  Parts  1 - 4.  Office  for  Official  Publications  of the  European  Communities,  .  . 
Luxemburg, 1996. 
13  OJ L 262, 27.9.1976, p. 201. 
14 OJ L 365, 31.12.1994, p.  1. 
6 agreed on the occasion of the  classificatio~ of the  substance for  that Annex. If no 
such  concentration  limit  appears  there,  the  "general"  concentration  limits  m 
Directive 88/379/EEC
15  on dangerous preparations appJy. 
Risk management aspects .also govern Directive 90/394/EEC
16
,  adopted'in 1990 and 
in force as from the end of 1992, on the protedion of workers from carcinogens. Its 
1
51  amendment
17  lays down that any substance which meets the classification criteria 
of Annex VI to Directive 67/548/EEC for a carcinogen of category I or 2 has to be 
.  considered  a  carcinogen.  This  definition  not  only  covers .substances  which  are 
intentionally  placed  on  the  market,  as  Directive  67/548/EEC  on  dangerous 
substances or Directive 88/379/EEC on dangerous preparations, but any substance 
which may incidentally appear at the workplace, for instance during a production 
process. A list of sucp substances including their occupational exposure limits is .in 
the annex to the Directive. It.is interesting to  note that the proposal for the second 
amendment
18  of Directive  90/394/EEC  also  includes  substances  which  fulfil  the 
criteria of Annex  VI  to  Directive 67/548/EEC for  a mutagen of category  I  or 2, 
since mutagens can be expected to show carcinogenic effects iri the human body. 
· A further example for the management of  risk is Directive 98/24/EC
19 of  April I998, 
to be. set in force in 2001  at the latest, on the protection of workers from  chemical 
agents  in  general.  This Directive considers substances  as  "dangerous" when· they· 
fulfil  any  of the  criteria  for  "dangerous"  laid  dowri  in  Annex  VI  to  Directive 
67 /548/EEC, whether or not the substance has obtained a harmonised classjfication 
and  labelling  under  that  Directive.  Also  dangerous  preparations  fall  under  the 
Directive. However, substances and preparations which are only "dangerous for the 
environment" are  exCluded,  since the  Directive is  restricted to  worker  protection 
issues. 
1.6.  Amendments and Adaptations to Technical Progress 
Amendments to the Directive 
At  the  time  of  adoption  of  Directive  67 /548/EEC  in  1967  the  date  for 
implementation of  its provisions was fixed at 1 January 1970. The 1st amendment to 
the Directive
20 related to the classification of certain dangerous substances and was 
also due to  enter into force at the beginning of 1970. However, due to  unexpected 
difficultie~  m  connection  with  the  implementation,  the  2nd  amendmene
1  set  the 
IS  OJ L 187, 16.7.1988 p.  14. 
16 OJ L 196, 26.7.1990, p.  1.  . 
17 0JL 179,8.7.1997,p.4 
IS OJ c 123, 22.4.1998, p. 21. 
19 OJ L 131, 5.5.1998, p.  11. 
20 OJ L 68, 19.3.1969, p.  1. 
21  OJ L 59, 14.3.1970, p: 33. 
7 implementation date forward to  1 January 1971, and, as this time limit proved to be 
·insufficient, the  3rd  amendmenf
2 prolonged the delay by a further year.  The  final 
date of  entry into force was therefore 1 January 1972.  . 
The 4th  amendment
23  was adopted in 1973 and Jntroduced the possibility to modify · 
the  Annexes  of the  Directive  by  an  "Adaptation to  Teclmical  Progress"  (ATP). 
Technical progress requires a rapid adaptation of the teclmical requirements of the 
Directive and the time-consuming preparation of an amendment was not considered 
suitable for this purpose. 
Whereas the  5th  amendment
24  laid down certain details of labelling,  a  major step 
forward  was  the  6th  amendment,  adopted  in  1979,  because  it  introduced  the 
notification system for "new" substances. It also provided for the establishment of 
EINECS,  the  list  of "existing"  substances.  Furthermore,  several  new  classes  of 
danger were added, including "dangerous for the environment". 
The  7
1
h  amendment,  of  1992,  essentially  required  that  the  principles  of risk 
assessment be laid down. It introduced the "sole representative" in the notification 
system, and added the Safety Data Sheet as a hazard communication facility for the 
professional  user.  Finally  the  g•h  amendmene5  replaced  the  term  "European 
Economic Community" by "European Comunity" in the Directive, to take account 
of  the modification of  the Treaty. 
Since the Directive is based on Article 100a of the Treaty, an amendment requires 
the  co-decision  procedure  bet\V(~en  European  Parliament  and  Council.  Such  a 
procedure may take two years under normal circumstances or half a year at least if 
quick agreement can be found. 
Adaptations of  the Annexes to technical progress 
Since the introduction of the "Adaptation to Teclmical Progress" (ATP) teclmique 
by the 4th  amendment to the  Dimctive in  1973  twenty-three technical adaptations 
have been introduced. Annex I was adapted 18 times, .whereas Annexes III, IV and 
VI were modified only 6 to 7 times. The other Annexes, namely II, V, VII, VIII and 
IX, were adapted less often. 
In principle the scientific and technical aspects of  the provisions in the Directive are 
discussed ·by  Commission  expert  groups,  of which  the  above-mentioned  CMR 
Working Group is the most prominent. The issues of  agreement are usually included 
in a Draft for a Commission Dire:ctive adapting Directive 67/548/EEC to technical 
progress. This Draft is submitted to the Regulatory Committee procedure according 
to  Article  29  of the  Directive, ·Where  distinction  is  made  between  the  A  TPs  of 
Annexes  I  (list  of  dangerous  substances  with  harrnonised  classification  and 
. 
22 OJ L 74, 29.3.1971, p.  15. 
23 OJ L 1'67, 25.6.l973, p.  1. 
24 OJ L 183, 14.7.1975, P: 22. 
2s OJ L 236, 18.9.1996, p. 35. 
8 labelling), III  (list of R-phrases),  IV  (list of S-phrases), V (test methods)  and  IX 
(provisions for child-proof fastenings and tactile warning devices), which follow the 
Ilia Comitology Procedure
26
,  and  the  ATPs  of Annexes  II  (danger  symbols),  VI 
(classification and labelling criteria), VII (information required for notification) and 
VIII  (additionar  information  required  for  .. notification)  which  follow  the  lllb 
Procedure. · 
2.  PRACTICAL OPERATION 
After 30 years of practical operation the Directive has generally proven effective in 
protecting  human  health  and  the  environment  against  the  hazards  of chemical 
substances placed on the  market.  The three  yearly report prepared  in ·accordance 
with Article 32 of the Directive confirms this assessment, even if there is room for 
.  . 
improvement. 
Classification arip  labelling, but  also  the notification of "new" substances provide 
informative illustrations of the effective practical operation of the Directive. Points 
requiring improvement shall be emphasised wherever necessary.  · 
2.1.  Classification and labelling 
.... 
Facts and figures 
"Moderately harmful" effects 
The fifteen  cla~ses of danger that the Directive defines  in Article 2 cover a wide 
range  of physico-chemical  and  toxicological  effects.  Substances  which  damage 
human health, in the short, middle or long term, fall into one of  three classes: "very 
toxic", "toxic" or "harmful". The divide between these classes and their boundaries 
. are determined by the criteria in  Annex VI  to the Directive. Therefore substances 
. which calise effects less than "harmful" are outside the scope. 
However,  during  the  review  of the  Directive  concerning  the. exemptions  in  the 
Accession Treaty of Austria,  Finland· and  Sweden
27
,  evidence  was  provided  that 
certain weak effects should be  taken on board.  If.  exposure to  a substance causes 
"dryness or cracking of the skin" or. "drowsiness or dizziness after inhalation", this 
should be ·signalled on the label. 
Thus, two new R-phrases will have to  be included by an Adaptation to Technical 
Progress by the end of 1998 in At1nex III, and their criteria for application and use in 
Annex VI. No additional category of  qanger is necessary, because these weak effects 
only need to  be taken  into  acc;ount  in  addition to  other more  severe  dangers of 
certain substances. 
26 OJ L 197, 18.7.19S7, p. 33. 
27 OJ C 241, 29.~.1994, p. 9. 
9 New "effects" 
Certain -new effects are causing concern but are  not yet covered by the Directive . 
. Immunological, net.iro-developmentallneuro-behavioural and reproductive/endocrine 
disrupting- effects  were  observed  in  connection  with· a  number- of pesticides, 
contaminants  and  other  chemical  substances.  Traces  of these  substances  can  be 
detected in the environment, from where they enter the food chain and subsequently 
may affect human health. Therefore they should be covered by the provisions of  the 
Directive. Inclusion of  these new effects would require one or several new classes of 
danger. 
Proper testing methods to detect  these effects, which are observed as a "by-product" 
during other investigations  are  not  yet available. ·However, first  efforts are  under 
way in Europe and in the United States. Once available for use, these methods can 
be  included in Annex V to  the  Directive.  Subsequently, classification criteria for 
these effects will need to  be developed for  Annex VI  and  the  necessary labelling 
elements introduced in Annexes II, III and IV. 
International harmonisation of  classification and labelling 
Acute toxic effects, well covered by the Directive, are at present under discussion at 
the Organisation for Economic Co-operation and Development (OECD). According 
to  the  present status of discussions  oral  effects will  be  divided  into  five  classes, 
which also cover acute oral effects weaker than "harmful" according to the meaning 
of Directive 67  /548/EEC.  If the outcome of the OECD  discussions is binding an 
amendment of the body of the Directive and the adaptation of Annexes II, III, IV 
and VI would be necessary. This would enlarge_ the number of substances covered 
by the Directive and enhance the protection of human health. 
Link with OECD testing methods 
OECD  also  establishes  testing  methods  for  dangerous  effects· for  use  in  their 
member  countries  once  such  me:thods  are  sufficiently  developed  and  approved. 
Development and approval of  the testing methods are actively supported by the EU 
Member  States,  who  are  membt:rs  of the  OECD,  and  the  Commission.  After 
approval the Commission normally proposes the OECD method to Member States 
for  inclusion  in  Annex  V  of Directive  67/54,8/EEC.  This  is  done. through  an 
Adaptation  to  Technical  Progress  and  does  not  pose  significant  problems  since 
Member States have already agreed on substance in the OECD. 
This ensures a high level of harmonisation between OECD testing methods and the 
methods  in Annex  V  and  eliminates  the  need  for  separate  developments  in  the 
Community, thus avoiding a duplication of  effort. Nevertheless the Community may 
also establish testing methods irrespective of  OECD developments. 
Activities  in the  Co~unity may  also  feed  back on OECD. activities.  Thus,  the 
Commission recently announced to OECD the  intention to delete a specific testing 
method for acute toxicity from Aimex V because this method requires a comparably 
large number of  test animals~ In addition, two further methods for acute toxicity are 
·available in the Annex.  To  keep  the  largest possible  extent of harmonisation the 
10 . Commission has requested OECD to  first delete the corresponding  OECD testing 
method: As a consequence OECD discussions are now under way. 
Classification of  "new" substances 
It is generally assumed that any chemical substance is hazardous. Environmentalists 
claim that the goal for the future should be  zero hazardous substances and that the 
notification scheme for "new" substances fails  to give  incentives to  develop non-
hazardous al temati  ves
28
• 
Yet an-overview in the.  three yearly report a·f the  740 "new" substances notified 
between  1994  and  1996  shows  that  on  average  only  70  % _were  clas~ified  as 
"dangerous". At the lower end of the scale were "new" substances for use in the 
p~ints ,industry,  the  lacquers  and  varnishes  industry
29
,  where  only  43  %  of the 
substances were classified as "dangerous". This is less than half of  the total number 
of  notified "new" substances. 
The highest percentage of  hazardous substances was found among the chemicals for· 
synthesis, which were "dangerous" in 88 % of  the cases. This is not surprising since 
substances have to be reactive, even "aggressive", if they are to function as building 
· blocks for other substances. 
Areas for possible improvement 
The  practical  operation  of the  Directive  over  the  last  few  years  has  revealed  a 
number of weclknesses, which mainly concern the structure and procedures of the 
classification, system and the compliance with the labelling provisions. 
Self-responsibility of  the manufacturer for classification and  labell~ng 
According to Article 6 of  the Directive "existing" dangerous substances not listed in 
Annex  I  have  to  be  classified  and  labelled  by  the  ma~mfacturer, distriblltor  or 
importer themselves. The self-responsibility only applies if an "existing" substance 
is known to  be.  dangerous or at the least is  suspected to  be dangerous.  Where the 
manufacturer  does  not  consider  the  marketed ·substance  to  be  dangerous  no 
classification or labelling are necessary. 
: E.ven if.this should ensure the protection of  health and environment from the hazards 
of "existing" dangerous substances the experience of Competent Authorities is that 
in certain cases 
/ 
28  Letter of Greenpeace international, European Unit, of 17  April  1998 to  Commissioner Bjerregaard, in 
connection with the Informal Environment Council in Chester on 24-26 April 1998. 
29  Notification  of New  Chemical  Substances  in  accordance  with  Directive  67/548/EEC  on  the 
Classification,  Packging  and  Labelling  of Dangerous  Substances  - Technical  Guidance  for  the 
Completion of a Summary Notification Dossier for a New Chemical Substance utilising the Structured 
Notification Interchange· Format (SNIF),  Base~set and Levels land 2. Office for Official Publications 
of the European Communities, Luxemburg, 1997 .. 
11 "existing" substances are not classified at all by the manufacturer, even if it can 
be re_asonably expected that they are potentially dangerous; 
"existing"  substances  not  listed  in  Annex  I  are  self-classified  by  different · 
manufacturers in a number of  different wa~s. 
The  self-responsibility  for  classification  and  labelling  of "existing"  substances 
should therefore be reconsidered as  well as  measures to  improve compliance with 
the provisions. This may include increased enforcement activities at Member State 
level. 
Harmonised classification and labelling 
Annex I of the Directive contains all substances where classification and labelling 
have been agreed for the Community, whether "new" or "existing". 
To reach agreement 
classification  and  labelling  of  every  recently  notified  "new"  substance  is 
circulated by the ECB _to  the national CAs with a minimum six month deadline 
for  confirmation  or  modifieation  ..  Under  this  procedure  classification  and 
· labelling of a range of notified substances is agreed before presenting them to an 
-Adaptation to Technical Progress (ATP) to update Annex I. Since the procedures 
for an ATP require approximately further six months a total of  one to two years is 
required on average· from acceptance by a nationai CA of the  classification and 
labelling proposal in the notification dossier until the entry into Annex I. 
the  CMR  Working  Group  discusses  the  available  toxicological  data  ·of  an 
"existing" substance during three meetings on average. The Group also takes into 
account special  data  and  views  that  industry  may  provide.  As  this  discussion 
process  takes  nearly  a  year  and  a  certain  number  of agreed  substances  are 
. collected before  presentc:ttiori  to  an A TP,  the  total  time  nec_essary  adds  up  to 
between one and two years. 
The  time  period  of one  to  two  years  to  update  Annex  I  for  both  "new" · and 
"existing" substances is unsatisfactory since potential users of  the substance are nc::>t 
officially informed during  this  period.  The delay may  even be  longer depending 
upon the .available resources. Questions should be raised on how to accelerate the 
updating of  Annex I. 
System of  R- and S-phrases . 
Aimex III  of the ·Directive  currently  contains  over  120  R-phrases  and  R-phrase · 
combinations.  Annex  IV  provides  almost  80  S-phrases  and  combinations.  The 
assignment  of these  phrases  and  their  combinations  to  dangerous  substances, 
following  the  criteria  in  Annex  VI,  is  subject  to  detailed  conditions  including.· 
·detailed  exemptions.  In  particular  S-phrase  assignment  can  be  "obligatory", 
"reconimended", "normallylimited to special cases'\ and so on. National experts in 
the  CMR  Working  Group,  where  classification  and  labelling  of  "existing" 
substances  ts  dealt  with,  have  indicated  that  the  system  has  become  extre!fiely 
.12 complicated and that a  fundamental revision of its practical· arrangements should be 
conside~ed to simplify the provisions. 
In. addition, the comprehension of the phrases by user~- should be assessed in order 
to ensure that the intended messag~  is clearly understood. 
,.  .  .; 
.  Enforcement 
During  the  inspection  of  100  companies
30  manufacturing  "new"  dangerous 
substances in the field of photochemicals, paints, intermediates, dyestuffs and paper 
. industry chemicals the classification of over 500 of  substances was examined. Since 
all substances were registered in Annex I of the Directive, selecting the appropriate 
classification and labelling should have. been an easy task. 
Howev~r,  the classification was not correct for 25 %-of the examined substances and 
over 40 % were not correctly labelled. These figures  should be considered rather 
high, since classification and labelling merely- had to be copied from Annex I. It is . 
therefore essential to reflect on how to lower this error rate. 
Since the responsibility for enforcement of classification and labeliing provisions 
rests with the Member States, it is necessary to e~amine whether national legislation 
should make manufacturers or anyone else placing a substance on the market, liable 
for any damage resulting from the "unillformed use" of  dangerous substances which 
are not classified and labelled according to the Directive. This would have to apply 
to 
all substances in Annex I and 
all  substances  classified  and  labelle4 · under  the  self-responsibility  of  the 
manufacturer according to Article 6 of  the Directive. 
It should further  be  considered  whether  a  substance  not classified  and  labelled 
according to the Directive should immediately be withdrawn from the market, either 
by the responsible entity having placed it on the market, or by national authorities. 
"New" substances not classified as "dangerous" . 
Whereas information on the classification and  labelling of substances which  are 
''dangerous"  are  publicly  avaihible  in  Annex  I  to Directive  67/548/EEC,  no · 
information is systematically compiled about substances which are  not classified. 
Since this concerns 30 % of  the notified "new" substances, it is not satisfactory that 
this information is not centrally stored except in the archives of CAs or the ECB. 
Ideas  sho~ld  be  developed. to  assure  that  this  information,  generated  under 
considerable efforts, remains available to stakehol~ers. 
·.  30 European inspection project Solid Enforcement of Substances in Europe (SENSE), Final report January 
1998. 
13 2.2.  Notification of "new" substances 
Facts and figures 
Number and countries of  notifications 
Shortly after 1981  when the notification scheme entered into force a dozen "new" 
substances  were  notified  per  year.  In  1996
32  over  350  "new"  substances  were 
notified  in  the  Community,  which  represents  an  average  of 1.5  substances  per 
working  day.  The  steady  increas'e  of the  yearly  number  of notified  substances 
dropped from 260 "new" substances in 1993 to 180 in 1994. This may be explained 
by the necessary· adaptation of notifiers to the entry into force of the 7
1
h amendment 
of the Directive in the autumn of 1993. But numbers rapidlyrecovered and reached 
a high point in 1996. 
Overall some 2100 "new" substances were notified up to date. Since the placing on 
the market of  a "new" substance has to be notified even if  it is already marketed by a 
different manufacturer, the total number of  notifications is 3800. 
By  country  the  largest  number  of notifications  was  processed  in  the  United 
Kingdom  and  in  Germany  with  some  25  %  each,  followed  by  France,  the 
Netherlands and Italy, each with about 10 %. 
By  origin of manufacturer,  non-EU  manufacturers  accounted  for  ±60  %  of all 
notifications  and  ±55%  of  all  notified  "new"  substances  and  were  almost 
·exclusively situated in Switzerland, Japan and the United States. This exemplifies 
that industry in other parts of the world is capable of coping with the provisions of 
the Directive. 
Areas for possible improvement 
The  notification  requirements  of the  Directive  are  deemed  too  restrictive  by 
industry, yet hostile to innovation. A further matter of  concern is the omission of the 
notification for "new" substances.  ·  · 
Innovation and competitiveness 
Industry continuously complains that the notification provisions of the Directive are 
too strict and stifle innovation.  They voice this opinion especially in  thiee areas: 
polymers, intermediates, resear~h and development. 
- Polymers .. 
32  71h Progress Report of the  European Chemicals Bureau of Directorate General "Joint Research Centre", 
1997, p. 10.  . 
14 Article 14 (2) of the Directive stipulates that every polymer which contains more 
than? % (by weight) of  a "new" substance must be notified. The requirements for 
the notifications of such polymers are laid down in Annex VII D of  the Directive, 
including special provisions to alleviate the testing burden. Thus, 
( 1)  the "family approach" places polymers \vith similar physico-chemical · 
properties into a group and toxicity testing is only necessary for one 
member. 
·  (2)  for  polymers  with  certain  physico-chemical  properties  a  reduced 
toxicity testing is acceptable.  · 
In  addition, a  Guidance Document on the polymer provisions was finalised  by 
Commission, . CAs  and  industry  in  1997
33
•  This  ·Guidance  interpretes  the 
provisions of  the Directive in the largest possible sense and will be in use until the 
year 2000, when it will be revised in the light of  the acquired experience. 
Industry  claims  that,  due  to  the· strictness  of provisions  for  the  notification, 
opportunities . to  develop  innovative  polymers  were  lost,  but  are  unable  to 
substantiate  these  claims.  It  may  be  that  industry  prefers  to  variate  the 
. composition  of "existing"  polymers,  in  order  to  make  further  use  of their 
production machinery and to avoid the risk of  failing in a costly notification. 
Notification data show about a dozen notifications· of "new" polymers per year 
since  1993,  when  Annex  VII  D  entered  into  force
34
•  This  represents 
approximately 3 % of  all notified "new" substances:· 
- Intermediates. 
Substances which appear temporarily during the numerous steps of  a synthesis are· 
called intermediates. If such an intermediate is processed in a factory other than 
the original one, it is "placed on the market" since it is made available to another 
manufacturer. This requires the usual set oftests to be carried out, as for any other 
substance placed on the market for final use by the public at large. 
Since an intermediate is· only handled by professional staff and on a controlled 
number  of sites, the exposure of man and the environment is limited. Therefore, 
industry  cla~ms that  a  reduced  test  set  would  be  sufficient  for intermediates, 
without lowering the level of  protection of  human health and the environment. 
Prop9sals ·on how to reduce testing for intermediates· are being discussed by the 
national CAs and with industry. In principle the testing requirements of the next 
lower tonnage level would appear ~o be sufficient for intermediates placed on the 
market  at  a  certain  level.  However,  it  is  not  yet ·entirely  clear  how "limited 
exposure" shall be assured. Discussions with the CAs are likely to be finalised by 
33  NOTIF/20/97, approved by the 54th  Meeting of the  Competent Authorities for New Substances on  15 
December 1997 in Brussels.  · 
H  Notification database of the European Chemicals Bureau (ECB). · 
15 the  end  of 1998  and  result  in  the  proposal  for  an  amendment  of Directive 
67  /548/EEC. 
· - .  Research and development. 
According to Article 13  (2) of the Directive "new" substances may be placed on 
the  market  in  a  quantity of up  to  100  kg ·per  year for  scientific  research  and 
development (scientific R&D), without any testing. For process-oriente_d research 
and development (PORD), the marketed quantity is unlimited, provided that the 
manufacturer respects certain conditions including a limited testing, but restricted 
to one year. Exceptionally this year may be extended for a further year by the CA. 
Industry claims that these  exe~nptions from the notification scheme are still too 
restrictive;  in  particular  the  one  year  limitation  under  PORD,  to  develop 
innovative·  substances.  The  CAs,  however,  feel  that  insufficient  use  has  been 
made of  the exemptions. Discus.sions with the CAs and with-industry have not led 
to a modification of the  Directive, but industry  keeps putting the issue on the 
table.  · 
In conclusion polymers, intermediates and  R&D  exemptions  are  the  three  main 
topics  where  industry  claims  that  alleviation  of the  current  requirements  of the 
Directive  is  necessary,  because  they  are  stifling  innovation.  On  an  international 
scale the chemical industry is voicing .these concerns in the framework of  the Trans-
Atlantic  Business  Dialogue  (T .t\.BD),  which  is  an  industry  driven  event  with 
participation of the chemical industry and the administration from both the United 
States and Europe. 
A recent  "Study ·on  the  impac:t  of EU  environmental  regulation  on  selected 
indicators  of  the  competitivem::ss  of  the  EU  chemical  industry"
35
,  however, 
concludes on the basis of empirical evidence, that the  strictness of environmental 
regulation is not a significant explanatory factor for the competitiveness of the EU 
chemical industry. The study asst!rts that environmental improvements can go hand 
in hand with an improvement of  the company's competitiveness. 
Circumvention_ of  the notification 
The inspection of±  100 compani(!S producing dyestuffs
36 revealed that almost 40 % 
of the  140 "new" substances examined had not been notified at all and were thus 
illegally marketed. A further, similar project showed, however, that only 5 % of  the 
233  "new" substances inspected were not notified. Especially the result of the first 
inspection project underlines the importance to enforce the provisions laid down in 
the Directive. 
Since the responsibility for enforcement rests with the Member States, it should be 
examined  whether  liability  for  any  damage  resulting  from the  use  of "new'' 
substances which are  not notified may not be  included in national  legislation.  In 
35 Sofres Conseil, Report for the European Commi.ssion, 1998. 
36 European inspection project on the Notification of  New Substances (NONS), Final report July 1996. 
16 addition non-notified "new" substances should immediately be withdrawn from the 
market by the manufacturer or anyone else who placed them on  the market or by 
nationaf authorities.  · 
Circulation of  notification dossiers 
After the· notification of a "new'' substance the dossier has to be circulated among 
national CAs in order to maintain the information on notified substances at the same 
level.  Since data must  be  kept  confidential the dossier is  transmitted through the 
Permanent Representation of the notifying CA's Member State in Brussels to  the 
ECB by diplomatic pouch, multiplied there _and transmitted back, via the receiving 
Member States' representations, to the other CAs. 
.  . 
This form of circulation takes 4 months for 50 % of the notification dossiers, and 
10 % of the dossiers. take· longer than one year. This is too  long for a number of 
CAs. Suggestions for  improv~ment  include 
direct electronic transmission between CAs and the ECB; 
. immediate circulation of the sumrilary information of a notification in  order to 
quickly identify repeat notifications; 
circulation of  notifications by ECB within 30 days. 
' 
These suggestions need consideration by Commission and CAs in the near future. in 
order to accelerate.the necessary flow of  information. 
Tonnage limits triggering data requirements 
.  ..  . 
· According  to  the  Directive  data  requirements . for  the  notification  of a  "new" 
substance depend  on  the· tonnage placed on the market.  According· to  Competent 
Authorities,  however,  certain  substances  such  as ·ingredients  for  cosmetics  inay 
require more data than provided according to their marketed volume. Consequently 
the link between tonnage limits and data requirements should be reviewed. 
Publication of  ELINCS 
The tist of  notified "new" substances ELINCS has last been published in 1994 and a 
new publication is being prepared for I<ite  1998. This is not in ~ccordance with the 
commitment to update  ELINCS  before  the end of every: year as  provided in the· 
above-mentioned Commission Decision establishing this list. It might be necessary. 
to reconsider the frequency and the .format of  publication. 
2.3.  Risk assessment 
Facts and figures 
Number and countries of  risk assessments 
During 1994 - 1996 almost 3  8  0 risk assessments for the "new" notified substances 
were  prepared  by  the  CAs  in  the  fifteen  Member  States.  "No  concern"  was 
concluded by over 50 % of the assessments, ±20 %·requested that the assessment be 
revised in the  light of the additional data on, the· substance. that the  manufacturer 
17 would have to provide when reaching the next higher tonnage limit. A further 20% 
of  the risk assessments required immediate collection of further information on the 
substance, less than 10 % made  :immediate "recommendations for risk reduction". 
Thus, a comfortable majority of 70 % of  all risk assesments expressed no concern or · 
only slight concern on the notified "new" sub~tances, only 30 % required imme~iate 
action. 
By  Member  State,  the  CA  of the United  Kingdom prepared  40  %  of all  risk 
assessments, Germany 30 %, France  15  %and the Netherlands 10 %.  Only 5 %of 
the risk assessments came from the remaining Member States. 
Coherence of  risk assessments 
In order to ensure a coherent outcome of risk assessments in all Member States the 
principles are laid down in Directive 93/67/EEC and detailed instructions are given 
in the Technical Guidance Document.  Even so, CAs from different Member States 
appear to differ in the interpretation of the guidelines, also the reporting format is 
not unique. However, these  dif:D:!rences  are  at present under discussion. within· the 
CAs and can be expected to be solved rapidly through the commitment of CAs to a 
uniform application of the guidelines. 
Risk assessment and notification 
An  example  for  the  role  of ·risk  assessment  in  the  notification  process  is  the 
notification of a substance for use as  a toner in laser printer cartridges. During the 
notific~tion process it became clear in the dialogue between the CA and the notifier · 
that the risk assessment would  iffil!lediately conclude the substance be withdrawn 
from the market. The intrinsic danger was much too high to tolerate the leaching of 
the  substance  from  printed  paper  into  the  water  during  paper  recycling.  As  a 
consequence the notifier \vith9rew the notification. 
Areas for possible improvement 
A  number of CAs  stressed  that  preparation  of a  risk  assessment  was  resource 
intensive and consumed too much time: Between one and two years are sometimes 
needed to complete the work.  In order to  alleviate the burden some CAs suggested 
that no ris~ assessment be prepared for 
substances not classified as "dangerous"; 
"new" substances notified with a reduced data set as laid down in Anexes VII B 
( 100 - 1000 kg/year or 500C  kg cumulative) and C ( 10 -.- 100 kg/year or 500 kg 
cumulative) ofthe Directive; 
substances placed on the market in quantities of  less than 10 tons; 
substances that would not be marketed within 1 to 3 years; 
site limited intermediates; 
substances intended for  cert~in use categories. 
18 The  underlying  tendency  Is  that  the  results  of the  classification  and  labelling 
exercis~ may. be  sufficient  to  appraise  whether  an  extensive  risk  assessment,  as 
required  by Directive  93/67/EEC,  is  neccessary.  This  approach  will  have  to  be 
discussed among Commission and Member States in the near. future. 
2.4.  Risk management 
Directive 67 /548/EEC includes an only rudimentary approach to  risk management. 
The  most  severe  conclusion  from  the  risk ·assessment  of a  "new"  dangerous 
substance according to Directive 93/67/EEC requires the notifier to  take action to 
lessen the risks to human health and the environment. 
An extreme  case  would  be  the  non-acceptance  ofthe notification  dossier by  the 
Competent Authority because of the  foreseeable  unacceptable risk that the "new" 
substance  presents.  Suggestions  were  made  by Competent Authorities  that  such 
"new" substances could be  c·ompiled  in  a  list  in  order to  avoid  that  subsequent 
· manufacturers submit notification dossier~ for the same suostance. 
The.main impact that Directive 67/548/EEC has on risk management lays in the link 
to Directive 76/769/EEC on the restrictions of marketing and use.  Half a year after 
publication of carcinogenic, mutagenic  or toxic to  reproduction substances  (CMR 
substances)  of category  1  or  2  in  Annex  I  to  Directive  67/548/EEC,  The 
Commission has tp submit a proposal to the European Parliament and the Council in 
order  to  pos·sibly  restrict  such  substances  under  Directive  76/769/EEC.  T~is 
proposal  has  to  take  account  of the  risks  and · advantages  of the  substances. 
Experience  has  shown  that  it  is  not  always  possible  to  meet  this  deadline,  the 
preparation of  the proposal to update Directive 76/799/EEC requires·more time. 
Where  dangerous  substances  requiring  restriction  measures,  such  as  the  above-
mentioned  CMR substances,  are  not  yet  covered  by  Directive  76/769/EEC they 
must be included by an amendment of this  D~rective by a European Parliament and 
Council Directive. The necessary co-decision procedure usually requires eighteen to 
twenty-four  months.  It  may  be  questioned  whether  such  a  procedure  can  be 
considered efficient to maintain a high level of protection for human health and the 
environment. 
2.5.  Structure of the Directive 
Directive 67 /548/EEC has been amended eight times after the adoption:in 1967 and 
its nine Annexes have been adapted to scientific and Jechnical progress twenty-three 
times. The dispersion among 32  pieces of legislation has made the .Directive very 
complex and makes the understanding of the complicated matter a difficult exercise. 
In addition the permanent adaptation of the Annexes requires a close follow-up by 
8?Y useL 
To  remedy  the  situation  the  Directive  was  informally  .consolidated  by  the 
Commission and made available  in English,  French,  German,  Italian,  Portuguese 
and Spanish in order to  cover the  most important languages in Europe and world 
wide.  The  consolidated  version  has  made  the  daily  work . With  the  Directive 
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• considerably easier, nevertheless the original texts are the ones that remain legally 
binding: 
The formal codification, which would officially assemble the multiple parts of the 
Directive ·and make it legally binding, ha:s  been severely hampered by  translation 
problems for Finnish and Swedish. In addition codification, by its official character, 
requires more efforts than the  informal consolidation. This is  especially important 
with regard to the permanent adaptations to technical progress. 
Some  provisions of the  Directive  are  almost  incomprehensible  because  they  are 
based on implicit expert knowledge, or need a clearer drafting, such as the definition 
ofpolymers in Article 2 (1) (c) or the 10-year-rule in Article 9. 
Another  aspect  that  complicates  the  understanding  of  the  provisiOns  is  the 
sometimes confusing structure of the Directive. Missing clarity makes it difficult for 
the beginner to  overview the manifold rules which are  laid down, and the trained 
user may overlook provisions which could be important for an actual problem. 
A  clear  structure  of Directive  67/548/EEC  is  even  more  important  because  the 
Directive  is  embedded  in  a  well-developed  network  of provisions  on  chemical.} 
substances. Provisions of  the Dir€:ctive 
are  "used"  by .other  Directives,  such  as  Directive  88/379/EEC  on  dangerous 
preparations or Directive 76/769/EEC on  the  restrictions on the marketing and 
use, or 
point  to  other  Directives,  such  as  Directive  93/67/EEC  on  risk- assessment 
principles or Directive '911155/EEC on the Safety Data Sheet, which are vital for 
the practical operation ofDire,::tive 67/548/EEC. 
· This  begs. the  question  whether  the  structure  of Directive  67/548/EEC,  when 
revised, would not benefit from the inclusion of  the provisions of some of  the other 
instruments dealing with chemical substances. 
3.  CONCLUSIONS AND RECOMMENDATIONS 
In  general  the  provisions· laid  down  in  Directive  67/548/EEC  have  proven 
satisfactory.  The requirement to 'classify dangerous  substances ~according to  their 
intrinsic physico-chemical and toxicological properties is undisputed.  The detailed 
classification system allows to take a large range of effects into account, whereby 
effective protection from the· multiple potential dangers· of chemical substances is 
possible. 
·The link with Directive 76/769/EEC relating to restrictions on the marketing and use 
has allowed to ban from use by the general public over 850 carcinogens, mutagens 
and  substances  toxic  to  reproduction  of category  1 and  2,  which  cause  special 
concern. The connection with Directive 90/394/EEC on the protection of workers 
from carcinogens controls the presence of carcinogens at the workplace when they 
are covered by the criteria ofDir,ective 67/548/EEC. 
20 Also  the  notification  of "new"  substances  is  accepted  by  all  stakeholders.  This 
provides  control  over  the  substances  prior  to  placing  them  on  the  market  and 
identifies the persons in charge. Acceptance also exist-s for the necessity to provide 
increasing  details  about  the  properties  of the  notified  substance  with  increasing 
amount of  substance placed on the market.  · 
However,  criticisms  have  been raised  over a  number  of points,  and  weaknesses 
detected. These concern 
Classification and labelling 
' 
the obligation of manufacturers to  self-classify and  label  "existing" dangerous 
substances; 
the  length  of procedures  necessary  to .  reach  harmonised  agreement  on  the 
classification  and  labelling  of dangerous  substances  and  to  publish  them  m 
Annex I to the Directive; 
the complex system ofR- and S-phrases; 
the insufficient enforcement of  the provisions for classification and labelling; 
the 'difficulty to trace the chemicals which have not been classified as dangerous 
under the Directive. 
Notification of  "new"substances 
the  hampering  of innovation  and  competitiveness  of the  chemicals  industry, 
especially in the fields of  polymers and intermediates and concerning exemptions 
for research and development;  -
,_  the circumvention of  the obligation to notifiy "new" substances; 
the  length of procedures  for  the  circulation of notification  dossiers  and  other 
information among the national Competent Authorities; 
the irregular publication of  the list of  notified "new" substances ELINCS. 
Risk assessment 
the outstanding efforts in personnel and time necessary to carry out a proper risk 
assessment. Risk assessment always "lags behind". 
Risk management 
there  is  no  adequate  follow-up  for  substances  classified  .  in  Annex  I  as 
carcinogenic, mutagenic or toxic to reproduction (category 1 or 2), even though  . 
the effects of  such substances are of  major concern; 
21 Structure of  the Directive 
the complicated structure of the Directive which has grown over more than thirty 
years through 8 amendments <md 23 adaptations to technical progress; 
the non-availability of  an officially consolidated version. 
To improve the practical operation of the Directive the following recommendations 
should be considered. 
Classification and labelling 
- Review of the obligation of manufacturers, distributors- and importers to. self-
classify and label "existing" dangerous substances. 
Acceleration of harmonised classification and labelling. Updating of Annex I 
on a twice-yearly basis. Review of  Annex I adaptation procedure. 
- Provision of  adequate expertise and resources in the relevant instances. 
Fundamental expert review of  the R-andS-phrase system. 
- Member S~ates to ensure the enforcement of  provisions. 
- Member States to consider liability as a means to improve compliance, and to 
consider withdrawal of  substances from the market in case of  non-compliance. 
- Commission to propose the establishment of a list of  substances which have 
not been classified as dangerous under the Directive. 
Notification of 
11new" substances 
- Polymers: A guidance document to  ease up  the notification of polymers has 
been agreed by Commission, Member States and industry. Revision foreseen, 
as appropriate, in about two years. 
Intermediates:  Improved  notification  scheme  currently  under  discussion 
between Commission and Member States. Input of  industry forthcoming. 
- Exemptions for research and deveiopment: Indu'stry to make better use of the 
existing possibilities for exemptions. 
Member States to ensure the enforcement of  notification provisions. 
- Member  States  to ·consider  liability  and  withdrawal  of non-notified  "new" 
substances from the market as means to improve compliance. 
- Accelerated  circulation of notification  dossiers,  possibly using  encrypted  e-
mail. 
22 - Review of tonnage  limits  triggering  data  requirements  for  notification  and 
possible inclusion of  further criteria for special cases. 
- Publication of the list of notified "new" substances ELINCS more regularly, 
possibly under a revised format.  ,, 
Risk assessment 
Risk assessments only for substances classified as dangerous. 
- Risk assessments  to  be  modulated  according .to  volumes  marketed,  with  a · 
minimum level of 1000  kg/year/manufacturer or a  total  of 5000  kg  on the 
market.Severity of  hazard is to be taken as the main qualifier, however. 
Special risk assessment conditions for site limited intermediates. 
- List of  "new" substances presenting an "unacceptable" risk. 
Risk management 
- Acceleration of  follow-up for substances classified in Annex I as carcinogenic, 
mutagenic or toxic to reproduction (category 1 or2). 
Structure of  the Directive 
- ·Restruct~ring of Directive to  give  it the  necessary clarity  and transparency, 
including provisions currently in other legal instruments, such as the principles 
of  risk assessment or the provisions on the Safety Data Sheet. 
23 Findings 
on 1the Operation 
of 
Directive 88/379/EEC 
on the approximation of laws, regulations and 
administrative provisions relating to the 
classification, packaging and labelling of 
dangerous preparations 
Annex 2 Table of  contents 
1.  - Background . 
1.1  Intro'duction 
1.2  Why a Directive on Dangerous Preparations ? 
1.3  Factors considered when drawing-up the Directive 88/379/EEC 
1.3 .1  Common . Points  between  dangerous  substances  and 
dangerous preparations 
1.3 .2  Differences  between  dangerous  substances  and 
preparations 
2.  Description of  Directive 88/379/EEC 
2.1  Scope 
2.2 .  Purpose-
2.3  Determination of  the Hazards of  Preparations 
2.4  Classification and Labelling 
2.5  Packaging of  Dangerous Preparations 
2.6  System for Specific Information (Safety Data Sheets) 
2.7  Compliance with the Provisions of  the Directive 
3.  Evolution 
3.1  Implementing Directives. 
3.1.1  Safety Data sheets for dangerous·preparations 
3.1.2  Child resistant fastenings- Tactile warnings 
3.2  Adaptations to Technical Progress 
3  .2.1  Classification and labelling of gaseous preparations 
3.2.2  Other adaptations to technical progress· 
4.  Evaluation 
4.1  Introduction 
4.2  Internal Market 
2 4.2.1  Pesticides 
4.2.1.1 
4.2.1.2 
Analysis of  the current situation 
Conclusions 
4.2.2  Preparations n<~t classified as dangerous 
4.2.2.1  Analysis ofthe current situation 
4.2.2.2  Conclusions 
4.3  Environment 
4.3 .1  Analysis of  the current situation 
4.3.2  Conclusions 
4.4  Practical Application of  the Directive 
4.4.1  Introduction 
4.4.2  Analysis of  the current situation 
4.4.3  Conclusions 
5.  Improvements 
5.1 ·  Proposal for a New Directive on Dangerous Preparations 
5.1.1  State of  play 
5  .1.2  Purpose of  the proposal for a new Directive 
5.1.3  Pesticides 
5  .1.4  Preparations not classified as dangerous 
5.1.5  Preparations dangerous for the environment 
5.2  Other Areas for Possible Improvements 
5.2.1  ·Enforcement 
5.2.2  Comprehensibility of  labels 
5  .2.3  Safety  Data  Sheets  for  Preparations·  not  classified  as 
dangerous  . 
5  .2.4  Intemation_al harmonisation of  classification and labelling 
of  chemicals 
5  .2.5  Technical issues 
3 1.  BACKGROUND 
2 
3 
4 
5 
6 
7 
1.1.  INTRODUCTION 
European chemical  industries  manufacture  and  use  a  large  number  of chemical 
products. 90 to 95% of all chemicals on the European market are preparations. The 
range  of uses  includes  industrial  chemicals,  such  as  solvents  and  coatings; 
petrochemicals,  including  fuels  and  lubricants;  agricultural .chemicals,  including 
pesticides and fertilisers; consumer products, such as detergents and  disinfectants; 
and many others. A majority of  these chemicals are of  low concern for human health 
or the environment but a significant proportion have properties which are hazardous 
either to human health and/or to the environment. 
Initially most legislation on chemicals  existed  at  national  level  but  considerable 
disparities between the national legislation of the Member States increased the need 
to introduce harmonised legislation on chemicals at European Union level. 
In 1967 the first Directive' concerning the classification, packaging and labelling of 
dangerous substances was adopted. 
Since 1969, in the context of a general programme dealing with the elimination of 
technical  barriers  to  trade,  particular  concern  was  given  to  the  classification, · 
packaging and labelling of  mixtures of chemicals (preparations). 
Up to 1988 the Council had adopted the following Directives concerning dangerous 
preparations:  in 1973  on solvents2.3,  in  1977 on prints, varnishes,  glues inks and 
related products4_5, and in 1978 on pesticides6_7. 
However, already since 1979 several Member States had envisaged methodologies 
for an overall evaluation of  preparations independent of  their area of  application. 
OJ L 196  of 16.8.1967 p.l 
OJ L 189  of 11.7.1973, p.7 
OJ L 229 of  30.8.1980, p.57 
OJ L 303 of28.11.1977, p.23 
OJ L 147 of6.6.1983, p.ll 
OJ L 203 of29.7.1978, p.13 
OJ L 88 of2.4.1981, p.29 
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1.2.  WHY A DIRECTIVE ON DANGEROUS PREPARATIONS? 
Towards  the 'end  of 1980  the  Cciuncil  of Ministers  of the  EEC  recognised  the 
advantage  of having  one  single  Directive  on  preparations  to  replace 'the  other 
existing Directives. As a conseque:nce it invited the services of the Commission to 
prepare an appropriate proposal..  · 
Directive 88/379/EEC& was adopted on 7 June 1988 and came into effect on 16 July 
1991. 
Objectiv~s · 
In 1988, the Directive had  two legislative objective:  . 
to · simplify  Community  legislation  on  the  classification  and  labelling  of 
dangerous  preparations  by  reducing  the · number  of  existing  directives  on 
individual  groups of  chemical preparations; 
- to meet fon;nal  requests from the Member States, to have an harmonised system 
applicabl~ to  all preparations which  the  Commission has  acknowledged  to  be 
justifi~d. 
The aim was therefore to classify and label all preparations according to a simple 
procedure  by  taking  into  ·  ac:cou:nt  the  degree  of hazards  they  might  present, 
irrespectively of  their uses. 
The objectives ofthe Directive are: 
to provide a high level of  protec:tion to persons who come into contact with such 
preparations , either at work or in private  (e.g.  at home),  by providing  a label 
giving essential  information on the hazards  involved and the precautions to be 
taken;  . 
- to  i~prove the functioning of the  Internal  Market by reducing the obstacles  to 
trade  of  chemical  preparations  that  anse  from  different  classification  and 
·I 
labelling. 
1.3.  FACTORS CONSIDERED WHEN DRAWING-UP THE DIRECTIVE ON DANGEROUS 
PREPARATIONS 
OJ L 187 of 16.7.1988, p.14 
5 The development of a directive on "general industrial " preparations did, however 
not mean that totally new legislation had to be set-up . ,Indeed, the progress made by 
. /  Community legislation on dangerous substances could be used as  a basis for this 
development.  Just  as  chemical  substances  form  the  ingredients  of chemical 
preparations, the dangerous substances Directive would logically serve as a basis for 
the dangerous preparation Directive. . 
lt is for  that reason,  that the  legislation  on  dangerous  substances  and  dangerous , 
preparations is so linked. Nevertheless, some· fundamental differences exist also and. 
need to be reminded.  ·  · 
1.3.1.  Essential  common  points 'between  the  Directives  on  dangerous 
substances and dimgerous preparations 
The  Dire~tive  on· the  classification,  packaging  and  labelling  of 
dangerous preparations is closely linked to Directive 67/548/EEC on 
dangerous substances and in particular on the following provisions: 
.  ..  .  .  ' 
. • .  the use· of  the same categories of dangers as defined in Article two of 
Directive  67/548/EEC.  Dangerous  preparations  are  classified  and 
labelled  on the  basis  of the  same  categories  of danger as  those 
applicable  to  dangerous  substances.  (e.g.  flammable,  irritant,  toxic 
etc.) 
•  the use of  the classification and labelling of  dangerous substances listed 
in Annex  I as well as their concentration limits, when speCified.··  · 
•  the use. of  the symbols and indication of dangers described in Annex 
II. Therefore, the symbols and the indications of danger described in 
Annex II to Directive 67/548/EEC apply also to preparations. 
•  the use of the nature of special risks (R phrases) listed in Annex III 
and of safety advice  (S  phrases) .listed  in Annex  IV to Directive 
67/548/EEC is also applicable to dangerous preparations. · 
·, 
•  the  use  of the  test. methods  described  i~ Annex  V to  Directive 
67/548/EEC when laboratory tests are performed on the preparations 
•  the use of the criteria to classify and label dangerous substances and 
· dangerous  preparations  contained  in  Annex ·VI . (Labelling . guide), 
· except when the ·classification of the preparation is carried out on the · 
basis of  the "conventional method". In this case solely the provisions 
of  the Directive on dangerous preparations applies. 
Because  of · the.  close  link  between  dangerous  substances  and 
preparations it must be underlined that any modification to the legal 
framework of·dangerous substances may have consequences for the 
classification of preparations and in. particular modifications to the 
labelling guide. (s.ee chapter on developments). 
6 1.3.2.  Key  differences  between  the  provzswns  of  the  directives  on 
dangerous substances and on dange~ous  preparations 
+The dangerous substances Directive uses a single system, based on 
test  methods, to determine the properties of the substances for  their 
classification and labelling under different categories of danger. 
The dangerous preparations Directive allows the use of 2 systems for 
the evaluation of health effects: 
- either the same as for substances (except for C, M ,T properties) 
or 
the use of  a conventional calculation method 
The reasons for this difference are: 
The  proposal  for  a  directive  elaborated  in  1983  provided  for 
derogation  . to  replace  the  detenriination  of  the  properties  of 
preparations  on  the  basis  of  laboratory  tests  by  a  theoretical 
assessment ofthe hazards. 
The approach pursued at the time anticipated the situation of today 
relating to the trade of chemical substances. The number of chemical 
substances  placed  on  the  European  market  until  September  1981 
(closing  date  for  the  European  Inventory  of Existing  Chemical 
Substances  EINECS)  was  100,106.  An  estimation  that  several 
hundreds new chemicals would be add€d each year to the number of 
substances already on the market indicated that the total  number of 
chemical substances was bound to  inflate with time.  On ·the basis of 
this  assumption,  it  was  estimated  that  the  number  of chemical 
preparations on the European market would at least be ten-times  the 
total number of  chemical substances. 
'  -
If all  preparations placed on the market were to  be dealt with in the 
same  way  as  substances,  under  the  provisions  of  Directive 
67 /548tEEC,  an  enormous  number of laboratory tests  would  have 
needed to be carried out to determine the hazardous properties of the 
preparations. This was  not acceptable for the following reasons:  . 
First from the financial burden point of view which  would have 
had to be born entierly by industry. 
Secondly,  from  an  economical  operators  point  of view;  this 
approach  would  have  resulted  in  sacrificing  the  potential  of 
SMEs' which play an  important role in this area of products of 
the chemical industry. 
7 - And  finally  also,  from  an  animal  welfare . point of view;  this 
approach would have necessitated ~e  use of to many animals for · 
. experimental purposes.  · 
The above important issues  advocated an alternative system for  the 
_ determination of the health effects of  preparations which is necessary 
for  their  classification  and  subsequent  labelling.  Therefore,  the 
establishment of  a ''conventional method " was well justified. 
+The  second ·important  difference  to  the  existing  legislation  on 
dangerous substances is the fact that no notification is required under 
the provisions ofthe Directive prior to placing  a preparation on the 
market. 
The reason for this difference is that: 
. The·  coricept  of new  and  existing  preparations  does  not  apply  to  · 
preparations·.  All  substances  both  .included  in  ELINCS  and  in 
EINECS are taken into account for the evaluation of  the hazards of  the 
preparations.  However, if  a preparation contains a new substance, the 
person responsible for placing the preparation on the  mar~et should 
prior to its placing on the market, notify this substance according the 
provisions ofDirective 67/548/EEC. 
Given the large number of preparations placed on the market and the 
possibility  for  industry  to  use  ·a  conventional  method  for  the 
determination ofhazardous·properties of  preparations as an alternative 
to testing,  . it  was  not deemed  crucial  by authorities to establish  a 
notification/authorisation . procedure  which  would  .  have  required  · 
considerable resources. 
8 2.  DESCRIPTION OF DIRECTIVE 88/379/EEC 
2.1.  SCOPE 
.  ·' 
The provisions of  Directive 88/379/EEC apply to preparations which contain at least 
· one  substances classified as  dangerous and which are considered to  be  dangerous 
within the meaning of  the Direc:tive. The exempted groups are : 
-a) medicinal or veterinary products as defined by Directive 65/65/EEC'9> 
-b) cosmetic products as defim:d by Directive 761768/EEC'Io> 
- c) mixtures of substances which, in the form of waste, are  covered by Directive 
,  75/442/EEC C11>  . 
-d) pesticides cover~d bX Dire<:tive 78/631/EEC'I2> 
- e)  munitions  and  explosives  placed  on the  market  with a  view of obtaining  a 
practical effect by explosion or a pyrotechnic effect 
- f) foodstuffs in a finished stage intended for final consumer 
- g) ~imal  feedingstuffs in a finished stage intended for final consumer 
-h) the carriage of  dangerous substances by rail, road, inland waterway, sea or air 
- i) preparations in transit which are under customs supervision provided they do not 
undergo any treatment or processing 
Normally, all the  exempted  groups  of preparations are  covered 'by  other specific 
Directives for the protection of health,  safety and the environment when they are 
placed on the market. However, the dangerous preparations Directive is regarded ~s a 
safety net for all preparations which are not more tightly regulated. 
It  must  be  underlined  that  the  Directive  on  dangerous  preparations  includes 
preparations intended for both industrial uses and the domestic market. 
For the .latter category of  users the Directive on dangerous preparations also provides 
for  special  labelling  requirements  for  preparations  which  are  not  classified  as 
dangerous but which owing to  their properties may present certain hazards to  the 
9 OJL.No 22, of9.2.1965 p.369/65 
r  10 OJL No 262, of27.9.1976 p.t69 
II OJL No194, of25.7.1975 p.39 
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9 users.  Examples  of such preparations  are  cyanoacrylate  glues  (instant  glues)  or 
paints containing lead derivatives. 
2.2.  PURPOSE 
The purpose of  Directive 88/3 79/EEC is to provide a legal instrument allowing to 
"  "  ' 
harmonise the  classification,  packaging and labelling  of  dangerous preparations 
pl&ced on the E.U. market. 
The aim is to protect both the professional users and general consumers as well as · 
the. environment from the hazardous properties of  dangerous preparations. · 
2.3.  DETERMINATION OF THE HAZARDS OF PREPARATIONS 
As. has  already  been  mentioned,  the  dangerous  preparation  Directive  is  a  legal 
instrument  that  requires  to  any  person  responsible  for ·placing  a  dangerous 
.  preparation on the market to classify,  package and  label it in accordance with its 
provisions. 
Providing that the manufacturer, the  importer or the  distributor; complies with the 
- requirements of.the Directive, he may place any dangerous preparation on the market  . 
without prior information to the national authorities.- . 
For .the  purpose of classification  with  respect  to  the  different  hazard  categories 
described in Article 2 of the Directive, the intrinsic properties relating to physico-
chemical ·and  health hazards  of the  preparation must be  evaluated.  The way this 
evaluation has t_o be c-arried out depends on the properties examined: 
- For  physico-chemical  hazards  deriving  from  explosivity,  flammability  or 
oxidisirlg properties, the evaluation must be carried out by using the test methods 
of  Annex V to Directive 67/548/EEC. 
•' 
- Regarding health effects; two options are available: 
• by using the test methods of  AnnexV to Directive 67/548/EEC 
• by the conventional method 
All health effects shall be assessed either by tests a.r by the conventional method. If 
the preparation has already been tested for some of  its properties, the results of  these 
tests are used for the classification of the preparation for those properties.  All other 
properties  have  to  be  assessed  by  applying  the  conventional  method.  However, 
properties as  carcinogenicity,  mutagenicity  and  toxicity  for  reproduction  should 
always be de~ermined by the conventional method, 
10 It is  important to  underline that when the  Directive was adopted, the  criteria for 
·classifying  a  substance  as  dangerous  for  the  environment  were  not  existing. 
Therefore, the evaluation of  environmental effects was not required for preparations. 
However, since that time, a new category of danger for the environment and criteria 
for the classification and labelling as dangerous for the environment have adopted 
for substances. Because of the _existing  link between the Directives this important 
change would  also  need  to  be  to  be  reflected  in  the  preparations  Directive.  (see 
evaluation 4.2.) 
2.4.  CLASSIFICATION AND LABELLING 
The classification of prep-arations,  denving from  the determination of the intrinsic 
properties of preparations,  is  performed by applying the criteria of the  Labelling 
Guide, Annex VI to Directive 67/548/EEC, and in addition by applying the rules set 
out  in  the  dangerous  preparation  Directive  in  the  case  where  the  conventional 
method is applied. 
The  conventional  method  is  based  on concentration  limits  applied  to  individual, 
classified substances. These 1:oncentration limits are: 
either  those  specified  in  .Annex  I  to  Directive  67/548/EEC .  for  the  substances 
included in this Annex, or 
these  specified  in  Annex I  to  the  Directive  on dangerous  preparations· where  the 
substance or substances do  inot appear in Annex I to Directive 67 /548/EEC or they 
appear in without concentration limits. 
The conventional method also takes into account the principle of additivity of some 
toxicological  properties.  In this  case,  the  mathematical  formulas  described  in the 
Directive can be used. 
The information deriving from the classification is used to determine the labelling by 
applying the rules of Article: 7 of the Directive of dangerous preparations. Article 7 
provides  for  the  appropriate  information  to  be  put  on ·the  label,  such  as  the  · 
identification of  the person responsible for placing the preparation on the market, the 
symbols and the indication of danger accompanied by the relevarit risk phrases (R 
phrases) and the safety advice (S  phrases) intended for safe handling and use of the 
preparation. 
In  addition,  the  labelling  must  also  take  into  account  special  requirements  for 
preparations described in Annex II to this Directive. These additional requirements 
are  mainly  intended  to  protect  the · general  public  from  the  hazards  of these 
preparations. 
In spite of the fact that the classification and labelling of dangerous preparations is 
carried out on the  basis of rules of the Directive on dangerous preparations,  it is 
important to  stress that the provisions of the Directive are intimately linked to the 
Community legislation on dangerous substances. 
11 2.5.  PACKAGING OF DANGEROUS PREPARATIONS 
The provisions for  the  packaging of  dangerci'us  preparations have been essentially 
taken from the Directive on dangerous substances. These provisions can be regarded 
__as  good  management  practices  and  are  not  specific  to  preparations.  During  the 
development  of  this. Directive,  specific  problems  of  packaging  relating  to 
preparations  have  been  identifi~d  such  as  child  resistant  fastenings  and  tactile 
warnings, which will be commented further down  in this Annex. 
2.6.  SYSTEM FOR SPECIFIC INFORMATION (SAFETY DATA SHEETS) 
·.When the Directive was adopted the authorities and the Commission were aware of 
the fact that the first information provided to the users, by a harmonised system of 
cla-ssification- and labelling of preparations,  ~as of course' of vital importance but 
insufficient in terms of safety with respect to  th~ir life cycle, especially regarding 
their manipulation, their use, their transport and their disposal. 
Therefore,  in  addition  to  the  information  provided  tQ  users· on  the  label,  the 
· dangerous  preparation  Directive .requires  more  detailed  specific  information  for 
industrial users such as  for example, first measures in case of fire or accidents, or 
storage  and handling,  in  th~ form  of  safety  data  sheets.  The  details  for  such 
information are set-up in a separate implementing Directive. 
2. 7.  COMPLIANCE WITH THE PROVISIONS OF THE DIRECTIVE 
The Directive places on the person responsible (manufacturer/importer/supplier) for 
the  placing  the  preparation  on  the  market  the  obligation  to  classify,  label  and 
package tqis preparations as  well as  to  compile and  submit a safety data sheet iri 
accordance  with  the  provisions  of this  Directive.  However,  the  Directive  is 
· addressed to the Member States who are responsible to take all necessary measures 
to ensure its correct implementation and enforcement. 
3.  EVOLUTION.· 
The evolution of the Directive on dangerous preparations took place very quickly 
after its  adoption for  two  essential reasons.  The first  one related to  requirements 
included in declarations made by the Council at the moment of  its adoption , such as 
the development of a conventional method intended for gaseous preparations. The 
second one related to technical progress such as particular labelling requirements for  · 
certain groups of preparations  (i.e~ elastomers) or specific packaging requirements 
12 intended to protect special target groups, i.e. children and blind or partially sighted 
people. All these developments have been made  eithe~ in the form  of amendments 
(imple_menting  dir~ctives) or as adaptations'to technical progress of  the Directive. 
It is  necessary  to  stress  at  this  point  that ·the  above  mentioned  adaptations  to 
technical  progress  were  undertaken  quickly  and  efficiently  following  a  simple 
comitology procedure set out in Article 15 of  the Directive. 
3.1.  . IMPLEMENTING DlRECTIVES 
3.1.1.  Safety data sheets for dangerous preparations 
It. ha5  been explained earlier that a  directive  impfementfng  safety 
data  sheets ·was  needed pursuant  the  provisions  of Article  10  of 
Dire.ctive. 88/379/EEC.  Directive  91/~55/EEC<IJ> was  adopted  only' 
three years after the dangerous preparations' DireCtive. This technical 
. directive specifies the conditions for which safety data sheets must be 
supplied for  dangerous  preparations to  industrial  users  and  their 
technical content. 
According to the Directive, safety data sheets have to be supplied to 
professional users for any preparation dangerous within -the meaning· . 
of Diret;tive. 88/379/EEC.  The  safety  data  sheets  are  aiming  to · 
warrant a high level  of protection by providing all the information 
required for  safe  handling  and· use of the preparations at the  work 
places. 
3.1.2.  Child resistant fastenings- Tactil~ warnings · 
the statistics  from  the poison centres of  the Member States  hav~ 
. shown  over  the  past  decades  that .  yo wig  children  remained  a 
particularly  exposed  target  group  to  dangerous  chemicals  and 
especially so for household products which fall under the provisions 
of  the dangerous preparation Directive. It wa5 felt appropriate by the 
authorities  and  the  Commission  that  this  problem  should  be 
addressed  in  the Directive by including special provisions for child · 
resistant fastenings. :Given that  blind or partially sighted people is  . 
also  a  target. group with special  needs  it was  also  appropriate  to 
introduce specific provisions for this case. 
These provisions called for an amendment to Directive 88/379/EEC 
in  a  first  step  by  Directive  90/35/EEC<I4>  and  an  adaptation  to  .  ' 
13 OJL No 76, of22.3.1991 p.35 
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13 technical progress  in  a second  step  by  Directive  911442/EEC  <Is>. 
Again it is important to stress the efficacy and the rapidity of these 
changes.  ·  · 
3.2.  ADAPTATIONS TO. TECHNICAL PROGRESS 
3.2.1.  Classification and labelling of  gaseous preparations 
Owing  to  their  physical  state  and  their  conventional  units  of  .  .  / 
measurement  differing  from  those  adopted  for  solid  and  liquid 
preparation~ ,  gases have to be treated as a separate case under the 
_provisions  of Directive  88/379/EEC.  After  consultation  With  the 
relevant  industrial  sector  and  discussions  at  Community  level, 
Directive  90/492/EEC<I6>  ~ontaining  additional  tables  With 
. concentration limits for the classification of  gases was adopted. This 
adaptation  to  technical  progress  contains  also  provisions  for  the 
. evaluation of  hazards deriving from physic~-chemical properties. · 
3.2.2.  Other adaptations  to technical progress 
In order to maintain consistency with the tec\mical developments of 
·. the Directive on dangerous  substances and , in particular with the 
.  Labelling  Guide  several  adaptations  to . technical  progress  were 
needed to the Directive on dangerOt1S preparations. 
Directives 93/18/EEC<17> and· 96/65/EEc<•s>·were adopted  in order 
to  introduce  criteria · for  the  classification  of the  -preparations 
containing substances affected by specific R-phra5es ( R 33,  R 64, 
R65).  .  . 
4.  EVALUATION 
' 
4.1.  INTimDUCTION 
After almost ten years  of practical  application  and  enforcement  by the  Member 
States,· the existing legislative framework on dangerous preparations has generally 
proven effective in gradually eli~inating the different technical trade barriers for the 
IS  OJL No 238, of27.8.1991 p.:i5 
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14 free circulation of  chemical preparations in the Community that arose from different  . · · . 
classification and labelling requirements. 
Harmonised  rules  for  the  classification;  packaging  and  labelling  of dangerous 
preparations together with existing rules on dangerous substances have contributed 
to the creation of  a comprehensive framework for chemicals, which is of  .paramount 
importance for the competitiveness of  the chemical industry.  · 
Directive  88/379/EEC  on dangerous  preparations pursued  a high  level  of health· 
standards through permanent  adap~ations to  scientific 'progress and  by taking into 
consideration newly emerging _effects related to the protection of human health such 
as Directive 96/65/EEC which introduces the classification of the preparations on 
the basis of  their aspiration haZard. 
.  . 
However, the Directive on dangerous preparations has shown to have a number of 
weak aspects and its implementation has given rise to a number of  problems.  These 
problems mairily_relate to the function of the Internal Market, the protection of the 
environment and to the practical application of  the Directive. 
4.2.  INTERNAL MARKET 
4.2.1.  Pesticides  (Plant  protection  products  covered  by  Directive 
91/414/EEC(l9)) and biocides covered by Directive 98/8/EC(20))).· 
4.2.l.l.Analysis of  the current situation 
The new harmonised authorisation process of pesticides which also 
includes  provisions  on classification,  packaging  and  labelling  laid 
down in the above mentioned Directives has brought to light the need 
for updating the legislation on classification, packaging and labelling 
of  pesticides. 
A study on the labelling of plant protection products, carried out by 
the  Commissio·n  services  clearly  demonstrated  that  differ.ent 
requirements in relation to  classification, packaging and labelling of· · · 
pesticides exist between Member States. 
In relation to the classification and labelling of pesticides for health · 
effects,  some  Member  States  use  the  provisions  of  Directive 
78/631/EEC and others apply the criteria of Directive 88i379/EEC. 
In some  cases,  Member  States  have  their  own  system  to  classify 
pesticides for other effects. 
Furthermore, depending on the Member States, the  transfer of the 
information on the label derives either directly from the classification 
19 OJL No 230, of 19.8.1991 p.l 
20 OJL No 123, of24.4.1998 p.1 
15 of the pesticides on the basis of their hazardous properties or results 
from  the risk assessment made by the competent authorities of the 
.·  Member States on the basis of  the intended use of the product. 
This  complexity  becomes  more  apparent  in the  way  that Member 
States classify and label pesticides for environmental effects. In this 
case,  both  classification  and , labelling  are  essentially  based  on 
national  criteria.  Whilst for  some Member States the evaluation of 
the  effects  of the  active  ingredients  on the  aquatic  environment is 
carried  out  on  the  basis  of the  criteria of Annex  VI  to  Directive 
67/548/EEC, _...the  evaluation  of the  effects  of pesticides  to  other 
compartments of  the environment is solely carried out on the basis of 
national legislation. 
The  packaging  requirements  for  pesticides  vary,  also  between 
Member  States.  In  general,  the  authorities  of the  Member  States 
require  that  packaging · is  made  according  to  the  provisions  of 
Directive·  78/631/EEC ... However,  some  Member, States  have 
introduced  particular  national  packaging  requirements  (i.e. 
requirement for child-resistant fastenings depending on the degree of 
hazards and the volume of  the package). 
For safety data sheets, some Member States apply the provisions of · 
Directive 911155/EECn for dangerous and even for some pesticides 
which  ·are  not  classified  as  dangerous  according  to  Directive 
88/3 79/EEC on dangerous preparations. Regarding submission of the 
SDS there are also differences between the Member States. In some 
cases  the  safety  data  sheet  is  provided  along  with the  registration 
dossier and in other cases there are no specific requirements. 
4.2.1.2.Conclusions 
On  the  basis  of this  analysis it is  obvious that differences do  exist 
between the Member States in relation to the classification, labelling, 
packaging and  submission of a safety data sheet of pesticides. This 
non-harmonised  situation  causes. ope.rational  difficulties  to  the  EU 
industry (e.g. same pesticide already authorised in one Member State 
have to be labelled in a different way_ to be pla_ced  ·on the market of 
. another  Member  State)  and  in  the  long  term  have  the  effect  of 
fragmenting the Internal Market by introducing obstacles to the free 
circulation  of these  specific  preparations  throughout  the  European 
Union. 
In  addition,  these  differences  may  also  lead  to  different  levels  of 
protection for both human health and the environment. 
16 4.2.2.  Preparations  not  classified as  dangerous  under  the  scope  of the 
existing legislative framework on dangerous preparations. 
4.2.2.l.Analysis of  the current situation 
Some Member States have introduced  into their legislation some of 
the  provisions  of the  existing  legal  framework  - notably  those 
concerning packaging, labelling and the submission of a safety data 
sheet for  some preparations that  are not classified  as  dangerous in 
order  to  improve  the  existing  level  of health  and  environmental 
standards. 
It must be stressed that this  issue concerns a lot more preparations 
than dangerous preparations. 
4.2.2.2.Conclusions 
Such  national  legislative  provlSlons  may  have  the  effect  of 
jeopardi_sing in the long run the achievement of the internal market 
for  chemical preparations and raise the  issue of a possible conflict 
between  national  measures  to  protect  human  health  and  the 
environment and  the free  movement of goods.  Also  these concerns 
have  been  reinforced  by  the  exemptions  granted  to  Sweden  and 
Austria under the Accession Treaty. 
I 
This  situation  which  was  also  re-enforced  by  the  fact  that  non-
classified preparations may  have a potential  risk to  health and the 
environment led the Commission to act at EU level.  This point will 
be developed in the following chapter. 
4.3.  ENVIRONMENT 
Classification criteria/or preparations "dangerous for the environment" 
4. 3.1.  Analysis of  the current situation 
Directive  88/349/EEC  classifies  preparations  as  dangerous  on  the 
basis of  their physico:.chemical properties and of  their health effects. 
During  1992-1993  two  Directives  (Directive  92/32/EEC(2 1>  and 
Directive  93/21/EEC!22>  were  adopted.  The  first  one  introduced, 
among other elements, a new category of hazard:  dangerous for  the 
environment. The second introduced criteria for environmental hazard 
21  OJL No 265, of 18.10.1996 p.15 
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17 classification 'as well  as  risk and safety phrases for  the  labelling of 
chemical substances. 
As · a  result  of these  two  Directives,  efforts  were  made  by  the 
Commission  and  the  Member  States · with  the  aim  of  finding 
appropriate  approaches  to  develop  rules  on  environmental  hazard 
classificati~n and labelling of  preparations. 
These efforts have,.  to  a great extent, been fostered  by  the need to 
establish  a  system  of criteria  for  environmental  classification  of 
preparations that is uniform, i.e.  that identical criteria be used for all 
categories  of preparations,  irrespective  of their  function  or  their 
practical  uses  and  to  guarantee  a  high  level of protection  for  the 
environment. 
In  a  general  sense,  it  was  obvious  thht  information  on  the 
environmental effects of  preparations is of  fundame~tal importance, if 
the users are to take account of  the hazards to the environment in their 
choice of products.  It was also essential to guide the users to handle 
the  preparations  in  a  correct  way  and  to  dispose  of them  in  an 
environmentally acceptable manner. 
This  information  is  most  readily  provided  _.,by  labelling  the 
preparations  and  by  compiling  safety  data .  sheets  for  preparations 
intended for industrial uses. 
4.3.2.  Conclusions 
The  Commission  was  required,  therefore  to  propose  Union-wide 
criteria for  classification  and  labelling  of chemical  preparations·  as 
dangerous  for  the  environment which deal  with  the  hazards  to  the 
. environment  whlle  assuring  the  free  circulation  of  chemical 
preparations within the Internal Market. 
4.4.  PRACTICAL APPLICATION OF THE DIRECTIVE 
4.4.1.  Introduction  / 
Until  the  adoption  of  Directive  88/379/EEC  on  dangerous 
preparations  major  differences  between  Member  States'  national 
measures concerning labelling of  dangerous preparations existed. 
The  objectives  of  the  Directive  were  therefore  to  achieve· a 
harmonised level of protection for human health by giving the same  . 
information through the label to all users across the European Union 
and to ensure equal competitive conditions for the chemical industry 
throughout the Internal Market. 
18 . 
_) 4.4.2.  Analysis of  the current situation 
Responsibilities for operating and en-forcing the Directive 
Obligation of  the person responsible for placing a preparation on the 
market 
According  to  the  existing  provisions  of the  current  legislative 
framework,  in  particular  articles  3  and  7  of  the  Directive 
88/379/EEC,  the  principle  of  the  so-called  self-responsibility 
applies.  This  means  that  the  obligation  to  classify  and  label  a 
preparation is placed on the person responsible for placing it on the 
market whether they are the manufacturer, distributor or importer. In 
addition, it is the obligation of  the manufacturer/importer/distributor 
to communicate the information on the dangero.tis properties of the 
preparation  to  the  professional  users  through  the  compilation  of 
safety data sheets. 
Obligation of  the Member States 
According to this Directive, it is the obligation of the authorities of 
the  Member  States  to  assume  overall  responsibility  for  the 
implementation  of this  legislation  and  to  provide  the  necessary 
controls and penalties to ensure that the legislation is being complied 
with fully  and properly by the person responsible  for  placing the 
preparation on the market (enforcement). 
Furthermore, Directive 88/379/EEC provides to  the Member States 
the possibility to take actions, which they consider appropriate and 
feasible  within  their  legal,  economic  and  political  national 
framework, against preparations which constitute a hazard to human 
health and the environment although satisfying the requirements of 
the Directive (safeguard clause). 
Problems identified in this area 
It  can  be  reasonably  expected  that  some  preparations,  although 
having  dangerous  properties,  are  not  classified  at  all  by  the 
manufacturers or that they are  classified and  labelled by  different 
manufacturers  in  different  ways.  This  occurs  because  of lack  of 
understanding or lack of expertise, especially in smaller companies 
and because of  different interpretations of  some rules. 
Another problem may be that the enforcement of this legislation is 
given different emphasis in different Member States.  For example, 
some  Member States may enforce  passively (i.e.  by  investigating 
only  complaints)  whereas  others  may  be  more  proactive  in  their 
surveillance  of products  on  their  market.  The  penalties  for  non-
compliance may also be different. Problems of compliance resulting 
in  different  labels  for  the same preparation occur in  all  Member 
States. 
19 Comprehensibility of the label 
One of the fuQdamental  objectives of the Directive is to provide all 
users with the same information through the label. The main benefits 
of uniform labels are that all users  are afforded the same  level of 
protection and  that  industry  has  to  meet  with the  same  labelling 
requirements across the European Union. 
'  However,  it  is  critical  that the information contained in  the  label 
actually penetrates  all target groups (consumers, professional users, 
manufacturers, authorities and medical staff).·  A preliminary study 
carried  out  by  the  Confederation of Family  Organisations  in  the 
European Community )  COF  ACE  indicated that current labelling 
provisions may not achieve this objective. Although  this study was 
limited  in  scope.  it  clearly  highlighted  the  heed  for  further 
investigation. 
A better understanding of the comprehensibility of this information 
among  EU  Member  States  is  a  pre-condition  for  cost  effective 
labelling requirements.  Seen·  i~ the broader perspective of ensuring 
the  protection  of the  general  public,  it  is ·closely  linked  to  the 
following questions : 
•  do users read the labels ? 
•  do they understand the information on the label ? 
•  does the  information make them behave in a way which reduces 
personal risks? 
•  do they get the information they need ? 
•  do they want more information or another kind of  information ? 
•  should the same information be presented in a different way ? 
Other practical issues 
There  are a number of technical issues to  be  addressed which the 
implementation of  Directive 88/379/EEC has revealed: 
1.  Metals/alloys 
There  is  no  definition  on, the  alloys.  The  question  therefore  on 
whether  an  alloy  should  be  considered  as  a  substance  or  a 
preparation  is  still  open.  This situation creates  uncertainty  to  the 
industry who  does  not know if Directive on dangerous substances 
applies or the one on dangerous preparations. 
20 2. Poison Centres 
The role of the  poison centres· needs .to  be  clarified.  The  Member 
States  implement  the  provisions  of article  12  of the  Directive  in 
different ways. The kind of  information required to be submitted  by 
the  person responsible  for  placing  on the  market  a preparation. to 
these centres varies between the Member States·. 
3. Preparation/article 
There is no  definition allowing to  distinguish between preparation 
from article. Member States apply different rules and thus the free 
circulation of  certain products is not guaranteed. 
4.4. 3.  Conclusions 
There is a need to  review all the areas covered under this chapter. 
Problems relating to the practical application of  the Directive should 
be  solved  in  order  to  create  a  transparent  and  precise  legal 
framework  for  both  the  Member  States  and  industry  to  operate. 
Correct implementation of the Directive will safeguard a high level 
of protection for human health and the environment.  In relation to 
the information contained in the labels there is a need for an in-depth 
analysis of the  relation between  the  national  background  and  the 
comprehensibility of  this information. 
4.5 International Harmonisation 
The summit in Rio iri 1992 adopted a programme of  action for 
sustainable developp1ent which includes a section on the international 
harmonisation of classification and labelling systems for chemicals. 
An Intergovernmental Forum on chemical safety (IFCS) has been 
established under the UN to supervise this programme. 
The programme has first started with the exercise on the 
harmonisation of  classification criteria for dangerous substances.  This 
exercise, of paramount importance for the trade of  chemicals 
throughout the world, is aiming to provide and int~rnationally agreed 
system for the classification and labelling of  substances. 
However this process is slow.  For example discussions on the 
harmonisation of  the end-points on acute toxicity in the Organisation 
for Economic Co-operation and Development (OECD) started in 1993 
and are stilton going._ The reasons for this include complexity of  the 
technical issues involved and the fundamental differences between 
Member. countries approaches. 
Recently a similar exercise for dangerous preparations was launched 
at the OECD. 
21 5.  IMPROVEMENTS 
. 5.1.  PROPOSAL FOR A NEW DIRECTIVE ON DANGEROUS PREPARATIONS 
5.1.1.  State of  play 
•  The proposal (COM(96)347  final) !23)  for a European Parliament 
and Council Directive on classification, packaging and labelling of 
dangerou~ preparations  was  adoptc;d  by  the  Commission  and 
subsequently  submitted  to  the  European  Parliament  and  the 
Council on 18
111  July 1996 
•  The Common Position following the first reading at the European 
Parliament was adopted on 24 September 1998 
5.1. 2.  Purpose of  the proposal for a new Directive 
In  generar the  purpose  of the  new  Directive  is  to  harmonise  the 
legislation .  on  classification,  packaging  and  labelling  of dangerous 
preparations and at the same time to ensure a high level of  protection 
for both human health and the environment. 
Following  the.  analysis  carried  out  in  the  forgoing  chapter  4: 
"Evaluation" the  new proposal was  basically introduced in  order to  . 
provide Union-wide solutions to the problems related to the Internal 
Market and the environment. 
Furthermore,  this  proposal  will  recast  existing  rules  of ·Directive 
88/379/EEC on classification, packaging and labelling of dangerous 
preparations,  its  adaptations  to  technical  progress  as  well  as  its 
implementation Directives.  In  this  way  the  Commission  puts  into 
practice the principle to simplify existing Community legislation and 
thus  make  ·this  legislation  more  easily  understandable  by  all 
interested  parties  involved  (authorities,  industry  and  finally  the 
general public).  . 
5.1. 3.  Pesticides 
Provisions  for  classification,  packaging  and  labelling  of pesticides 
are·. introduced  in~o the  scope  of the  new Directive.  The  present 
Directive 78/631/EEC on  classification,  packaging and  labelling of-
pesticides  has  raised  criticisms  on  a  number  of points  and  its 
weaknesses  has  been proven as  it  covers only  dangerous  physico  .. 
, chemical properties ahd acutely toxic properties. 
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?I The  new  Directive  takes  into  consideration  all  the  dangerous 
properties for the classification and labelling of pesticides similar to 
all other chemicals covered by the Directive. 
The proposal for the  classifica~ion and labelling of pesticides will be 
the  responsibility  of the  manufacturer;  however,  the  final  decision 
will be  taken in  the context of the authorisation procedure of these 
preparations  by  the  competent  authorities  for  the  Member  States 
applying the rules of the new Directive. The new Directive will not 
affect specific Community legislation in relation to the authorisation 
procedure of pesticides (plant protection products and biocides). The 
proposal also includes provisions in relation to safety data sheets for 
pesticides. It places the obligation on the manufacturer to  compile a 
safety data sheet which will have to  be submitted with all the other 
information to the competent authorities for the authorisation of  these 
chemicals.  Lastly,  a  practical  consequence  of the  inclusion of the 
pesticides  in  the  new Directive will  be  that  Directive  78/631/EEC 
will be repealed. 
Therefore,  the  objective  to  ensure  equal  competition  rules  among 
firms  producing  pesticid~s, to  estaolish  a  real  Internal  Market  for 
these chemicals and to introduce a high level of environmental and 
health protection will be guaranteed. 
5.1. 4.  Preparations not classified as dangerous 
The new Directive extends the  application of certain  provisions to 
preparations  which  although  not  classified  dangerous  within  the 
meaning of  the Directive, may present a danger to the user. 
According to the new Directive the person responsible for marketing 
preparations not  classified as  dangerous  for  professional  users  will 
have  to  compile  and  submit on request  a  safety  data  sheet  to  the 
recipient of  the preparations. 
Safety  data  sheets  giving  detailed  information  about  the  chemical 
composition and  the  dangerous  properties  of the  preparations,  as 
well as precautionary measures for use, shall be submitted on request 
also for  preparations not classified as  dangerous but which contain 
1 % or more of substances dangerous for health or the environment, 
or substances for which there are Community exposure limits at the 
workplace.  This  information  is  needed  by  the  employers  and  the 
economic  operators  to  take  the  necessary  measures  to  protect  the 
employees at the workplace. 
It  should  be  mentioned  that  this  provision  would  not  affect  the 
legislation of  the Member States concerning worker protection at the 
work place.  It  defines the obligations of the person responsible for 
the marketing of  such preparations. There is a link, however, between 
the  proposed  Directive  and  the  Community  legislation  for  worker 
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by the person responsible for marketing a preparation will be used by 
the employer in accordance with the existing and specific legislation 
issued for the protection of  workers. 
5.1. 5..  Preparations dangerous for the environment 
The new proposal for a  directive introduces a transparent and easy-to-
use methodology for the classification of preparations  dangero~s for 
the  environment.  A  similar  approach  to  the  one  used  for.  the 
classification of preparations dangerous for human health is used for 
the classification of  preparations dangerous for the environment. 
The. classification of a preparation as dangerous. for the environment 
is,  normally  carried  out  by  applying  the  conventional  method. 
However,  under  certain  conditions  the  acute  toxicity  for  aquatic 
organisms can  also  be  determined by applying the  test methods of 
Annex V to 67/548/EEC. 
In that respect, the provisions of  the new directive are consistent with 
the  rules  developed  earlier  in  the  case  of  health  effects  of 
preparations. 
The  conventional  method  is  based  on  the  classification  of the 
substances and their concentration limits in the preparation. 
The  proposed  approach  is  considered  as  theoretically  logical  and 
scientifically justified. In addition, the total fraction of preparations 
being classified as dangerous for the environment on the basis of  this 
proposal and on the basis of the assessment carried out using national 
product register  does  not  seem to  be  significantly higher than  the . 
total  fraction  classified  as  dangerous  for  human  health.  In  other 
words, ~he criteria introduced for the classification of  the preparations 
as dangerous for the environment guarantee a high level of  protection 
of the environment  as  the  criteria for  human health  en~ure a high 
level of  protection for health .. 
Furthermore, the  label of a preparation will  inform users about the 
dangerous properties of a preparation and give advise for the safe use 
of the preparation.  The warning symbol for substances dangerous for 
the environment will also be used for preparations dangerous for the 
environment. 
24 5.2.  OTHER AREAS FOR POSSIBLE IMPROVEMENTS 
The  Commission  is  convinced  that  the  new  proposal  for  a  Directive  on 
classification, packaging and labelling of dangerous preparations is a rather 
satisfactory  basis  and  an  important  step  to  tmprove  EC  legi~lation  on 
chemicals. 
However,  there  may  be  other  ways  of further  improving  the  legislation 
pertaining  to  the  area  of  hazard  assessment  of  chemical  preparations. 
Proposals which have been put forward,  and which ~he Commission believes 
merit further discussion, include : 
•  reinforcing enforcement ~echanisms  at national level 
•  studying comprehensibility ofthe labelling requirements 
•  developing  a  system  for  the  compilation  of  safety  data  sheets  for 
preparations not classified as dangerous 
•  introducing  a  harmonised  system  for  the  classification  of dangerous 
preparations at United Nation  level. 
•  revtewmg  some  technical issues to  improve practical application of the 
Directive 
5.2.1,  Non- compliance and Enforcement 
The  Directive  88/379/EEC  as  well  as  the  future  proposal  for  a 
directive requires manufacturers, importers and suppliers of chemical 
preparations to  carry out a hazard  assessment,  to  package, to label 
and  to  compile  a  safety  data  sheet  for  their  products.  This  basic 
. hazard  information  obtained  by  the  original  manufacturer is  made 
available  either ·to  subsequent  users  to  enable  them_  to  take 
appropriate  measures  to  reduce  the  risks  at the workplace  or it  is 
addressed directly to the general public. 
This requirement should be considered by industry as a real challenge 
and  should  increase  the  self-responsibility  of  manufacturers, 
importers or suppliers of chemical preparations.  Already, examples 
such as the establishment of an  environmental management system 
(based  on the  international  standard  ISO)  at  companies  level,  are 
emerging  where  companies  have  re-evaluated  the  requirements  of 
their  customers and  made  changes which resulted  in an  improved 
service,  increased  competitiveness  and  lower  impact  of chemical 
preparations on the human health and the environment. 
However self-responsibility of industry  needs to  be  coupled with a 
mechanism  for  auditing  and  controlling  companies.  Enforcement, 
therefore, becomes a growing focus of  attention in this context. 
When the proposed directive is  adopted Member States will also be 
responsible  for  enforcing  the  new  provisions  concerning 
25 classification  and  labelling  fo~ the  environment.  It is  therefore 
essential that_ Member States should take  all necessary measures to 
improve their monitoring and control J;Ilechanisms,  for  example by 
strengthening their inspection systems and by taking administrative 
and  judicial  measures,  in  order  to  ensure  that  this  legislation  is 
properly implemented and eventually epforced. 
It is important for  the Commission to  identify the causes of delays 
and non-compliance by  Member States and where necessary ensure 
that the Member States_ take the appropriate measures to remedy the 
situation. 
'Another possible  option to  improve  compliance  is  to  increase  the 
.legal liability for industry so that they are responsible for accidents to 
occur  as  a  result  of not  applying  correctly  the  Directive  (i.e.  not 
labelling  or  wrong  labelling).  However  this  system  of  self-
enforcement could result in disproportionate legal or insurance costs 
for SMEs, and needs to be examined thorou~hly. 
5.2.2.  Comprehensibility of  labels 
.  The issue of how to improve understanding of  the information on the 
label  of.dangerous  preparations  by  the  receiver  is  crucial.  In this 
·context, the  following  are  some of the  questions which need to  be 
addressed such as : 
•  What will be the benefit or risks of simpler information ? 
•  What  will  be  the  added  value . of more  common  and  easily 
recognised names of  chemical compounds? 
•  Will more information lead to decreased comprehensibility? 
•  How  can  general  education,  specific  training  and  increased 
awareness  (environmental,  consumer,  health)  be· an  effective 
method to improve comprehensibility? 
The answers to  these questions should be  analysed in order to  find 
concrete ways to improve the existing situation, if  necessary. 
In  view  of the  central  importance  of this  issue,  the  Corrimission 
initiated a major study on the comprehensibility of labelling in 1998 
and has given its  commitment to  report to  Council on the  findings 
within  two  years  after  adoption  of the  proposed  directive  .  on 
dapgerous preparations.  The. findings would also have implications 
for the labelling provisions for the dangerous substances directive. 
26 5. 2. 3.  Safety Data sheets for preparations not classified as dangerous. 
The new proposal for a directive on dangerous preparations introduces 
the obligation for the manufacturer, importer or supplier of  a "non-
dangerous" preparation to provide a safety data sheet to the 
professional users. (This issue was explained under point 5.1.4) 
However there are many such preparations on the European market. 
Establishing and updating full data sheets may be costly, may entail a 
disproportionate burden to the producers  which also includes a lot of 
SMEs  and a great load of  follow-up work  for the enforcement 
authorities. Among the producers, SMEs may have particular 
difficulties because often they do not have the necessary technical or 
human resources. 
There is, therefore, a need for the Commission to examine this issue 
and to amend the "Safety Data Sheets" Directives to take into account 
the principle of  proportional information before the implementation 
date for the new proposal of  the directive on dangerous preparations. 
5. 2. 4.  ·  Internationql  harmonisation  of ·classification  and  labelling  of 
chemicals. 
A world-wide system of  classification and labelling of  preparations, 
both for safe transport and safe use it is highly desirable and it would 
at the same time improve safety and facilitate international trade. 
Because of  the magnitude of  the task, its potential trade implications 
and safety benefits and the fact that it can only be accomplished 
through international efforts, this exercise should be given the highest 
priority and necessary resources. The Commission and the Member 
States should reflect on how the on-going process which is rather slow 
at this moment could be further improved and accelerated. 
5.2.5.  Technical issues 
The Commission and the Member States should discuss all technical 
issues  such  as  alloys,  articles  and  the  role  of the  poison .  centres 
which create practical problems with the application of  the Directive 
with view of finding  acceptable  and  operational  solutions  to  these 
problems.  An  option  is  to  establish  a  Guide  to  Dangerous 
Preparations Directive which will address all  these  issues and  their 
respective  solutions.  This  guide  will  be of outmost  importance  in 
particular for the SMEs. 
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ii 1.  INTRODUCTION 
The  Council of the European Communities, in approving the Fourth Community 
Action Programme on the Environment (1987-1992), stated that one of the priority 
areas was the evaluation of  the risks to·the environment and human health posed by 
chemical substances.  This Action Programme underlined the need for a legislative 
instrument, which would provide a comprehensive structure for the evaluation of  the 
risks posed by "existing" chemicals. In particular, the Action Programme stated that 
such a legislative instrument "will establish a  procedure for 'treating priority lists of 
chemicals for immediate attention,  as well as  setting out the means for  gathering 
information,  requiring  testing  ·and  evaluating  the  risks  to  people  and  the 
environment". 
As  a  result  the  Commission  considered  there  was  an  urgent  need  to  introduce 
regulatory measures in this area, since a harmonised approach to risk evaluation and 
control of "existing" chemicals would provide the basis for  a high and  consistent 
level of protection for man and  the environment throughout the  Community  and 
would  in  addition  prevent  the  fragmentation  of  the  Community  market  for 
chemicals. 
In 1989, during the negociations of the 8th amendment to Directive 76/769 on the 
restrictions  on  the  marketing  and  use  of  certain  dangerous  substances  and 
preparations, the Council recognised that the control of chemical substances should 
be based on the evaluation of  their risks to :nan and the environment. 
In the  Organisation  for  Economic  Co-operation  and  Development  (OECD),  the 
importance  of the  work  carried  out  on  "existing"  chemicals  had  already  been 
recognis~d with the  1987 Decision-Recommendation of the OECD Council on the 
Systematic  Investigation  of Existing  Chemicals.  This  OECD  Act  stated  that 
"Member  Countries  should  establish  or  strengthen  national  programmes  to 
systematically  investigate  existing  chemicals".  In  1988  the  OECD  launched  an 
extensive programme on "existing" chemicals, in  which some EC  Member States 
were alre~dy active. 
At  the  end  of 80s,  a  general  overview  of the  Community  situation  showed 
considerable  disparities  in  the national  legislation  concerning  chemicals  in  the 
Member States. It therefore became necessary to introduce uniformity in the internal 
market as  well  as  to  guarantee  a  co-ordinated  approach  towards  a  high  l~vel of 
protection to man and the environment. 2.  OBJECTIVES OF THE REGULATION 
Council  Regulation  (EEC)  793/93  on  the  evaluation  and control  of the  risks  of 
existing substances was adopted on 23  March 1993  and entered into force  60 days 
after its publication in the Official Journal of the EC, on 4 June 1993. It is based on 
Article  1  OOA  of the  Treaty  and  is  generally known as  the  "Existing  Substances 
Regulation". 
Regulation 793/93 aims at the protection both of man from exposure to  dangerous 
. substances via all possible routes and of all the compartments of the environment. 
"Man" comprises in this context "worker, consumer and man via the environment". 
The basic principle of  the Regulation is that controls on hazardous chemicals should 
be based on an assessment of the actual risks to human health and the environment, 
rather than the hazardous properties of the substance only.  This approach, based on 
sound science, was supported by Industry and the other stakeholders. 
The choice of legal instrument was determined by the need for quick and uniform 
action on "existing" chemicals in the Community.  · 
It was important to have a centralised system for data reporting and collection and a 
single, consistent picture for each chemical.  This required Industry to organise itself 
and to provide consistent and joint data for each specific chemical. 
Thus, the Regulation introduces procedures for 
•  the collection of data on "existing" substances produced in or imported into the 
Community; 
•  the preparation of lists of priority substances for which the need for assessment is 
greatest; 
•  the assessment of  risks; and, 
•  the identification of  any measures needed to control those risks. 
In  order  to  make  the  Regulation  fully  applicable  a  number of steps  had  to  be 
completed,  the  most  important  of  which  was  the  adoption  of  Commission 
Regulation (EC) No  1488/94 of 28  June  1994, which lays down the principles for 
the  assessment  of risks.  This  Regulation  entered  into  force  60  days  after  its 
publication in the Official Journal ofthe EC. 
One of  the purposes of the Regulation was to ensure that each substance is assessed 
on the basis of the same criteria.  The Regulation was also designed to  encourage 
that a Member State would not notify its intention to restrict the marketing and use 
of a chemical without carrying out a risk assessment according to principles agreed 
by all Member States.  Thus, _the  Regulation introduced a  coherent and  consistent 
system for evaluating the risks  related to chemical substances, which is  applicable 
throughout  the  Community  and  at  the  same  time  avoids  fragmentation  of the  -
Internal Market. 
2 The EU work conducted under Regulation 793/93  is co-ordinated with "existing" 
substances  work  done  in  the  Organisation  for  Economic  Co-operation  and 
Development, which contributes to Chapter 19 of  Agenda 21. 
Overall, the Regulation: 
•  provides a  comprehensive system to  determine possible risks from  "existing" 
chemicals and related measures for reducing those risks; 
•  is not intended to rapidly manage urgent or emerging new problems for those 
"existing" substances which are not already on the priority lists; 
•  ' is not intended to cover the risk assessment and the corresponding risk reduction 
measures of harmful  "existing"  substances which are  not industrial chemicals 
and are controlled by other legislative instruments. 
Substances covered by tlze Regulation 
Regulation 793/93 sets up a programme designed to identify and. control the risks 
posed by some of  the  1  00,106 chemical substances in the  European Inventory of 
Existing  Commercial  Ghemical  Substances  (EINECS).  EINECS  is  a  closed 
.inventory and it serves, in the  first instance, Community-wide as  a  legal tool for 
distinguishing "existing" from "new" chemicals. 
EINECS was drawn up by the European Commission in application of  Article 13 of 
Directive  67/548,  as  amended by Directive  79/831,  and  iri  accordance  with the 
detailed  provisions of Commission  Decision  811437.  It lists  and  defines  those 
chemical  substances  which  were  on the  European  Community  market  between 
1 January  1971  and  18  September  1981.  In  terms  of Article  1(4)  of amended 
Directive  67/548,  these  are  substances  to  which  the  pre-marketing  notification 
provisions of  the Directive do not apply. 
EINECS includes 
•  industrial chemicals; 
•  substances  produced  from  natural  products  by  chemical  modification  or 
purification,  such  as  metals,  minerals,  cement,  refined  oil  and  gas  and  their 
products including pitch;  · 
•  substances produced· from animals and plants, such as lanolin, turpentine, rosin oil 
and resin acids, except where they are used solely in foodstuffs; 
•  food additives; 
•  ingredients or active  substances of pesticides, fertilisers,  medicaments, such as 
aspirin and paracetamol, and cosmetic products; 
•  monomers; 
•  natural polymers; including natural rubber and starch; 
•  some waste and by-products, including some by-products of processed coal, such 
as coke and emil tar pitch. 
3 EINECS does not include 
•  synthetic polymers (these are  registered in EINECS under-their building blocks, 
monomers);  ·  · 
•  intentional mixtures; 
•  medical  preparations,  cosmetic  preparations  and  pesticide  preparations  as 
intentional mixtures; 
•  food, feedstuffs; _ 
•  alloys, such as stainless steel, but includes most individual components of  alloys; 
•  most naturally occurring raw materials, including coal and most ores. 
It is  important  to  note  that  EINECS  represents  appr'oximately  0,006%  of the 
16 million substances  which  have  been  attributed  a  Chemical  Abstracts  Service 
Registry Number (CAS RN) by the Chemical Abstracts Service, which identifies the 
substances referred to at least once in the scientific literature.  On the other hand, 
EINECS probably overstates the number of substances c·ommercially significant by 
at least a factor 4. 
For  "new"  substances,·  those  chemicals  marketed  after  18  September  1981,  a 
notification procedure  was  established  tinder  Directive  79/831,  which  is  the  6th 
amendment  to  Council  Directive  67/548  on  the  approximation  of  laws  on 
classification,  packaging  and  labelling  of dangerous  substances.  This  requires 
notification of "new" substances to Governments before they are marketed.  Council 
Directive 92/32, the 7th amendment to Directive 67/548, introduces the requirement 
to  carry  out  risk  assessments . for  every  "new"  substance .  notified  under  this 
Directive. 
Reporting and collection of  information 
.  Since it would not be" possible  t~ try to collect the information and to evaluate the 
risks for all "existing" substances, the Regulation makes a distinction in approach in 
terms of  the quantities produced or imported of  the substance. 
Thus, the Regulation provides for a systematic approach for  "existing"  substances 
produced or imported in quantities in excess of  10 torui.es/year;_ for the substances of 
smaller production or import. volumes, the  collection of information and  the risk 
evaluation are carried out on a case-by-case basis. 
Approximately 70 "existing" substances -ranging from Vitamin A and castor oil to 
limestone,  nitrogen  and  carbon  dioxide.- do  not  require  reporting  because  it  is 
generally supposed that there are no risks associated with them.  They are listed in 
Annex II to the Regulation.  The Community_ may decide, at a future date, to request 
information to be reported on any of  these substances, but this would only be done if 
there  were  valid  reasons  to  believe  that  the  substance  presents  a  serious  risk to 
people or the environment. 
4 The syste'matic approach for  the  collection of information provides for  a step-by-
step procedure that includes as: 
-PHASE I 
the collection of information to be submitted by Industry, for those substances of 
a relevant production or import volume - in excess of 1000 tonnes/year - which 
are included in Annex I,  as  a pragmatic list of High Production Volume  (HPV) 
substances.  For these  substances,  a complete  data set had  to  be  submitted by 
manufacturers or importers over a  12-month period, ending in June  1994.  This 
pragmatic step was chosen, since it could be  implemented more  quickly  and it 
took  into  account  the  work  already  done  in  s9me  Member  States  and  would 
therefore avoid duplication of work arid waste of  resources~ 
- PHASEII 
the systematic collection of  information for all other substances of a production or 
import volume in excess of 1000 tonnes/year, which do not appear in  Annex I. 
For these substances a c.omplete data set had to be submitted by manufacturers or 
importers over a 24-month period, ending in June  1995~ 
-PHASE III 
the systematic collection of information for substances of a production or import 
volume  between  10  and  1000  tonnes/year  (Low  Production  Volume  (LPV) 
chemicals).  For these substances a limited declaration form had to  be submitted 
by manufacturers or importers within a period of 24 months, starting from  June 
1996 and ending in June 1998. 
Data on some 1500 substances were delivered during the' first of  these phases.  Data 
on some 1000 substances were delivered during the second phase. The processing 
of the information for  phase III  is  ongoing. It is  expected, though,  that  between 
15,000 to 20,000 substances will be notified in this phase. 
The data reporting from manufacturers and importers represents an  important and 
necessary step as it gives to  the authorities a complete picture of the Community 
market in HPV and LPV "existing" substances. 
Data includes 
•  the name of  the substance; 
•  produced and/or imported quantities; 
•  classification and labelling information under Directive 67/548; 
•  reasonably foreseeable uses; 
•  physico-chemical properties; 
· •  tox;icological and ecotoxicological properties. 
In this phase of data reporting, chemical companies are allowed, when appropriate, 
to present jointly substance-related data, in order to avoid any ~uplication of  work. 
5 
.. 
,• A preliminary analysis of the data submitted, shows that there are substantial_ data 
gaps in- the knowledge of the  effects of these HPV chemicals.  The Commission 
services are currently carrying out a detailed study to confirm the initial findings. 
For substances of  lower volume  - exceeding  10  tonnes/year but not greater than 
1000  tonnes/year - a  smaller information  package is acceptable.  The  data to  be 
submitted includes 
•  the name of  the substance, 
•  produced and/or imported quantities, 
•  chtssification and labelling information under Directive 67/548, 
•  reasonably foreseeable uses . 
. The information about the properties of the substance, behaviour and effects .do not 
require reporting.  In a subsequent stage on the basis of the experience gained with 
the HPV substances, it will be ·decided what other data are necessary for the priority 
setting. 
Potential number of  substances for assessment under the Regulation 
The data provided by Industry under Regulation 793/93 shows that of the 1  00,1 06 
substances listed on EINECS, on the market there are approximately: 
•  2,500 HPV chemicals (1,000 tonnes/year or more); and, 
•  between 15,000 to 20,000 LPV chemicals (10 to 1000 tonnes/year). 
The remaining 80,000 or so substances are produced or imported in quantities of  less 
than 1  0 tonnes per year or are not traded at all. 
According to Industry there are 
•  1  ,000 HPV substances; and, 
•  200 LPV substances, 
which are potential candidates for a risk  asses~ment under Regulation 793/93, but 
these figures need to be verified.  This of course excludes substances primarily used 
as active ingredients of  pesticides and medicaments, for example. 
Therefore, when the concept of  "the burden of  the past" is referred to, in terms of  the 
actual number of "existing" substances on the market covered by Regulation 793/93; 
Industry's estimated figure is  1,200. 
Until  now,  of the _100,106  EINECS  substances,  approximately  3,000  (2,150  if 
generic  entries  excluded)  have already  been classified as  dangerous  and  labelled 
accordingly.The  classification  is  based  on  physico-chemical  and_  toxicological 
properties, on specific_ effects  on  human health and  environmental effects.  These 
substances are listed  in Annex I  of Directive 67/548  and others_ are  continuously 
examined and added to Annex I.  The total number of substances listed in Annex I, 
"new" and "existing", is currently approximately 4500. 
6 Form and content of  information 
The  Community decided that information should to  be  submitted in computerised 
form,  since this enables large  volumes  of data on. thousands  of substances  to  be 
handled quickly and consistently. 
All these data are collected by means of diskettes, using a special software package, 
called  HEDSET  (Harmonised  Electronic  Data  Set),  and  stored  in  the  IUCLID 
(International Uniform Chemicals Information Database), former EUCLID, managed 
by the Commission.  The diskettes, together with guidance notes and the address for 
reporting information, are available free of  charge from the Commission Offices. 
The data set represents an important tool since it facilitates the selection of priority 
lists of substances that require priority attention because of their possible effects on 
man and the environment. 
Confidential information 
· IUCLID is publicly available with the exception of confidential information. Some 
of  the reported information inay be commercially sensitive and should therefore not 
be accessible to  competitors.  Companies  are  required  to  inform the  Commission 
about  the  data  that  should  be  treated  as  confidential  and  the  reasons why  its 
disclosure would harni them industrially or commercially. _ 
Additional information on reported substances 
Once a company has reported information on a substance, the report is to be updated 
•  when  new  uses  of  substance  lead  to  substantial . changes  in  human  or 
environmental exposure to it; 
•  when  new  information  on  its  properties  or  effects  could  influence  the 
Community's view on its potential risk; 
•  every three years, if the amount produced or imported is no longer in the volume 
range that the company reported. 
If  there are reasons to believe that the substance may pose a serious risk, Industry 
can  be  asked  to  report  further  information,  including  additional  testing.  This 
requires  a  formal  decision of the  Regulatory  Committee under Article  15  of the 
Regulation. 
If  a  company is  aware that an ·  EINECS  substance,  produced or imported  in· any 
quantity by it,  may present a serious risk to  human health or the  environment, it 
must inform the Commission services, even if it has not previously reported on the 
substance.  '  -
7 Priority lists 
Due to the large number of substances covered by the Re.gulation, a priority setting 
approach was adopted. 
The Regulation, however, does not define the system to be used in drawing up the 
lists  of priority  substances,  since  the  Commission  considered  that,  given  the 
changing scientific nature of. this area,  it was  more appropriate· to  remain flexible 
and to leave this task to the Commission services and the Member States by means 
of the  Regulatory Committee procedure.  Work being carried out in other fora or 
under other Community legislation as well as previous work under such programs or 
legislation are to be taken into consideration.  · 
I 
It should be noted that, given the deadlines imposed by the Regulation, the first list 
, had to be published before June 1994 and no repprting was required until then.  The 
first  list  was  then  prepared  in  an  empirical  fashion,  by  considering  national 
proposals in the light of  work carried out under other programs.  The same approach 
was used for the second -and third priority lists.  From 1999, the lists will be drawn 
up agreed by the Regulatory Committee using the priority-setting scheme foreseen 
by the Regulation (see below). 
The Regulation sets out the factors to  be ·taken into account in drawing up priority 
lists.  The  information provided  by companies  will  be  given ·a set  of scores  by 
computer. 
A substance may obtain high scores if, for example, 
•  it is produced in large volumes;  • 
•  it is used in a dispersive way rather than, say, in a few sealed systems; 
•  it stays in the environment for a l_ong  time without breaking down into harmless 
substances; 
•  it is highly toxic to humans, animals or plants; 
•  it has chronic effects; 
•  it is carcinogenic, toxic to reproduction or mutagenic; 
•  little is known about its properties, uses or effects.  -
Substances will be ranked for  assessment on the basis of these and  other.factors, 
such  as  assessments  already  carried out  for  OECD  or other international  bodies. 
However,  such  an  automated  system  is  only  a crude  indicator.  The  process  will 
therefore  require an evaluation by  experts.  The  Commission and Member States 
·will thus ensure that substances do not appear on a priority list unless they are of 
significant ~ontem. 
-Some  substances  may  have  undergone  an  equivalent  assessment under other EC 
legislation.  They will not be  assessed again under the Regulation. · For example, 
substances, which are used mainly as pesticides, are  not considered for  listing on 
priority lists under this Regulation. However, "existing" substances, which_are, for 
example,  used  as  active  substances  in  plant  protection  products  as  well  as  for 
industrial purposes, will be considered under both  ~irective 911414  and Regulation 
793/93. 
8 The  Commission  has  published  each  priority  list  in  the  Official  Journal  of the 
European Communities.  If a substance produced or imported appears on a priority 
list, the companies concerned are required to provide further information. 
Mixtures of  substances may be included on pnority lists, if the mixtures themselves 
appear on EINECS.  They will then be treated under the Regulation just like other 
priority substances. 
Each substance on a priority list  is  allocated to  a Member State for  detailed  risk 
assessment on a voluntary basis.  The Member State  appoints a "Rapporteur"  to 
carry out an assessment of  the risks. This work includes, amongst other tasks 
•  the evaluation of  the information submitted by Industry; 
•  the evaluation of  other available information; 
•  the  identification of the  need  for  further  data and/or testing to  be  imposed  on 
Industry. 
Risk Assessment 
The Member State "Rapporteur", acting on behalf of the Community, performs the 
evaluation  of the  environmental  risks  and  puts  forward  recommendations  for 
appropriate measures. 
The division of work between Member States should in principle allow a Member 
State,  which had  already begun work  on  an "existing"  substance,  to  continue  its 
work within the Community.  Member States, which have not carried out any work 
on "existing" substances, should start to collaborate at Community level and, in this 
way, acquire in this way an experience similar to that of  the other Member States. 
The evaluation of risks  is  based  on  Regulation  1488/94,  which  was  adopted  by 
Commission in  1994  and  follows  in  principle  the  criteria previously  adopted  for 
"new"  substances  in  Commission  Directive  93/67.  This  should  ensure  that  all 
substances are judged on the same basis. 
The  Regulation  is  supported by  a  more  detailed  Technical  Guidance  Document, 
published in  1996, which indicates how the assessment should be performed.  The 
Technicaf Guidance  Document  does  not  have  a  legal  status  which,  given  the 
continuous developments in the methodology of risk assessment, facilitates a more 
rapid review and revision than would be the case if  it was a formal legal text. 
A  risk  assessment  for  chemical  substances  entails  four  major  steps:  hazard 
identification,  dose  (concentration)  - response  (effect)  assessment,  exposure 
assessment and risk characterisation. 
Hazard  identification  is  the  identification  of the  adverse  effects  (acute  and  also 
longer-term effects), which a substance has an inherent capacity to cause on human 
health and the environment. 
Dose  (concentration)  •  response  (effect)  assessment  is  the  determination  of the 
relationship between dose or level of  exposure to a substance, and the incidence and 
severity of an effect. In some cases, a dose -response relation for  health effects in 
9 humans or effects on the environment can be established on the  basis of actually 
measured data. In general, results from laboratory tests· have to be used. 
Exposure  assessment  is  the  determination  of emissions,  pathways;  and  rates  of 
movement of a substance and its transformation or degradation, in order to estimate 
the  concentrations/doses  to  which  human  populations  or environmental  spheres 
(water, soil and  ~ir) are or may be  exposed.  lt_describes magnitude, duration, and 
route  of exposure  to  the  nature,  size,  and  classes  of the  human  populations 
(including  occupational  and  public  exposure  routes)  and  environmental 
compartments  exposed  .. To  assess  the  likely  exposure,  the  "Rapporteur"  will 
consider the properties of the  substance and its  fate  in  the environment.  He  will 
consider how much is  produced, how it is  stored, transported, used (e.g.  in a few 
dosed systems or in many dispersive uses) and disposed of.  From this and other 
information, the "Rapporteur" will  predict realistic worst case levels of human or 
environmental exposure. 
Risk characterisation is the estimation of the incidence and severity of the adverse 
effects likely to occur in a human population or environmental sphere due to actual 
or predicted exposure to  a  substance,  and  may  include  'risk  estimation',  i.e.  the 
quantification of  that likelihOod. 
The  risk assessment  should  also  include  the  characterisation of the  uncertainties 
inherent in the process, especially when quantitative results are not feasible. 
Many  substances  have  already  undergone  some  form  of risk  assessment,  for 
example in the OECD or IPCS.  The "Rapporteur" should not in principle duplicate 
work already carried out.  In some cases-such a report may be used as the basis of 
the  assessment,  but  it  will  be  necessary  to  review  those  data  in  the  light  of 
information reported  by ·companies  under  the  Regulation  and  it  may  still  be 
necessary to require additional information. 
The "Rapporteur" will send the assessment to the Commission services, which will 
circulate  it  to  other  Member  States.  This  will  ensure,  for  example,  that  each 
.  I 
Member State has the  opportunity to  comment on any  assessment carried out  in' 
other countries.  The assessments  are  discussed by an  expert group before being 
submitted to the Regulatory Committee for opinion before publication. 
It should be noted that in dra\ving  conclusions on the risk assessment some value 
judgement is involved. 
The "Rapporteur" drafts a risk assessment report for consideration by the Member 
States  and,  where  appropriate,  formally  requests  further  delivery  of data  and/or 
testing.  .  Any further testing is carried out according to good laboratory practice as 
laid down in Directives 87118 and 88/320 and where possible will avoid or limit use 
of animals as per Directive 86/609.  Although in principle further testing should be 
carried out by all companies, such testing, where necessary, should be carried out by 
only one company on behalf of  all. 
It may happen that while some  base set data elements are missing, other data are 
available as a result oftests not listed in Annex V of Directive 67/548 which might 
compensate for the missing data: .  The "Rapporteur" should use expert judgement in 
deciding whether or not to  agree  to a derogation from completion of the base set, 
10 considering the relevance of the test, its inherent quality, the accuracy and detail of 
the report, the extent to which statistical methods have been applied and advise other 
Member States of  his decision.  If the "Rapporteur's" decision is contested, the issue 
could  ultimately  be resolved  by  a  vote,  but  preferably  such  an  iss~e should  be 
resolved through bilateral discussion. 
The "Rapporteur" prepares a draft assessment and proposes further data delivery and 
testing, whereas the formal decisions are taken by a  Committee of Member States; 
which finally delivers an opinion on the report, which js then published.  Decisions 
are taken by majority voting as  laid down in article 148(2) of the  Treaty of Rome 
(establishing the European Communities).  Provisions exist for resolving a situation 
where the Committee fails to deliver an opinion on such draft proposals. 
According to Regulation 1488/94, which outlines the principles of risk assessment 
for "existing" substances, the risk assessment concludes one·ofthe following 
•  more information and/or testing is needed to  complete the risk assessment (and 
arrive at one of  the other conclusions); 
•  the substance is of low current concern and no further action is needed; 
•  there is a potential risk to human health and the environment,. 
for each protection goal (e.g. population, environmental sphere). 
Risk Reduction Strategy (or Risk Management).  Links with the other Community 
instruments  · 
The situation with "existing" substances is such that they remain on the market as 
before, unless specific action is taken.  Regulation 793/93 does not' directly provide 
for risk reduction action though it may trigger it. 
If the conclusion of the risk assessment of an "existing" substance is that the risks 
are not adequately managed, the "Rapporteur"  is  required to  propose a strategy to 
reduce these  risks.  On the  basis of the  risk evaluation and of the  recommended 
strategy, the Commission then submits for opinion to the Regulatory Committee a 
draft Recommendation of  the measures to be taken. 
Where  the  strategy  recommends  marketing  and  use  restrictions  under  Directive 
76/769,  an  analysis  of the  advantages  and  drawbacks  of the  substance  is  also 
required and the availability of the replacement substances should be considered. 
Since  the  provisions  of Regulation  are  not  more  specific,  a  second  Technical 
Guidance Document was published in June 1998  to assist the "Rapporteur"  in this 
additional  analysis.'  The  guidance  on  the  risk  reduction  strategy  outlines  the 
possible measures that can be taken during the life cycle of the substances to reduce 
exposure, the available instruments as well as the criteria effectiveness, practicality, 
economic  impact  and  monitorability  which  should  be  considered  in  selecting  a 
strategy. 
11 Other than restrictions on marketing and use, risk reduction measures could involve 
redesigning  processes,  licensing  of  certain  operations,  recommendations  ·for 
establishment or revision of  the classification, occupational exposure limits (OELs), 
emission  limit  values  and/or  effluent  monitoring  as  well  as  making  available 
accurate  information and  safety training.  The  classification  of a  substance  may 
trigger a series of  controls in industrial installations and for hazardou$ waste.  Actual 
setting  of OELs  or envirol}mental  emission  limits  is  beyond  the  scope  of this 
exercise and is  carried out under other legislation.  In addition to  recommending 
regulatory control, consideration may be given to such non-traditional approaches as 
voluntary agreements, information programs, guidance and technical standards, and 
economic instruments. 
It should be noted that for a substance which has not been classified as  dangerous 
(i.e.  which· does· not  appear  in  Annex  I  of Directive  67 /548)  a  provisional 
classification  must  be  provided  during  the  data  collectiGn  phase,  if_ data  exists 
supporting  such  a  classification:  During  the  risk  assessment  procedure,  this 
classification will  be  examined  by the  competent  expert  group  working  for  the 
Regulation and then submitted to the competent expert group working for Directive 
67/548.  If  the substance is classified as dangerous, it will then be included in Annex 
I of this  Directive.  On the  other  hand,  as  a result of the work done  under  the 
Regulation, an already published classification could be revised. 
In  conclusion,  the  Regulation  establishes,  in  Article  11,  a  link  between  the 
Regulation  itself  and  the  Community  measures  in  force  which  can  help  in 
diminishing the  threats  posed  by  the  substance under scrutiny.  These  are  (non-
exhaustive list) 
•  Directive  67/548  relating  to  the  classification,  packaging  and  labelling of· 
dangerous substances; 
•  Directive 76/769 on the approximation o'f the laws, regulations and administrative 
provisions of  the Member States relating to restrictions on ~he marketing and use 
of  certain dangerous substances and preparations; 
•  Directive 89/391  on the safety and protection of health of  workers at work which 
places  an obligation on employers to evaluate the risks to the health and safety of 
workers arising from the use of  new and "existing" chemicals; 
•  Directive 90/394 on the protection of workers from the risks related to exposure 
of  carcinogen~ at work;  · 
•  Directive 92/85 on the safety and h.ealth at work ofpregnant workers and workers 
who have recently given birth or are breastfeeding; 
•  Directive 94/33 on the protection of  young people at work; 
•. Directive 98/24  on, the protection of the health. and safety of workers  from  the 
risks related to chemicals agents at work; 
•  Directive  92/59  on  general  product  safety  which  provides  for·  temporary 
restrictions on products in emergency situations; 
•  Directive 7.6/768 relating to cosmetic products; 
12 •  Directive  79/117  prohibiting  the  placing  on  the  market  and  use  of Plant 
Protection Products containing certain active substances; 
•  Directives 86/362, 86/363 and 90/642 .providing fdr maximum pesticide residue 
limits in agricultural products and foodstuffs;  · 
~t  Council Directive 76/116 and 97/63 relating to fertilisers. 
It should powever be pointed out that Article 11, while establishing a link with other 
legislative measures, draws a clear line between the activities to be carried out in the 
framework of the Regulation and those taking place in other contexts, such as the 
ones previously described. These follow-up risk management activities, which are 
supposed to take place in the  framework of other instruments, should then be  the 
subject of  new legislative proposals to be presented by the Commission.  The nature 
of  this link is non-automatic. 
Therefore,  once  the  complex  and  comprehensive  risk  assessment  activities  are 
completed and  where  appropriate  risk reduction measures  are  recommended  and 
published in the Official Journal, the precise tasks described in the provisions of the 
Regulation are to be considered accomplished. 
Of course there is an important monitoring role still to be played in order to ensure 
that the follow-up actions envisaged are fully accomplished by all stakeholders. 
The international context 
This mainly concerns the requirement under Article 8(2) of Regulation 793/93 that 
priority substances shall be selected considering, inter alia, work done and programs 
in other fora.  · 
In  order to  avoid duplication of effort regarding future  work and to  go  as  far  as 
possible  in  mutually  recognising  existing  work  done  in  other.  fora,  interaction 
between the Community program and other programs  is  necessary at  the  various 
stages of  the process, from defining priorities through to accepting risk assessments 
for  those  substances  selected  as  priority.  Programs  at  OECD  and  UN  are 
conceptually  similar  to  the  "existing"  substances  program  and  susceptible  to  . 
interaction  rather  than  the  other  Community  programs  which  have  a  different 
objective. 
Interaction between the EU and OECD on "existing" substances is well established, 
with formalised  contact  both  at  the  stage  of determining  priority  substances  for 
assessment  and  in  the  discussion  of  individual  risk  assessments  for  both 
programmes.  However, these arrangements have failed to prevent some duplication 
of activities.  There are currently ongoing discussions between the EU, OECD and 
the  UN's International  Programme  of Chemical  Safety  (IPCS)  with  the  aim  of 
improving co-ordination between them. 
13 3.  THE PRACTICAL OPERATION OF THE REGULATION 
... 
Three  expert  groups  and  one  committee,  chaired  by  the  Commission,  are 
established in support of  the process envisaged in the Regulation: 
•  the 
11Risk Assessment Technical Meeting
11
, 
•  the "Risk Reduction Strategy Meeting", 
•  the "Meeting of  the Competent Authorities", 
•  the Regulatory Committee established under Article 15. 
All  these expert groups and the  committee are composed of representatives of the 
EU  Member States and  EFT A Countries.  Several  observers  are  also  invited  to 
participate, except for the Article 15 Cominittee.  These are 
•  Industry,  represented  by  CEFIC,  by  other Industry  associations  which  are  not 
members  of  CEFIC, i.e.  AISE  (detergents),  CONCA  WE  (oil  companies), 
EUROMETAUX (non-ferrous  metals),· as  well  as  by  companies producing or 
putting on  th~ EU market the assessed substances; 
•  NGOs,  i.e.  EEB,  BEUC,  TUTB  and,  since  mid  1998,  Friends  of the  Earth, 
Greenpeace and WWF; 
•  OECD and IPCS. 
"Risk Assessment Technical Meetings" 
The risk assessment process and  the  preparation of the risk assessment report are 
appraised by the "Risk Assessment Technical Meeting". 
Each risk assessment report is submitted by the Member State "Rapporteur" to the 
Technical Meeting for a preliminary discussion. 
The EU report is then presented at the OECD SIDS  (Screening Information Data 
Set) Initial Assessment Meeting (SIAM).  · 
.One  or  more  discussions  follow  the  preliminary  discussion  at  the  "Technical 
Meeting". 
The  comprehensive risk  assessment  report  is  then finalised  and  a  summary  risk 
assessment report is prepared for publication in the. Official Journal. 
"Risk Reduction Strategy Meetings" 
Whenever  appropriate  and  (in  principle)  as  soon  as  the  need  is  identified,  the 
Member State "Rapporteur" should commence work oo. risk reduction measures.  A 
draft  proposal  should  then  be  presented  in  the  form  of a  comprehensive  risk 
reduction  strategy  and  a  summary  risk  reduction  strategy  (which  will  be 
incorporated into the Official Journal publication).· 
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.. These draft proposals are examined and discussed by the "Risk Reduction Strategy 
Meeting". 
"Meetings of  the Competent Authorities" 
All  the  risk assessment  reports  and risk reduction strategies  are  endorsed  by  the 
Competent Authorities. 
,_ 
The Competent Authorities are  designated by Member States to participate in the 
implementation of the  Regulation,  in collaboration  with  the  Commission.  Each 
Member State can designate one or more Competent Authority. 
Tlze Regulatory Committee 
Regulation 793/93 provides in its Article  15  for the establishment of a Regulatory 
Committee  composed  of representatives  of Member  States  and  chaired  by  the 
representative ofthe Commission. 
The main responsibilities ?fthis Committee are to deliver  an opinion on 
•  the  adaptation of  certain annexes of  the Regulation to technical progress; 
•  the  adoption of  certain implementing measures in respect of  the Regulation. 
The  latter  is  by  far  the  most  important  task  entrusted  to  the  Committee.  The 
implementing measures concerned are 
•  priority lists (Article 8); 
•  designation of Member State  "Rapporteur"  for  each  priority  substance (Article 
10(1)); 
•  decisions to request  manufacturers or importers to provide further information on 
a given substance (Article 1  0(2)); 
•  decisions to  impose  on manufacturers or importers  further  testing  on a  given 
substance (Article 1  0(2)); 
•  recommendations on the results of  the risk evaluation and where necessary on the· 
risks management measures to be implemented (Article 11 ); 
•  additional testing on any EINECS substance (Article 12(2)). 
According to the principles established in Council Decision 87/373 which lays down 
the  procedures  for  the  exercise  of the  implementing  powers  conferred  on  the 
Commission, the Committee referred to  in Article  15 of Regulation 793/93 can be 
considered of a "mixed" nature, its features belonging at the same time to procedure 
III a and III b. 
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·1}1 4.  STAGES IN THE OPERATION OF THE REGULATION 
Council Regulation (EEC) No 793/93 of23 March 1993 (OJ No L 84, 5.4.1993, p.l) 
on the evaluation and control of the risks of "existing" substances entered into force 
· on 4 June 1993.  In order for the Regulation to become fully operational a number of 
necessary stages had to be. completed.  These include: 
•  the  Commission Regulation (EC) No  1488/94 of 28  June  1994  (OJ No L  161, 
26.6.1994, p.3) laying down the principles for the assessment of risks to man and. 
the environment.  The aim of this Regulation was to ensure that a harmonised 
risk assessment is being conducted throughout the EU; 
•  the Technical Guidance Document in support of  Commission Directive 93/67 on 
risk assessment for new notified substances and Commission Regulation (EC) No 
1488/94 on risk assessment for  "existing"  substances,  published  in  1996  (739 
pp).  This Document is, of course, much more detailed than the above mentioned 
Commission Regulation.  It will be regularly revised; 
•  the Technical Guidance Document on development of risk reduction strategies 
published in 1998 (95 pp). 
The first  list of priority substances (42  substances) was published in Commission 
Regulation  (EC)  No  1179/94  of 25  May  1994  (OJ  No  L  131,  26.5.1994,  p.3), 
followed by the  second  list. (36  substances) published in Commission Regulation 
(EC)No 2268/95 of27 September 1995 (OJ No L 231, 28.9.1995, p.18) and finally 
by  the  third  list  (32  substances)  published  in  Commission  Regulation  (EC)  No 
143/97 of27 January 1997 (OJ No L 25, 28. L1997, p.13). 
16 5.  FINDINGS 
110 substances that have been selected as "substances requiring immediate attention 
because of their potential effect on man on the environment" in the 3 priority lists 
published in 1994, 1995 and 1997. 
The  Member State  "Rapporteurs"  are  listed  hereunder with the  indication of the 
number of  substances they should assess. 
Member State  Number of Substances  Finished Risk Assessments 
D  ·33  3 
NL  22  5 
UK*  21  5 
F*  9  1 
DK  5  1 
FIN, I  4  1(1) 
B, S  3  0 
AEN  2  2(A E) 
IRL 
.. 
1  1 
L  PT  0  0 
*  2 substances are shared by F and UK.  . 
The complexity of the risk assessment process necessitated a lengthy lead-in time 
before technical work on individual substances could commence because of  the need 
for  the development of two  detailed  technical  guidance  documents,  one  on  risk 
assessment and one on risk reduction. 
Out of the total of 110  priority substances,  38  have been or are  being discussed. 
19 risk assessment reports have been completed.  For 14  substances risk reduction 
measures are recommended;  for 3 substances further testing is required and for 2 
substances there is no need for risk reduction measures. 
To date, the time necessary from the publication of a priority list to  the circulation 
of the first draft of the risk assessment report at the Technical Meeting appears to 
average between 18 and 29 months.  In general, a further 9 to 25 months are needed 
from  the  circulation of the  first  draft  until· an agreement is  reached  on the  risk 
assessment  report.  During  1998,  the  pace  of completion  has  increased.  It is 
currently taking 9 months to finalise the assessment discussions.  This improvement 
comes as a result ofthe increased technical competence of  the those national experts 
working on the risk assessment process. 
The timescale for the process of determining risk reduction strategies is  variable, 
depending to a large degree on the availability of  the Member State "Rapporteur's" 
resources. 
A Commission Recommendation concerning the results of the risk evaluation for 4 
substances and strategies for reducing the risks for 3 of them should in principle be 
published before the end of 1998. 
17 This means that, since. 1994, only 4 substances have gone through the whole process 
foreseen in the Regulation. 
After the publication of the Recommendation, work should start in the Commission 
services,  Member  States  and  Industry  on· the  proposed  measures.  For  two 
substances voluntary agreements are foreseen.  For one substance restrictions on its 
marketing and use are recommended.  In this case, DGIII should, according to these 
conclusions, prepare a Proposal for modification of  Directive 76/769. 
The operational experience gained so far highlights a number of issues, some linked 
to the degree of commitment of the key actors, some linked to the lack of qualified 
resources or,  simply, to the lack of resources, some of them structural, and others 
technical. 
Commitment 
•  Many  Member States  may  have  overestimated  their  ability  to  implemenf the 
Regulation.  Given  the  "voluntary"  nature  of the  scheme  established  by  the 
Regulation  - in  practice  some  Member  States  have'  so  far  chosen  priority 
substances in the light of national interests and of their previous work in other 
programmes  -,  there  is  now  a feeling  amongst  some  of the  more  committed 
Member States that their share of  the burden is disproportionate. 
_Moreover, some Member States have had difficulty committing any resources to 
the programme.  This is the  case  of Luxembourg and Portugal,. who  have  no 
substances to assess .. 
•  Some companies may not regard this work as  a priority because the substances 
are already on the market.  For "new"  substances,  Industry's interest is  to  co-
operate actively in the risk assessment in order to place its product on the market 
as quickly  as possible, whereas in the case of the "existing" substances Industry 
tends to be less proactive, awaiting for the results of  the assessment before taking 
any action.  The "burden of proof' to  show that a chemical is  not safe during 
actual use is on the public authorities (the Commission services and the Member 
States), which collect and assess all data from  Industry and take decisions as to 
the nee_d for regulatory restrictions. 
•  Initially, there were considerable delays  by  Industry in providing the HEDSET, 
which  allows  for  the  selection  of the  priority  substances  for  assessment,  in 
accordance with Article 3 of  the Regulation. 
There  have  also  been  delays  caused  by  Industry  in delivering  addition.al  data 
before and during the risk assessment process in accordance with Articles 9 and 
10 ofthe Regulation. 
Importers  of substances  are  also  known  to  have  difficulties  in  obtaining  the 
requisite information from producers because they are located ih another Member 
State or outside the EU. 
18 A problem related to the credibility of data has also been raised. Industry has not 
always submitted all relevant available data during the data collection phases and 
there is difficulty in continuously updating the data. · 
•  The information regarding the obligations put on producers and importers under 
the Regulation has not reached all  the -parties concerned, in particular the small 
and medi'um sized firms. 
•  Lack of enforcement activity in Member States in support of the Regulation has 
not helped to encourage Industry to improve its compliance with deli~ery of data. 
•  Some Member States make  substantial  contributions  to  other international risk 
assessment programmes (e.g. Germany, Sweden and UK ~o IPCS programme) in 
parallel to  their  contribution  to  the  Regulation,  thus  diverting  resources  away 
from EU work. 
Resources 
•  A lack of commitment is reflected by the limited availability of resources in the 
Member States and the Commission to carry out the necessary activities. 
Structural 
•  The "burden of proof' to  show that a chemical is  not safe during actual  use  is 
placed  on  the  public  authorities,  the  Commission  services  and  the  Member 
States. 
•  The long and complex stages and procedures foreseen in the Regulation (selection 
of priority  substances,  choice  of Member  State  "Rapporteur",  collection  of 
information,  risk  assessment  activities,  technical  evaluation  of  the  risk 
assessment reports, risk reduction strategies) are one of the major causes for the 
delays experienced in the operation of  the Regulation.  However, this problem is 
not  unique  to  Regulation  793/93,  as  similar  problems  have  beset  the 
implementation of Directive 91/414 concerning the  placing of plant protection 
products on the market. 
•  The  absence  of deadlines  for  Member  States  in  the  Regulation  means  that 
Competent Authorities are not working to a target for submitting completed risk 
assessment reports. 
Some  deadlines  for  Member  States  and  Industry  are  agreed  at  Technical 
Meetings, but they are not always respected. 
Other deadlines are  fixed  during bilateral contacts  between Member States and 
Industry but the Commission has no means to monitor progress on these. 
•  A priority setting approach was included in the  Regulation in order to draw up 
lists of "existing" substances, which should be assessed first.  However, there are 
doubts as  to whether this approach was  applied  successfully for  the  first  three 
priority lists to  pinp'oin~ substances of  greatest concern. 
19 •  The risk assessment process, which determines  the nee'd for control for "existing" 
substances measures, may be too ambitious.  The risk assessment is based on an 
in-depth  consideration  of the  risks  to  human ·health  and  the  environment  of 
exposure to  substances.  The  nature,· scope and  amount of data to  be  assessed 
means the risk assessment process is lengthy.  The requirement for a Member 
State  "Rapporteur"  to  seek  agreement  of other  Member  States  through  the 
Techriical  Meetings  delays  the  risk· assessment  process  further,  but  has  the 
advantage that all the Member States acquire the same level of  experience. 
On  the  other  hand,  it  should  be  pointed  out  that  the  comprehensive  risk 
assessment conducted  under  the  Regulation  covers  the  production  and  current 
uses  of the  substance,  which  is  defined  by  the  chemical  name,  the  Chemical  . 
Abstracts Service Registry Number (CAS RN) and the EINECS Number. Under 
current  practices,  the  comprehensive  risk  assessment  will  then  not  cover,  in 
principle, the evaluation of the risks posed by the substance when present as an 
impurity in another substance or mixture of substances.  In the case of  cadmium, 
for exampie, the risk assessment under the Regulation will not cover the effects 
caused by the presence of cadmium in fertilisers.  Thi,s  would be  covered if the 
fertiliser itself is evaluated. This situation should be clarified. 
As only the uses ofthe substance known to the Rapporteur and those involved in 
reviewing  the  report  are  assessed,  it  could  happen  that  a  potential  risk  is  not 
assessed simply because a particular use of  a substance is not common in the EU 
or 'not known to  the "Rapporteur".  A good example of this is  acrylamide.  The 
risk assessment under the Regulation was virtually completed when· an accident 
occurred  in  Sweden,  where  acrylamide  was  used  or  produced  in  situ,  in 
circumstances which have still to be clarified, during the construction of  a railway 
tunnel.  Without this accident, the evaluation would not have focused on the use 
of  the substance as a grouting agent in tunnels, because this use was not known in 
Europe  (~crylamide has been used  in chemical grouting agents for a number of 
years  in the  USA  and  Japan).  Now the  evaluation  will  be  completed  by  the 
Member  State  "Rapporteur",  focusing  on  this  use  and  investigating  local 
environment  and  worker  protection  issues.  The  need  to  review  the  risk 
assessments inthe light of new information is therefore apparent. 
•  The Regulation was  not  intended  to  provide for  "targeted"  risk assessments  of 
substances, which are of immediate concern. 
Moreover, even when it is  apparent early on in the risk assessment process that 
the risks from the substances are confined to one area (e.g. workers), until now a 
full  risk  assessment  of all  areas  (workers,  consumers  and  environ.Inent)  is 
performed. 
•  As downstream users of substances are not covered· by the Regulation, it can be 
difficult for suppliers to  obtain the exposure and usage. information from  users 
because o.f commercial confidentiality concerns. This, in tum, makes it difficult 
for the Member State "Rapporteur" to determine appropriate draft proposals for 
risk reduction measures.  ' 
•  Once  the  risk  assessment  activities  are  completed  by  the  Member  State 
"Rapporteur"  (and where necessary risk reduction measures recommended) there 
20 is no clear provision in the Regulation for providing an adequate 'follow-up to the 
prob!ems  highlighted  in the  risk  assessment report  (and  in  the  risk  reduction 
strategy) forwarded to the Commission.  The main· problem areas in this respect 
include 
the confusing situation concerning the  choice of the legal  act in  which the 
Commission  incorporates  the  results  of  the  risk  assessment  and·  the 
recommended risk reduction strategy; 
the  missing  automatic  or  semi-automatic  link  with  the  other  Community 
legislative instruments (Directive 76/769 on marketing and  use  restrictions; 
worker and consumer protection legislation),· which are to take on board the 
conclusions of  the risk assessment for the substance concerned; 
consequently, the fear by the Member State "Rapporteur", after the extensive 
and resource consuming  evaluation carried out on a substance, that the work 
is not adequately acknowledged. 
•  Risk assessments on "existing" substances produced for the OECD and IPCS 
are different from those produced for  the EU Regulation.  OECD and IPCS 
"risk assessment reports" consist simply of information on .hazard assessment 
and  some  uses  of the  substances  (they  are  in  fact  initial  risk  assessment 
reports), whereas the  EU  risk assessment reports are comprehensive, taking 
account of all the exposure scenarios for a particular substance. Because the 
same  terminology  is  applied  to  all  three  types  of assessment,  the  risk 
assessmen~ process for the EU  Regulation appears slow and cumbersome in 
comparison to the other two. 
This has an important consequence in  that it  is  not possible at the  moment to 
avoid duplication of work between different international organisations, i.e. the 
same substance is  sometimes  assessed  by a non-EU  OECD Member Country 
and an EU Member State. 
•  The  management  of Regulation  relies  on  two  separate  Commission  services; 
DGXI/E/2's  role  is  essentially  a  policy  and  administrative  one  and 
DGJRC.IHCP.ECB's role is both technical and managerial.  DGJRC.IHCP.ECB 
provid~s all of the technical advice on policy issues which DGXI requires.  As 
well  as  organising  the  Technical  Meetings,  DGJRC.IHCP.ECB  holds  all  the 
factual scientific information relating to the Regulation.  The management of the 
Regulation  therefore  is  essentially  a joint effort.  However,  the  geographical 
separation of DGJRC.IHCP.ECB  and  DGXI  has  mitigated  against  the  shared 
understanding of  priorities and objectives. 
Technical 
•  The  risk  assessment  process  requires  a  high  level  of scientific  and  technical 
expertise.  Some  Member  States  are  not  able  to  deliver  the  planned  risk 
assessments because they lack the requisite human resources and/or scientific and 
technical  expertise.  The  anpual  CEFIC  Seminar  (April  1998)  highlighted  the 
· problem of  scarcity of  experienced eco-toxicologists. 
21 6.  DISCUSSION. 
Chemicals are useful and toxic at the same time.  It is in fact the dose which causes 
toxic  effects:  sugar  and  salt,  if consumed  by  the  kilogram,  may  be  as  lethal  as 
milligrams of cyanide or strychnine.  In addition to  their toxicity, chemicals may 
also be explosive; flammable or corrosive.  Yet others may have deleterious effects· 
on our environment, such as chlorofluorocarbons. 
Given  that  all  chemicals  are  potentially  dangerous,  it  was  reasonable  that 
precautions are taken to assess each chemical and to  ensure that appropriate steps 
are taken to reduce the potential risks associated with their use to an acceptably low 
level.  For instance, many drugs are highly toxic chemicals, but as long as they are 
packaged correctly (to protect children, for example), and as long as the dose levels 
are controlled and recommended conditions of  use are followed carefully, the risk to 
the public is acceptably small. 
Similarly, many household cleaning products are  potentially very dangerous  - for 
example, bleach and ammonia - but provided they are packaged correctly in solid, 
strong  containers  with  child-proof  fastenings  and  are  clearly  labelled,  with. 
recommendations  for  safe  use  clearly  displayed,  they  can  safely  be  used· in the 
home. 
At  the  time  of adoption, the  Regulation  was  seen  as  a milestone  in  Community 
legislation,  as  it  set  up  a  complete  and  unified  framework  for  the  systematic 
evaluation of the risks posed to man and the environment from "existing" chemical 
substances.  On  the  basis of this  evaluation, recommendations for  risk  reduction 
measures can be  made  and thereby fed  into the  numerous _legislative  instruments 
ensuring risk reduction. 
The "burden of  the past" 
Over the last two years the Regulation has come under increasing political pressure. 
The Regulation has  not yet provided the  fruitful  output, which was· hoped for  in 
.1993, thereby prompting discussions about its usefulness_. 
In  many· different  fora,  the  concept  of "the  burden of the  past"  has  arisen.· The 
reasoning behind this concept is as follows: there are 100,106 "existing" chemicals; 
for the majority of these chemicals little data is available; furthermore, there is no 
practical possibility to  assess  the  risks  of all of these chemicals within the  near 
future.  The  immediate  concern  is  therefore  that  man, and  the  environment  are · 
potentially  exposed  to  a  lar_ge  number  of chemical  substances  for  which  the 
··  hazardous properties and  risks are unknown. 
As previously mentioned, according to  a CEEIC calculation, the estimated lowest 
figure for the number of "existing" substances which represent the "burden of the 
past"  under Regulation 793/93  is  1,200  (see  item  in Section 2 on the  Potential 
number of  substances for assessment under the Regulation). 
22 Chemicals framework legislation 
' 
Some Member States would like over-arching legislation which sets out the basic 
principles  governing  all  EU  legislation  concerned  with  chemicals,  including 
''existing", "new",  pesticides, biocides and  other chemical preparation (intentional 
mixtures) etc.  All chemicals legislation would be based on an identical principles, 
e.g. placing the burden of proof on industry. This is potentially a time consuming 
option,  which  could  exacerbate  delays  in assessing  chemicals  further,  but  would 
have  clear  advantages  in  terms  of harmonising  the  basic  principle  involved  in 
chemical assessment. Nevertheless, simply re-assembling existing legislation into a 
new  common  Directive  would  not  in  any  way  speed  up  the  process  of risk 
assessment. 
Persistence and bioaccumulation 
These characteristics are put forward by certain Member States and NGOs as a basis 
on which risk reduction strategies should be determined without the need for a risk 
assessment.  Currently they are already taken into account during the priority setting 
process, which is used under Regulation 793/93, and by the current risk assessment. 
However, the properties are not given the degree of importance as certain Member 
States are proposing. 
Mixtures 
Regulation 793/93 has come in for some criticism because the approach used is that 
chemicals are considered on an individual basis, while most exposure to  chemicals 
is actually exposure to mixtures.  However, intentional mixtures are covered by the 
Directive  88/379  on  the  classification,  packaging  and  labelling  of dangerous 
preparations.  The  problem  of unintentional  mixtures  is  much  more  difficult· to 
address. There is indeed an urgent need to acquire much more data on exposure to 
chemicals for  human health and  the environment (be  it individual  susbstances of 
mixtures) and an improved collection of  epidemiological evidence. 
Hazard versus risk 
Risk assessment is not an easy concept to understand, but it is of major importance 
since it is ·a key element of the chemicals control programme.  The final goal of  this 
programme is to manage or control a chemical -to have emission values to water, to· 
control  it in  the  workplace,  to  control it as a  waste  product - but,  before  those 
management  decisions .can  be  made,  it  is  necessary  to  assess  and  evaluate  the 
chemical. 
A  risk  assessment  involves  four  steps:  hazard  identification,  dose-response 
assessment, exposure assessment and risk characterisation. The first  two steps, the 
hazard identification and the dose-response assessment are usually called the effects 
assessment  or  hazard  assessment.  The  goal  of the  effects  assessment  or  hazard 
assessment is to determine at which exposure levels the chemical causes no adverse 
or irrev:ersible effects.  In the risk characterisation these levels are compared to the 
actual expected exposure levels, determined in the exposure assessment, in order to 
reach a conclusion on the anticipated risk. 
23 That part of the analysis can be  done for  any particular use pattern .of a substance. 
For  an-aerosol  freshener  used  in ·the  home,  for  instance,  one  can  calculate  an 
exposure scenario which will give average concentration of the substance in the air 
in· a home under normal  conditions,  and  by comparing that to the  ~oncentrations 
known to  be toxic or  known to  have deleterious  effects,  one has,  in very  simple 
terms, conducted a risk assessment. 
The distinct steps of  h~zard assessment and risk assessment provide different levels 
of knowledge of the potential risk of a chemical. This distinction can exploited to 
use the results of  the hazard assessment to determine a need for a  risk assessment. It 
is therefore important to maintain and exploit this distinction. 
Gr01iping of  substances 
There  are  two  different  ways  of grouping  chemicals  for  the  purpose  of priority 
setting: 
•  based on· chemical structure similarity; 
•  based on similar use patterns. 
The basis of grouping chemicals according to  chemical structure is that substances 
with similar structures may have similar chemical properties, though this would only 
hold true for limited classes of chemicals. Thus, by grouping substances in this way, 
the hazard assessment on these classes would be carried out more efficiently. The 
advantage of grouping according to  use  pattern is that the exposure assessments of 
all  the chemicals are  considerably lightened.  It would therefore be an advantage to 
attempt to group chemicals using both criteria. 
The  DGJRC.IHCP.ECB  has  already  clustered  the  EINECS  chemicals  based  on 
chemical  structure.  Furthermore,  a  use-clustering  of the  HPVCs  has  also  been 
carried out.  The difficulty is  how to summarise this information in a simple way, 
which assists in choosing those groups of chemicals· which need the most attention. 
This  problem  is  being  worked  on  by  the  DGJRC.IHCP.ECB  in  the  context  of 
preparations for the fourth priority list. 
Tlte "burden ofproof" 
The US  Chemical Manufacturers Association (CMA) has been challenged by  the 
Vice President of the USA to  carty out an extensive testing programme to  address 
the concern that little data is available on most of the US High Production Volume 
(HPV) chemicals.  This challenge is the consequence of a growing awareness of  the 
11burden of the past
11  in the US.  The testing prograinme will result in Screening 
Information Data Sets  (SIDS)  or  possibly even hazard  assessment reports  in the 
form  of SIDS  Initial  Assessment  Reports  (SIARs),  which will  be  subject to  the 
OECD review.  This leads to the question of possible .;:o-operative action between 
the US, Japan and the EU on data generation.  The US initiative may result in the 
testing of  approximately 200 chemi<;als/year.  If  this initiative is followed by similar 
initiatives in the  EU and Japan, possibly 400 chemicals can be tested ~d  initially 
risk assessed per year. 
24 "Targeted" risk (!Ssessments 
Focusing  on  the  real  areas  of concern  seems  to  be  a  possible  way  forward  to 
substantially accelerate the ongoing risk ass~ssment procedures.  Indeed, if there is 
an  indication  ~at a  substance  presents  potential  risks  only to  a specific area,  to 
workers for example, or if a substance has been already extensively studied in other 
fora;  it  is  possible  that  a  comprehensive  risk  assessment,  as  foreseen  by  the 
Regulation,  would  be  unnecessary.  A  "targeted"  risk  assessment  can  then  be 
conducted,  which is  generally  less  extensive  and  therefore  prepared  in a  shorter 
time, compared to the comprehensive risk assessment.  However, the length of  time 
to undertake a "targeted" risk assessment may still be substantial. 
~ 
"Targeted" risk assessments are  being conducted under the supervision of different 
Commission services which are responsible for different pieces of legislation based 
on the outcome of risk assessment, but do not have a uniform or consistent way of 
endorsing them.  · 
25 7.  RECOMMENDATIONS 
A basic principle for the implementation of the recommendations is that the "burden 
of proof' to show that a chemical is not safe during actual use should be placed on 
Industry.  An  attempt  has  been  made  to  deYelop  the  recommendations  so  that 
Industry is requested to play a more active role on the testing and evaluation of their 
chemicals, but in  such a way ·that Industry's e\'aluations undergo a review by the 
Member States . 
. The  prelimi~ary recommendations  are  based on  the  findings  in Section 5 and  the 
discussion in Section 6.  These can be summarised as  the following key elements 
underlying the recommendations 
•  it is essential to define the actual size of problem that the Regulation is trying to 
address (i.e. the number of "existing" substances which constitute the "burden of 
· the. past"  and  what  is  currently  kno\m on  those  chemicals,  before  any  more 
detailed solutions can be developed); 
•. the problem of  the lack of  information on "industrial chemicals"; 
•  the need to develop strategies to improve and streamline the risk assessment and 
risk reduction process. 
Recommendations for "existing" substances on the current priority lists 
a.  To review the priority status of  the substances 
It is necessary to establish which of those substances on the current Priority Lists, 
which have not yet been examined, really are ''of concern" and need to be  assessed 
first. 
b.  To review optio.nsfor expediting completion of  risk  assessments 
Possible  options  include:  checking  the  possibility  and  viability  of  grouping 
substances  even  if  they.  have  been  allocated  to  different  Member  States 
"Rapporteurs";  challenging  Industry  to  proYide  initial  risk  assessments  on  a 
voluntary basis;  requesting  Industry and  "Rapporteurs" to  use external contractors 
for the completion of  the fisk assessments.  · 
c.  To  clarify  the  commitment of Member  States'  in  order to  ensure  effective 
operation of  the Regulation and mobilise the necessary resources 
In order for the chosen solutions to be achievable, it is essential that Member States' 
commitment be  determined,  in  terms  of political  support  and  in  terms  of actual 
resources, both to completing work on the assessments for the remaining substances 
o~  the current priority lists and working on "existing" substances in future. 
26 Recommendations  [or other "existing" substances on the market 
.  .  . 
d.  To clarify the extent of  the "burden of  the past" 
In  order  to  ensure  that  appropriate  and  realisable  solutions  are· developed  for 
assessing  those  remaining  substances  which  are  "of concern",  it  is  essential  to 
ascertain the  number of "existing"  substances which constitute the  "burden of the 
past".  It is  also essential to create  an  inventory of what data is  available on these . · 
chemicals and what data is not available. 
e.  To  revise  the Annexes to  Regulation  793193  to  include  all High ·and Low 
Production  Volume  .chemicals  based  on  Industry  data  held  at 
DGJRC.IHCP.ECB 
Under the three data collection phases of Regulation 793/93 producers and importers · 
of "existing" substances produced or imported in volumes exceeding  10 toimes per 
year have been required to submit a HEDSET to the Commission. The Commission 
database on "existing"  chemicals,  IUCLID,  thereby  contains the  definitive  list  of 
substances, naming all producers and importers which produce or import substances 
in volumes exceeding 10 tonnes per year. 
By incorporating some of this information into the Regulation, there will be both a 
transparent  and  definitive  legal  reference  of those  EINECS  substances  above 
1  0 tonhes  per year which are  on  the  market.  This  could be  used,  in  future,  for 
example, to  require Industry to  provide data for the substances which are produced 
or imported  in  volumes  in  excess  of 10  tonnes  which  are  not  contained  in  the 
Annexes, in a procedure similar to the one implemented for "new" chemicals under 
Directive 67/548.  This would require an amendment to the Regulation. 
f.  To  assess  the  issue  of how  best  to  deal  with  those  "existing" substances 
manufactured or imported in quantities of  less than 10 tonnes per year 
The  first  issue  which  needs  to  be  addressed  is  how many  "existing"  substances 
manufactured or imported in  quantities of less than  10  tonnes per year are  really 
relevant in terms  of Regulation  793/93.  It co.uld  be  argued  that  any  substance 
produced in volumes below 10 tonnes per year is not of relevance, as it is at most a 
local environmental problem, a .site-specific worker protection problem or possibly 
an  infrequent  potential  consumer  problem.  Most  "n~w" chemicals  which  are 
produced in volumes below  10  tonnes  are  speciality chemicals, notably  colorants, 
which have very specific uses.  1f this is extrapolated to "existing" chemicals, then it 
might  be  assumed  that  very  low  volume  "existing"  chemicals  are  speciality 
. chemicals with unique or very restricted uses. 
The  second  issue  that  needs  to  be  explored  is  whether  ".existing"  substances 
manufactured or imported in quantities of  less than 10 toimes per year need to be risk 
assessed..  Community legislation currently in place might be  sufficient because it 
· already requires risk reduction based on hazard.  It could be argued that only those 
substances which do not automatically get regulated by these legislative instruments 
should be risk assessed. 
27 A  ~ird issue  is  how  to  gather· more  information  about  "existing"  substances 
producea or imported in less than 10 tonnes per year .in order to address concerns. 
Possible options to be e_xplored include a mandatory registration system for EINECS 
chemicals at 1 tonne production volume (current limit is  10  tonnes)~ and. a challenge 
or mandatory programme regarding the use of  any chemical in a consumer product to 
report the identity of  the substance to the Commission. 
In exploring the options it is essential to remember the following: 
•  the  Commission's  resources  are  finite  and  if more  work  is  to  be  done  on 
"existing" substances, less must be done elsewhere (e.g. on "new".substances); 
•  if rules are changed 'for reporting substances, these should be changed in such a 
way that there  is  greater consistency  between  the  different  substance  classes 
covered by different pieces of  EU legislation. 
•  "targeted" risk assessments could be the best solution either as sOon as a specific 
· concern with regards to  su~h a chemicals is identified, or as a part of  a mandatory 
"self assessment"  scheme  similar  to  the  "self classification"  under  Directive 
67/548. 
g.  To  review those  "existing" substances  which  constitute  "the burden of  the 
past" to  see if  their  hazardous properties  have been  assessed,  and if not, 
~ecure  Industry  commitment  for  an  initial  risk  assessment  under  the 
supervision of  Member States as a matter ojpri~rity 
This  requires  pla~ing  the  burden  of proof on  Industry,  making  the  information 
generated by Industry publicly available and establishing an -efficient review system 
for the work carried  out by  Industry.  Indeed,  it  has  to  be born in  mind  that  the 
authorities will still have the task to· control and verify the assessments submitted by 
Industry  and  that  a  mechanism  has  to  be  found  to  guarantee  acceptability  and 
credibility  of Industry's  work.  A  possible  way  forward  could  be  to  have  the 
assessments done by outside experts I consultants whose independence would have . 
to be monitored. The costs for this could be borne by Industry. 
lt.  To· seek  international co-operation  to  share  the  initial risk  assessment  of 
"existing" chemicals which represent the "burden of  the past" 
The  separate,  but related,  initiatives  of the  United  States government  and  of tht;: 
International Council of Chemical Associations (ICCA) have been cited recently in 
the  press  and  others  are  being  discussed  in  the  EU,  BIAC  and  various  national 
chemical industry associations. They all involve a significant increase in the pace of 
closing  SIDS  gaps  and  arriving  at  an  initial  assessment  of the  hazard  of HPV 
chemicals.  They '·an  recognise  that  the  OECD  HPV  Chemicals  Programme  is 
instrumental in reaching international consensus on the content of  these assessments 
and their supporting SIDS dossiers. The ICCA initiative rests heavily on working as 
far as possible under the OECD framework; that of the United States is focused on 
generating SIDS test data on HPV chemicals, but will also contribute the US input to 
the OECD programme. 
28 The US is willing to complete SIDS testing on-the US HPV chemicals by 2004 under 
its  Vice Presidenticd  initiative.  ICCA  is  urging  its  member  companies  to  work 
together to fill SIDS and undertake initial hazard assessments on approximately I 000 
HPV chemicals by the  end of 2004.  The details of how  tnis  will  be  done  by the 
chemicals industry are still under discussion; however, the objective is to contribute 
to  the  OECD  HPV  Chemicals  Programnie  to ·make  the  results  internationally 
acceptable and to ensure that the burden is equitably shared in the industry. 
i.  On  the basis of tlze  initial risk assessment,  rank the  ''existing" substances 
according to whether they are "of  concern", ''further information is needed" 
or ~re "not of  concern" 
To  ensure  that  in future,  efforts  and  resources  are  directed  appropriately  towards 
those "existing" substances which are of  most concern.· 
j.  To  draw up further priority lists from those  "existing" substances which are 
"of  concern" 
These  priority  lists  should  contain  groups  of substances  with  similar  structures 
and/or use patterns.  Concern can also be linked to  monitoring evidence,  collected, 
stored and made available through a central archive, held for example at the EEA. 
k.  To review options to speed-up the completion of  risk assessments in future 
In  addition to  the  above mentioned recommendations,  the  options should include 
making more use of "targeted assessments" and  giving the whole procedure much 
more flexibility. The rigid application of  the complete risk assessment procedures for 
all possible cases (as suggested by the Technical Guidance Document, even if it is 
evident that there is no concern for many areas) is one of the reasons for the slow 
progress made so far. 
l.  To exploit the distinction between hazard and risk assessment 
The distinction between the hazard and risk assessment can be exploited to develop a 
community  policy  on  persistent,  bioaccumulative  and  toxic  substances.  Such  a 
policy would consider the work carried out under the UN  ECE and the UNEP on 
POPs  and. should  include  the  possibility  to  examine  the  risk  posed  by  existing 
chemicals to the marine environment. The policy should elaborate conditions which 
would  enable  a  link  between  the  hazard  assessment  and  possible  risk  reduction 
measures, without requiring completion of  a risk assessment. 
The development of such a policy should consider the  potential effects related to 
endocrine disrupters. 
m  To expand the involvement of  concerned industry sectors 
Carry out. comprehensive consultation with  industry  sectors concerned in order to 
receive their feedback, and to consider whether special measures would be needed to 
take account of  the possi_ble  implications for SMEs of any changes to the legislation 
or to the risk assessment procedures. 
29 n.  To  review the need for better internal co-ordination  within ,the Commission 
services  in  order  to  improve  efficiency,  effectiveness  and  consistency  of 
approach in both the processing of  risk assessme.nts and the determination of 
risk reduction strategies for chemicals 
The review should highlight the need in future  for the following:  one  Commission 
body,  such as  the  current Technical  Meeting,  to  consider all  risk  assessments  of 
"existing"  chemicals  both  under  Regulation  793/93  and  other  procedures  ;  one 
Commission body for determining the most appropriate 
1
tools for implementing risk 
reduction measures on these existing chemicals; and, a unique Commission database 
for all chemicals which gives a reference to  relevant legislation including ongoing 
developments.  · 
Furthermore the  review should highlight the need for closer co-operation between 
the technical group working on classification and labelling and the technical group 
on risk assessment.  For example,  during the risk assessment process .it  would be 
useful  to  know  if a  substance  had  been  evaluated  for  a  specific  effect  for 
classification and labelling purposes, even if  it has been decided that it does not have 
the specific effect. 
o.  To  identify  specific  research  needs  wlziclz  would  make  possible  the 
development of assessment tools  in  areas of  current concern,  which are not 
. currently covered  '  . 
On~  area of  research priority is the potential effects of mixtures of chemicals to man· 
and the environment. 
Another  area  of research  priority  is  endocrine  disrupters  and  in  particular  their 
potential synergistic effects. 
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CAS  RN:  Chemical  Abstracts  Service  Registry  Number  attributed  by  the  Chemical 
Abstracts Service  to substances referred to at least once in the scientific literature. 
Competent Authorities: In the context of  legislation on "new" and "existing" chemicals, 
each  Member  State  designates  one  or  more  Competent  Authorities  to  participate  in 
implementation in collaboration with the Commission.  Th~  Commission holds a meeting 
of  the Competent Authorities for Regulation 793/93 on a regular basis (normally twice a 
year).  Competent Authorities are responsible for the endorsement of  all risk assessments 
reports and risk assessment strategies. 
EINECS: European Inventory of Existing Commercial Chemical Substances, deemed to 
be  on  the  European Market between  1
51  January  1971  and  18
1
h  September  1981.  The 
definitive  list  of 100,106  "existing"  chemicals  which  in  principle  are  governed  by 
Council Regulation (EEC) 793/93.  Closed list. 
EUSES:  European  Union  System  for  the  Evaluation  of Substances.  This  computer 
program  is  a  decision support instrument  to  assist  the  risk  assessor  to  carry  out the 
exposure and effects calculations as defined in the TGD. 
Existing Substances: Substances listed in EINECS (100,106 substances, closed list). 
Hazard  assessment:  Hazard  identification  and  establishment  of  dose-response 
relationship for observed adverse effects in the specified (eco)toxicological endpoints. 
Hazard identification: Identification of the  adverse effects which a substance  has  an 
inherent capacity to cause. 
HEDSET:  Harmonised  Electronic  Data  SET.  This  is  the  Commission  Data  Entry · 
Programme which has to  be  used  under Council  Regulation (EEC)  793/93  to  submit 
summary information on chemicals.  The Expanded HEDSET is a term for  a yet to  be 
developed  HEDSET  which  is  based  on  a  format  which  is  being  developed  by  the 
Commission and the US EPA for submitting comprehensive data-sets to both authorities. 
HPV chemicals:  High  Production Volume  chemicals  .. Chemicals  placed  on  the  EU 
market in volumes exceeding 1000 tonnes per year per producer or importer. 
IPCS:  International Programme on Chemical Safety, a joint programme of ILO, UNEP 
and  WHO, established in  1980.  Part of its activities involves the  publication of both 
Environmental Health  Criteria (EHC)  and  Concise International Chemical  Assessment  .  . 
Documents (CICAD) on the evaluation of  risks posed by  chemicals. 
IUCLID:  International  Uniform  Chemical  Information  Database.  This  is  the 
Commission  database  used  to  store  and  distribute  the  information  collected  under 
Council Regulation (EEC) 793/93. 
LPV chemicals:  Low Production Volume chemicals: Chemicals placed on the market 
·in volumes between 10 tonnes and 1000 tonnes per year per producer or importer. 
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./UrD'· New  Substances:  Substances  riot  listed  on  EiNECS.  These  substances  are ·in  the 
"European ~ist of Notified Chemical Substances" (ELINCS) (>  2100 substances,  ever 
growing list) following notification to Competent Authorities of  placing on the market. 
J 
Notification procedure for a new substance: Su_bmission of a technical dossier to  the 
Competent Authority of a Member State, containing information specified by the sixth 
amendment to Directive 67/548/EEC.  · 
OEL:  Occupational  Exposure  Limit.  Most  often  an  OEL  refers  to.  the  ai'rborne 
concentration  of a  substance  averaged  over  a  reference  period,  such  as  an  8 ·hour 
workshift, or over a  15  minute period during a work shift \vhere peak exposures may 
occur,  which if not exceeded is  unlikely  to  lead  to  adverse  health effects  in. exposed 
workers, when exposed daily over a standard working lifetime. 
OECD: Organisation for Economic Co-operation and Development. 
Outcome of risk assessment: One or more of the following conclusions/results for each 
human population and environmental protection goal defined under Regulation 1488/94: 
· •  need for further inforn1ation and/or testing· 
•  at present no need for further information and/or testing and no need for risk reduction 
.measures  . 
•  need for limiting the risks. 
PHASE I, ·II,  III:  The  systematic  approach  for  the  collection  of information  to  be 
submitted  by Industry  in  a  step-by-step  procedure  according  to  production  or  import . 
vol1,1me.  Phase I concerned all HPV  chemicals, which are  listed in Annex I of Council 
Reg.' (EEC) 793/93. The reporting period for Phase I ended June 4, 1994. For Phase II all 
HPV chemicals, which are not listed in Annex I, had to be reported by June 4,  1995. For 
Phase III a reduced HEDSET (Chapter 1 only) for all LPV chemicals had to be submitted 
by June 4, 1998. 
Priority Lists: Lists  of substances  prioritised  for  risk assessment  owing  to  potential 
concerns for man and the environment and for which a comprehensive risk assessment 
should be carried out, as defined under Regulation (EC) 1488/94. 
"Rapporteur": The  authority,  appointed  by  the  Government of each  Member  State, 
which is responsible for carrying out a risk assessment on an "eXisting" substance and for 
proposing risk reduction measures, where relevant. 
Regulatory Committee: Established in Article 15 of Regulation 793/93, this Committee 
is  composed  of representatives  from  the  EU  Member  States  and  chaired  by  the 
representative of the  Commission.  Its  opinion  shall  be  delivered by the  majority  laid 
down in Article 148(2) of  the Treaty of Rome. 
Risk Assessment:  A  process  to  determine  the  relationship  between  the .  predicted 
exposure and adverse  effects in four  major steps:  hazard  identification, dose-response 
assessment, exposure assessment and risk characterisation.  · 
32 Risk Assessment Report:  A  vmtten:  report of the  risk  assessment  as  defined  under 
Regulation (EC)  1488/94 , for each prioritised substance,  drafted by  the  "Rapporteur", 
discussed ana agreed at Risk Assessment Technical Meetings and ultimately published in 
both summary and comprehensive report formats. 
Risk Assessment Technical Meeting:  An expert group  composed .of technical expert 
representatives  of the  EU  Member  States,  and  EFTA  Countries,  given  the  task  of 
discussing and agreeing upon the content and conclusions of each risk assessment report. 
Several  observers  (Industry, NGOs  and  international  organisations)  are  also  invited to 
.participate. 
Risk characterisation: Estimation of the incidence and severity of the  adverse effects 
likely to occur in a human population or environmental compartment due to  actual  or 
predicted exposure to a substance. 
Risk Reduction Strategy:  Recommended measures proposed by  the  "Rapporteur"  in 
order to reduce the risks, to be discussed and agreed upon at the Risk Reduction Strategy 
Meeting 
Risk Reduction Strategy Meeting: An expert group composed of representatives of the 
EU Member States, and EFT  A Countries, given the task of discussing and agreeing upon 
each risk reduction strategy presented by the "Rapporteur".  Several observers (Industry, 
NGOs, and international organisations) are also invited to participate in the discussions. 
SIAM:  SIDS  Initial Assessment Meeting  organised by  OECD  at  which the  SIAR is 
presented. 
SIAR :  SIDS  Initial  Assessment Report.  This  iG  the  name  of the  assessment  reports 
discussed in the framework of  the OECD "existing" chemicals programme. The EU risk 
as~essment reports enter the OECD programme as SIARs. 
SIDS :  Screening Information Data Set.  This is  the internationally accepted minimum 
data-set required for carrying out a risk assessment. 
"Targeted"  risk assessment:  A  less  extensive,  more  specifically  focused  evaluation 
(because of  a specific concern) than a comprehensive risk assessment. 
TGD:  Technical  Guidance  Documents  on  Risk  Assessment  and  Risk  Reduction 
Strategies provide technical guidance in support of Council Regulation (EEC)  793/93. 
The TGD on Risk Assessment lays down the methodology agreed by Member States, for 
carrying out a risk assessment in accordance with Commission Regulation  1488/94/EC 
and Commission Directive 93/67/EEC. 
UN:  United Nations. 
Voluntary agreement:  For the  purpose  of this  Regulation,  the  concept of voluntary 
approaches  by  Industry  as  a  substitute  or  complement  to  legislation.  The  agreement 
concerns  a well-defined  scope  of application  and  normally  includes  a  timetable  for 
implementation. 
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,' APPENDIX I 
Official Journal References of Community legislation 
Referred to in the text of the report: 
I 
Council Directive 67/548/E~C  OJ No.  196,  16/08/1967  On  the  approximation  of  laws,  regulations  and  administrative 
p. 000 I - 0005  provisions relating to the classification, packaging and  labelling of 
dangerous substances 
Council Directive 761116/EEC  OJ No.  L 024, 30/01/1976  On the approximation of the laws of the Member States relating to 
p. 0021 - 0044  fertilisers 
Council Directive 761768/EEC  OJ No.  L 262, 27/09/1976.  On the approximation of the  laws of the  Member States relating to· 
p. 0169-0200  cosmetic products 
Council Directive 761769/EEC  OJ No.  L 262, 27/09/1976  On _the  approximation of the  laws,  regulations  and administrative 
p. 020 I - 0203  provisions  of. the  Member  States  relating  to  restrictions· on  the 
marketing and use of  certain dangerous substances and preparations 
Council Directive 79/117/EEC  OJ No.  L 033,  08/02/1979  Prohibiting the  placing on the  market and use  of plant protection 
p. 0036-0040  products.containing certain active substances  . 
Council Directive 79/831/EEC  OJ  No.  I 259,  15/1011979  6111  amendment  of  Council  Directive  67/548/EEC  on  the 
(6'h  amendment  of  Council  p. 0010- 0028  approximation  of laws,  regulations  and  administrative  provisions 
Directive 67/548)  relating to the classification, packaging and  labelling of dangerous 
substances 
Commission Decision  OJ No.  L  167,  24/06/1981  Laying  down  the  criteria  in  accordance  with  which  information 
81/437/EEC of II May 1981  p. 0031-0038  relating to the  inventory of chemical substances is  supplied by the 
Member States to the Commission  · 
Council Directive 83/189/EEC  OJ  No.  L  109,  26/04/1983  Laying down a  procedure  for  the  provision of information  in  the 
p. 0008-0012  field of technical standards and regulations 
Council Directive 86/362/EEC  OJ No.  L 221, 07/08/1986  On the fixing of maximum levels for pesticide residues  in  and on 
p. 0037-0042  cereals 
Council Directive 86/363/EEC  OJ No. L 221, 07/08/1986  On the fixing  of maximum levels for  pesticide residues  in  and on 
p. 0043- 0047  foodstuffs of  animal origin 
Council Directive 86/609/EEC  OJ No.  L 358,  18/1211986  On  the  approximation  of  Jaws,  regulations  and  administrative 
p. 000 I - 0028  provisions of  the Member States  regarding the protection of animals 
used for experimental and other sCientific purposes 
Council Directive .87/18/EEC  OJ No.  L 015,  17/01/1987  On  the  harmonisation  of  laws,  regulations  and  administrative 
p. 0029 - 0030  provisions  relating  to  the  application  of the  principles  of good 
laboratory practice and the verification of their applications for tests 
on chemical substances 
Council Directive 87/373/EEC  OJ No. L 197, 1817/1987  Laying  down  the  procedures  fo~ the  exercise  of implementing 
p. 0033 - 0035  powers conferred on the Commission 
Council Directive 88/320/EEC  OJ No.  L  145,  J.l/06/1988  On  the  inspection  and  verification  of Good  Laboratory  Practice 
p. 0035- 0037  (GLP) 
Council Directive 88/379/EEC  OJ No.  L  187,  16/07/1988  On  the approximation  of the  laws,  regulations  and  administrative· 
p.-0014- 0030  provisions  of the  Member  States  relating  to  the  classification, 
packaging and labelling of  dangerous preparations. 
Council Directive 89/391/EEC  OJ  No.  L  183, 29/06/1989  On the introduction of measures to encourage improvements in  the 
p. 0001-0008  safety and health of  workers l!:t  work 
Council  Directive  COM  316  OJ No.  C 318, 20/12/1989  Re-examined proposal for a Council Directive amending for the 8111 
FINAL  SYN  119  (proposal for  p. 0010  time  Dire~tive  761769/EEC  on  the  approximation  of the  laws, 
81h  amendment  to  Council  regulations  and  administrative  provision  of the  Member  States 
Directive 761769/EEC)  relating  _to  restrictions  on  the  marketing  and  use  of  certain 
dangerous substances and preparations 
Council Directive 89/677/EEC  OJ No.  L 398, 30/1211989  8
111  amendment of Council Directive 76/769/EEC on the restrictions 
p. 0019- 0023  of  marketing  and  use  of  certain  dangerous  substances  and 
4 
preparations  ' 
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Council Directive 90/394/EEC  OJ No. L 196,26/07/1990  On the protection of workers from  the risks  related to  exposure to 
p. 0001  - 0007  carcinogens at work (Sixth individual Directive within the meaning 
of  Article 16(1) of Directive 89/391/EEC 
Council Directive 90/642/EEC  OJ. No.  L 350,  1411211990  On  the  fixing  of maximum  levels  for  pesticide  residues  in  an  on 
p. 0071-0079  certain products of plant origin, including fruit and vegetables 
Council Directive 91/414/EEC  OJ No.  L 230,  19/0811991  Concerning the placing ofp1ant protection products on the market 
p. 000 1 - 0032 
Council  Directive  92/32/EEC  OJ No.  L  154, 05/06/1992  7"'  amendment  of  Council  Directive  67/548/EEC  on  the 
(?"'  amendment  of  Council  p. 0001  - 0029  approximation  of laws,  regulations  and  administrative  provisions 
Directive 67/548/EEC)  relating to  the classification, packaging and  labelling of dangerous 
substances 
Council Directive 92/59/EEC  OJ No.  L 228, 1110811992  On general product safety 
p. 0024- 0032 
Council Directive 92/85/EEC  OJ No.  L 348,  28/111199~  On the introduction of measures to encourage improvements in the 
p. 000 1 - 0008  safety  and  health· at work  of pregnant workers  and  ~vorkers who 
have  recently  given  birth  or  are  breastfeeding  (tenth  individual 
Directive  within  the· meaning  of  Article  16  (1)  of  Directive 
'  89/391/EEC) 
Council  Regulation  (EEC)  OJ No.  L 084, 05/04/1993  On the evaluation and control of  the risks of  existing substances 
793/93  p. 0001  - 0075 
Commission Directive  OJ No.  L 227, 08/09/1993  Laying down the principles for assessment of risks to  man and the 
93/67/EEC  p. 0009-0018  environment  of substances  notified  in  accordance  with  Council 
Directive 67/548/EEC 
Commission  Regulation  (EC)  OJ  No.  L  131,  26/05/1994  Concerning  the  first  list  of priority  substances  as  foreseen  under 
1179/94  (1"  list  of  priority  p. 0003 - 0004  Council Regulation (EEC) 793/93 
substances  under  Council 
Regulation (EEC) 793/93) 
Council Directive 94/33/EC  OJ No.  L 216, 20/08/1994  On the protection of  young people at work 
p. 0012-0020 
Commission  Regulati~n  (EC)  OJ  No.  L  161, 29/06/1994  Laying down the principles for the  assessment of risks to man and 
1488/94  p. 0003 - 00 11  the environment of existing substances in  accordance with Council 
Regulation (EEC) 793/93 
European  Parliament  and  OJ No.  L 365, 31/12/1994  Amending  for  the  14"'  time  Directive  761769/EEC  on  the 
Council Directive 94/60/EC  p. 0001-0009  approximation  of  the  laws,  regulations  and  administrative 
provisions  of the  Member  States  relating  to  restrictions  on  the 
marketing and use of  certain dangerous substances and preparations 
C.ommission  Regulation  (EC)  OJ No.  L 231, 28/0911995  Concerning the second list of priority substances as foreseen under 
2268/95  (2"d  list  of  priority  p.0018-0019  Council Regulation (EEC) 793/93 
substances under  Council Reg. 
793/93) 
Commission  Regulation  (EC)  OJ  No.  L  25,  28/0111997  Laying  down  the  procedures  for  the  exercise  of implementing 
143/97  (3'd  list  of  priority  p. 0013-0014  powers conferred on the Commission 
substances under Council (EEC) 
Regulation 793/93) 
European  Parliament  and  OJ  No.  L 335, 06112/1997  Amending  Directives  76/116/EEC,  80/876/EEC,  87/284/EEC  and 
!  Council Directive 97/63/EC  p. 00 15 - 00  16  89/530/EEC on the approximation of the Jaws of  the Member States 
I  relating to  fertilisers .  I 
I Council Directive 98/24/EC  OJ No L 131, 05/0511998  On the protection of the health and safe~ of  workers from the risks 
p. 0011-0023  related to chemical agents at work.  ' • 
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APPENDIX II LIST OF STAKEHOLDERS 
COMPETENT AUTHORITIES 
Austria 
Belgium 
Denmark 
Finland 
France 
Germany 
Greece 
· Ireland 
·Norway 
European Free Trade Association Secretariat (EFTA) 
. European Surveillance Authority (ESA) 
EUROPEAN COMMISSION 
DIRECTORATES GENERAL INVOLVED 
Environment, Nuclear Safety and Civil Protection 
Joint Research Centre 
Industry 
Employment, Industrial Relations and Social Affairs 
Agriculture 
Italy 
Luxembourg 
Netherlands 
Portugal 
Spain 
Sweden 
:United Kingdom 
Enterprise Policy, Distributive Trades, Tourism and Social Economy 
Consumer Policy Service 
INDUSTRY 
APPENDIX III 
Association lnternationale de Ia Savonnerie, de Ia Detergence et des Produits d'Entretien (AISE) 
European Association of  Metals (EUROMETAUX) 
European Chemical Industry Council (CEFIC) 
Oil Companies European Organisation for Environment, Health and Safety (CONCA  WE) 
NGOs 
Bureau Europeen des Unions de Consommateurs (BEUC) 
European Environmental Bureau (EEB) 
Friends of  the Earth 
Greenpeace International 
European Trade Union Technical Bureau for Health and Safety 
World Wildlife Fund for Nature (W\VF) 
INTERNATIONAL ORGANISATiONS 
International Programme on Chemical Safety (IPCS) 
Organisati~n for Economic Co-operation and Development (OECD) 
37 Links between international programs carrying out 
risk assessments (RA) on existing chemicals 
IPCS 
- Environmental Heald{ Criteria 
(EHC) 
- Concise International 
Chemical Assessment 
Documents (CJCAD) 
OECD· 
SIDS Initial Assessment 
Reports (SIAR) for High 
Production Volume 
Chemicals 
Agenda 21 
Implementation of Chapter 19 
Programme Area A 
200 substance reports by  1997 
A further 300 by 2000 
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restrictions on the marketing and use of certain dangerous 
substances. and preparations 
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1.1  Context 
The Treaty of Rome (1957)  envisaged from  the outset the  creation of an  internal 
European  market  and  the  main tasks  of the  Community  were  purely  economic. 
Consequently, the first legislative actions on chemicals taken by the Co~unity  were 
motivated by the efforts to complete the internal market by harmonising specifications 
that otherwise could create obstacles to the free movement of  ~ods. 
Article 100a of the Treaty, introduced by the Single European Act in 1987, provides 
for the approximation of provisions applying in Member States through Community 
measures  adopted  by  qualified  majority.  It requires  that  the  Commission  in  its 
proposal concerning health, safety, environment protection and  consumer protection 
take as a base a high level of  protection. 
·Many Directives and Regulations pursuing the goals of creating a common market 
and  of ensuring  chemical  safety and  environmental protection  have  been adopted 
during the last 30 years, among others, Directive 761769/EEC on restrictions on th~ 
marketing and use of certain dangerous substances and preparations. This Directive 
was introduced in 1976 to deal with situations where classification and labelling of 
chemicals  were not  sufficient to  protect health  and  the  environment  and Member 
States were introducing national restrictions on the marketing ar;td  use of chemicals 
thus creating barriers to trade. The Directive sets out detailed rules for restriCtions on 
marketing and use harmonising the legislation throughout the Community and at the 
same time providing for a high level of  protection of man and the environment. It is 
complemented by a number of other Directives limiting the marketing and  use of 
chemicals in particular fields  e.g.  Directive 76/117  !EEC limiting the marketing and 
use of  certain dangerous chemicals in agriculture, Directive 761768/EEC setting down 
rules for the use of chemicals in:  cosmetics and Directive 73/204/EEC governing the 
use in detergents. 
Restricting the marketing and use of dangerous substances and preparations is only 
one instrument used  by the  Community  to  control  the  risks  to  health  and  to  the 
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protection of health and the enviroriinent  and  of the health and  safety of workers. 
) 
Examples  are  Directive  96/61/EC  concerning  integrated  pollution  prevention  and 
control and Directives 90/394/EECand 98/24/EC on protection ofhealth and safety of 
workers from risks related to chemical agents at ~ork. 
1.2  Objectives 
The objectives of  Directive 76/769/EEC are,· according to Article 1  OOa of  the Treaty, 
to guarantee free movement of goods within the single market and at the same time 
provide a high level of protection of man and the environment. These objectives are 
clearly spelled out in the recitals to the Directive: rules concerning the placing-on the 
market of dangerous substances and preparations must-aim at protecting the public, 
and particular persons using such substances and preparations. The restrictions should 
contribute to  the protection of the environment from all substances and preparations. 
which have  characteristics of ecotoxicity or' which could pollute the  environment. 
They should also  aim  to  restore, preserve, and improve the  quality of human life. 
Harmonised rules  should remove, the  obstacles to  trade  and  the  functioning of the 
internal market created by different provisions in the Member States. 
2.  DESCRIPTION OF THE DIRECTIVE  -
2.1  Structure 
The Directive consists of two main articles and an annex. In the articles it is  stated  .  . 
that the Directive _is  concerned with_· restricting the marketing and use of dangerous 
substances and preparations listed in the Annex and that Member States· shall take all 
necessary measures to  ensure that these dangerous substances and preparations may 
. 
only be placed on the·market or used subject to conditions specified in the Annex. In 
the Annex the substances are listed and the restrictions specified. 
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date,  it has been amended  18  times providing  for  restrictions  on 42  substances or 
groups of substances (covering about 900 individual substances in total).  Proposals 
for  amending Directives are  adopted by The  Council and the European Parliament 
according to the co-decision procedure. 
A  Committee  procedure  to  adapt  the  Directive  to  technical  progress  has  been 
introduced to take account of new scientific knowledge on risks of chemicals or the 
development of  less dangerous substitUtes for restricted substances. According to this 
procedure restrictions on substances already included in the Annex to. the Directive· 
can be changed by Commission Directives. This procedure is  considerably quicker 
and  simpler than  the  co-decision  procedure.  The  proposals  are  approved  by  the 
Member States on the basis of a qualified majority foliowed by formal  adoption by 
the Commission. Up until now, this procedure has been used four times to  adapt the 
Directive to technical progress. 
2.2  Scope 
The  Directive  covers  the  placing  on  the  market  and  use  of certain  dangerous 
substances  and  preparations.  In  certain cases  it also  applies  to  articles  containing 
dangerous substances. Examples are proaucts containing asbestos  or certain plastic 
·products containing cadmium. 
The  provisions  of the  Directive  are  not  applicable  to  ·tran·sport  of dangerous ·  .. 
substances and preparations, for exports to non-EU countries, J;o  ~ansports in transit 
regime, nor to marketing and use for research and development or analysis purposes. 
The first substances to be included in the Annex to the Directive were polychlorinated 
biphenyls and terphenyls (PCB and PCT) and monomer vinyl chloride. The reason for 
introducing harmonized provisions were, apart from the establishment of an internal, 
market, the dangers to human health associated with the use of these substances. The 
substances subsequently introduced into the Annex by the first seven amendments to 
the Directive adopted between 1976 and 1985, are all dangerous to human health and 
.  . 
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retardants  used  to  fire-proof  textiles  and  garments  (tris  (2,3  dibromopropoyl) 
phosphate,  tris-aziridinyl  phosphinoxide  and  polybrominated  biphenyls  (PBB)), 
certain dangerous substances usedin toys and jokes (e.g. benzene, bensidine, volatile 
esters of 9romoacetic acids etc.). Also the restrictions on the use of asbestos fibres 
were introduced during this time~ 
Restrictions  on  substances  dangerous  especially  to  the  environment  were  first 
introduced in the early 1990s following  an  increased public concern about the risks 
posed  hx  chemicals  to  the  environment  and  the  entry  into  force  of the  Single . 
European  Act. . Restrictions  on  substan~es used  as  biocides  and  dangerous  to  the 
aquatic environment such as mercury, arsenic and tin compounds were included in the 
Annex  by the  eighth  amendment.  Other  examples  of substances  dangerous  to  the 
environment included in the Annex  are  pentachlorophenol  (PCP)  (mainly used  for 
wood-preservation),  cadmium  and  hexachloroethane  (used  in  non-ferrous  metal 
industries). 
Restrictions especially directed to the use by consumers of  dangerous substances was 
introduced in the mid 1990s by the  14th  amendment. The initiative was taken in the 
context of  the programme "Europe against cancer" and is focusing on cane,:er causing 
substances. Substances classified as carcinogenic, mutagenic or toxic_ to reproduction 
category 1 and 2 (c/m/r) are, subject to an assessment ofthe risks and advantages of 
the substances, included in the Annex and banned for consumer use. The list of c/m/r 
substances  in  the  Annex  is  constantly  up-d:tted  by  amending  Directives  as  new 
substances are classified under Directive 67/548/EEC. 
2.3  Provisions 
The provisions in  the  Directive  are  constructed  according  to  two  main principles. · 
'  They either provide for a ban, with or without excemptions, on the marketing and/or 
use of  the substance, or provide for controlled use. 
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cases. The more common approach is a ban with exemptions. A ban with exemptions 
means that marketing and use of the substance are prohibited except for applications 
that are expressly allowed. 
Controlled use means that marketing and use ·of a substance and the preparations and 
products containing it are allowed except those which are expressly forbidden.  This 
means  that  only  those  products  and  applications  will  be  limited  which  present  a 
special risk and where safer substitutes exist. This approach is the predominant one 
used in the Directive. 
The choice of strategy depends of course of the nature of the risk,  e.g.  whether the 
effects  are  life  threatening,  'irreversible,  long.:term,  global  etc.,  but  also  on  the 
complexity  of the  situation.  The  scientific  uncertainties  about  the  risks,  technical 
·knowledge in general  about the different applications  of the  substance,  as  well as 
information on safer substitutes influence the choice of strategy. Finally, the benefits 
of the proposed strategy i.e. the reduction in risk and the costs of  the measure should 
be in proportion one to the other. 
Although following the two main strategies, the specific provisions on each substance 
vary considerably in the Directive as illustrated by the following: 
- The ban on  marketing  and  use  is total.  This  is  the  case  for  PCB  and  of some 
substitutes to PCB the so called Ugilecs. 
- In other cases certain exemptions are granted, e.g. when no replacement substances 
are  available  for  certai~ applications,  as  in  the  case  of pentachlorophenol  where 
exemptions from the ban were granted for four specific uses. The exemptions may be 
permanent or limited in time (fixed date or end-of-use period of  products concerned). 
- The marketing and use is banned only in  relation to  the  general  public, 'whereas 
professional users may continue to use the substance for cert:ain applications or as an 
intermediate.  This  provision  is  often  combined  with  specific  requirements  for 
labelling 
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'  . 
specific  applications  (e.g.  in  textiles),  or  for  uses  posing  a  particular  risk  (e.g. 
treatment of industrial waters),  or as  component together with other materials,  but 
otherwise substances can be used. 
- Limit values are.also set e.g. the restrictions only apply when the content of  a certain 
substance in the final product reaches certain threshold values. 
-.Finally,  marketing  and  use  is  allowed  only when  specific  labelling  and.  safety 
requirements are observed. 
2A  Sources of limitations 
The initiative by the Commission to propose a new amendment limiting the use of a 
substance  not  previously  restricted  or  to  adapt  existing  provisions  to  technical " 
progress can have many different sources. 
Notifications under Directive 83/189/EEC 
A  proposal from  the  Commission  is  usually  triggered  by  a  notification  from  a 
Member State under Directive 83/189/EEC of its  intention to  unilaterally introduce 
limitations  at  national  level.  Directive  83/189/EEC  lays  down  a procedure  for  the 
• 
provision of  information in the field of  technical standards and regulatipns; it gives to 
the  Member States  and  the  Commission the  possibility of objecting  to  a notified 
national proposal because of its likely trade effects. In fact, proposals for most of the 
amendments  of Directive  79/769  have  had  their  origin  in  notifications  from  the 
Member States under Directive 83/189. 
International organisations 
Many  international  organisations  are  actively  involved  in  questions  of chemicals 
safety and control, and protection of  human health and the environment. Among them 
are  organisations of the  UN (WHO,  F  AO,  UNEP,  UNECE,  ILO),  the  OECD,  the 
Council of Europe, and several organisations pursuing the protection of the marine 
environment like  the North  Sea  Conference,  OSP  ARC OM,  and .  HELCOM.  Many 
Member States of the  European Union are  also members of these organisations.  In 
some cases; the Union itself is  a formal  member, too.  In cases where not all of the 
Member States are  contracting parties to  an  organisation or when some. of the  El! 
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orginisations and others do  not apply the same rules, the functioning of the internal 
market can be disrupted and  there is  a need to  introduce harmonised provisions at 
Community level. The 15th amendment to Directive 76/769/EEC on hexachloroethane 
follows  an  initiative  in  P  ARCOM  to  phase  out  the  lise  of hexachloroethane  in 
production of  nq,n-ferrous metals. 
Council Resolutions 
Declarations and Resolutions from  the Council of the EU have been major driving 
forces  during  the  establishment,  the development,  and  the  definition of long term 
objectives  in policy  of chemicals  control,  and  health  and  enviroru:D.ent  protection. 
Resolutions on specific topics have been adopted, e.g.  on cancer prevention (1990) 
which motivated  a major part of Directive  94/60/EC  amending  for the. 14th  time 
Directive 761769/EEC by prohibiting the placing on the market for use by the general 
public  of substances  that  are  classified  as  carcinogenic,  mutagenic  and  toxic  to 
reproduction.  Another resolution  concerned  cadmium  (1988)  and  led  to  Directive 
911338/EEC  amending  for  the  lOth  time  Directive  791769/EEC  by  restricting 
marketing and use of  cadmium for plating and in polymers as pigment and stabiliser. 
Existing Substances Regulation 
If  the result of  the evaluation under Regulation (EEC) 793/93 is a recommendation to 
limit the marketing and use  of a priority substance,  the  Commission shall propose 
Community measures in the framework of  Council Directive 761769/EEC. The details 
of  the strategy are further developed in the frame work of Directive 76/769/EEC and 
the strategy can be implemented either by an  amendment following the co-decision 
procedure or as an adaptation to  technic~! progress by Committee procedure. 
In practice, as risk assessments under the Existing Substances Regulation are  fairly 
new and the procedure has initially been lengthy only a few  risk assessments have 
been concluded. A proposal for measures within the framework of Dir. 761769/EEC 
concerning  one group  of substances,  short  chain chlorinated  paraffins (SCCP),  is 
expected shortly.  On the basis of the progress achieved recently, it is also expected 
that the process will accelerate and that results from risk evaluation under regulation 
793/93  will  be  at  the  origin  of an  increasing  number  of Community  initiatives 
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concerning restrictions ori marketing and use in the futl,rre. 
New Substances Notification 
'  , 
Any new substance to be placed on the market has to be notified by the manufacturer, 
. distributor or the importer to the national competent authority. "Notification" includes 
the submission of  detailed data and only after approval of  the notification dossier may 
the  substance be marketed.  It is  obvious  that,  as  for  ex;isting  su])stances,  Member 
States and/or the European Union can, on· the basis, of  the technical dossier submitted 
during  the notification  and  the  risk  assessment  carried  out  by  them,  take  actions 
.  .  .  -.  .  .  : 
concerning safety requirements. These can include restrictions on marketing and use 
under Directive 76/769/EEC. Up to now one notification of a new substance has led 
to  such  a  measure:  a  family  of PCB-substitutes  (Ugilecs)  banned  by the  lith 
amendment. 
Safeguard Clauses 
Several Directives and Regulations concerning chemicals control and safety contain 
safeguard  clauses.  They allow  a Member  State,  when  it  has justifiable reasons  to 
consider that  substances  or preparations  that  have  been  accepted  as  satisfying  the 
requirements of the Directive concerned nevertheless constitute a danger for man or 
the  environment,  can  temporarily  take  measures,  e.g.  prohibit  the  placing  oil  the 
market  or  subject  the  substance  to  special  conditions  in  its  territory.  It  must 
immediately inform the Commission and the other Member States of  such action and . 
give reasons for its  decision and  the  Commiss!on must  take a decision thereon.  A 
possible measure following such an action is a proposal of  an amendment to Directive 
76/769/EEC.  One  example  is  the  13th  amendment  to  Directive  76/769/EEC 
prohibiting the marketing for consumers of  aerosols which contain substances that are 
(provisionally)  classified  as  flammable  or  extremely  flammable.  This  amendment 
follows  the  application  of the  safeguard  clause  of the  Aerosols  Directive by one 
Member State. 
2.5  Risk assessment and cost benefit analysis 
In the proces's to elaborate a proposal for further restrictions on the marketing and use. 
of dangerous  substances  and  preparations  it  is  important  to  make· sure  that  the  · 
proposal fulfils the general objectives of  Directive 761769/EEC to establish an internal· 
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environment. 
It is also important that the proposal is proportionate i.e. that the costs of  the measure 
are proportionate to the benefits. In the Communication from the  Commiss~on  on 'An 
Industrial Competitiveness Policy for the European Chemical Industry:  an Example' 
(Com(96)  187  final)  actions  to  imprqve  the  regulatory  framework  are  explicitly 
mentioned as part of the. measures to· improve the competitiveness of the chemical 
industry.  The  Commission has  commicted  itself to  carry  out  risk  assessme11ts  and 
adequate  analyses of the costs  and bf:nefits  prior to  any  proposal or adoption of a 
regulatory measure affecting the chemical industry. 
Risk assessment 
Risk assessments of  chemicals are carried out under different legislative frameworks 
such  as  Regulation  793/93  on Existing  Substances  and  Directive  98/8/EC  on  the 
placing on the market of biocidal products. These programmed assessments are very 
comprehensive, and, ·although being extremely valuable sources of information, tend 
to be rather time-consuming. 
In most case~, proposals for  harmonise~ restrictions on marketing and use have to be 
developed under time constraint. The Commission has to react within a limited period . 
of time  e.g.  to  notifications  by Member States of unilateral  actions,  to  immediate 
threats to  health or the environment or to  initiatives by  international organisations 
disturbing  the  internal  market.  Targeted risk  assessments  have  been  developed  for 
application  primarily  to  urgent  problems  arising  in.  the  context  of  Directive 
76/769/EEC. 
Due  to  the constraint in time· under which the  assessment  has to  be  carried out  a 
· targeted risk assessments  is  different from  a programmed assessment in two major 
aspects: the scope of  the assessment and the data availability. 
A targeted risk assessment  is  limited in scope.  The  assessment could  fo_cus  e.g.  on 
those  areas  that  would  be directly  concerned by the  proposed  measure  to  restrict 
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substance  suspected  to  be  major  sources  of risk,  to  certain  populations  such  as 
~onsumers  or to  criti~al effects of  the substance. The targeted assessments have to rely 
mostly on already available data.  The time constraint does not allow new data to be 
generated.  Toxicological  experiments  or  exposure  measurements  do  often  take 
considerable time. For example, studies on chronic toxicity or cancer could take up to 
two years to complete. 
Targeted risk assessments are carried .out  in the frame work of Directive 76/769 by 
independent consultants 
interactively and transparently with active and co-operative contributions from all 
parties  such  as  industry  (producers,  users  etc.),  Member  State  authorities,  the 
scientific community, interest groups, consumers, etc. 
according to  the  Community's established procedures  for  risk  assessment.  The 
generally accepted standards fot risk assessments are not lowered. For the areas of 
concern,  the  actual  risk  assessment  should  follow  as  ·closely  as  possible  the 
established ·Community  principles  as  laid  down  in  .Directive  93/67/EEC, 
Regulation  (EC)  No  1488/94,  and  the  supplementary  Technical  Guidance 
Documents. 
with quality assurance and peer review. Where appropriate and in accordance with 
the  Commission  Communication . on  consumer  health  and  food·  safety 
COM(97)183  final,  the  Scientific  Committee  on  Toxicity,  Eco-toxicity  and 
Environment  is  consulted  to  give  its  scientific  opinion  on  the  targeted  risk 
assessment. 
Analysis of  advantages and drawbacks  · 
Risk assessment provides only part of  the information necessary for risk management. 
To  establish  that  the  proposed  measures  are_  proportionate  the  advantages  and 
drawbacks  of adopting  restrictions  and  using  replacement  substances  or  other 
alternative solutions must be analysed. Furthermore, .an  economic evaluation of the 
benefits and costs linked to a proposed measure is a systematic approach that provides 
a coherent way of organising thoughts about the policy problem and  policy options 
and  helps  to  organise· information  that  will  be  of importance  to  poiitical  decision. 
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and benefits are, and who bears them). 
The advantages  of a proposed  restriction can be understood  to  mean  the  positive 
implications  of the  restriction.  Clearly  positive  is  the  extent  to  which  the  risks 
identified during the risk assessment will be limited, taking into account any increase 
in  risk  to  human  health  and  the  environment  arising  from  an  increasing  use  of 
replacement substances. The risk reduction can have positive effects on future costs of 
environmental  remediation  and  health  care  presently  incurred  in  dealing  with  the 
existing.risks. There maybe positive effects and reduced costs in matters linked to 
occupational safety, treatment of  waste and landfill sites, quality and use of formerly 
contaminated products, as well as medium and long-term advantages resulting from 
the  development  of alternative  technologies,  the  production  and  marketing  of 
substitutes,  increase  of  long-term  competitiveness,  creation  of  new  jobs. 
Administrations and control authorities might experience less costs than when using 
other risk reduction strategies (e.g. monitoring of  emission limits achieved by  end-of~ 
pipe technologies). 
Drawbacks are understood to mean the negative implications of the restriction. They 
include  possible  new  risks  due  to  the  substituting  chemicals,  a  range  of costs  to 
industry  (investments,  development of alternatives,  compliance  costs),  notably  the 
producers,  processors  and  users  of the  substance  to  be  restricted,  costs  to  the 
consumers due to  ~.g. higher price, poorer performance of substitutes, closing down 
of  production facilities, loss of  amenity to consumers, costs to society as a whole, e.g.  · 
administrative  costs  of enforcing  the  restriction,  loss  of employment,  transfer  of 
benefits to other countries/regions, _etc. 
In principle, an analysis of advantages and drawbacks will start off with a qualitative 
analysis,· where advantages and drawbacks are described but not quantified or valued. 
The analysis should then move on to quantification to increasing degrees, depending 
on  what  is  needed  to  make  a  convincing  comparison  between  advantages  and 
drawbacks.  Due  to  uncertainties,  it  will  usually  be  difficult  to  fully  quantify 
advantages  and  drawbacks  that  are  only  indirect  consequences  of an  envisaged 
restriction. 
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less dangerous substitutes has to be addressed. It is not possible or necessary, except 
in certain cases, to carry out full  assessments of available substitutes. However, the 
analyses  should  provide  enough  information  to  assure  that  restrictions  on  one 
substance do not create new, possibly more serious risks and that the substitutes are 
' 
technically and ~conomically feasible. 
The analysis of  advantages and drawbacks in the frame work of  Directive 76/769 are, 
in analogy with the targeted risk assessments, carried out by independent consultants. 
However,  the  analysis  procedure  is .less  well  developeq  not least  because  of the 
absence to  date of any. accepted  set of Community  procedures  in the  field.  Initial 
guidance  is  given  in. the  Technical  Guidance  Document  on  development  of risk 
reduction strategies.  The work  should  be done  in  a transparent  way  involving  all 
stakeholders. 
Work  to  further  develop the  methodology  for  targeted  risk  assessments  and  cost· 
benefit analyses  in  the  frame  work of Directive  761769  is  on-going.  This work is 
presented in the DG III Working paper on Risk Management in the framework of 
Council Directive 761769/EEC (Doc. 981RiMa03). 
3.  EVALUATION 
Directive 76/769/EEC has been evaluated against the general objectives in relation to 
the internal market and to health and the  environm~nt set by the Treaty. The capacity 
of the  Directive to  meet  these  objectives  is  of course  depending  on the  practical 
operation  of the  Directive  and  this  is  why  the  practical  operation  has  also  been 
evaluated in terms of  procedures and the structure of  the legislation. 
3.1  Internal market 
According to Article lOOa of the Treaty one objective of the Directive is to establish 
an internal market with chemicals circulating freely without any barriers to trade. The 
Directive provides for total harmonisation in the area c?vered by the provisions of  the 
Directive.  However, Article 36  of the Treaty gives the Member States· the right to 
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the  areas  outside the  scope of the Directive the  Member States  can,  after having 
notified the Commission and Member States under Directive 89/183/EEC, introduce 
national  provisions  restricting  the  marketing  and  use  of chemicals.  The  measures 
should  not  constitute  arbitrary  barriers  to  trade  and  should  be  justified  and 
proportionate. If the unilateral  restrictions  introduced by a Member  State solves  a 
national  health  or  environmental  problem  without  disrupting  the  internal  market 
harmonised measures are not introduced unless there is a need to  raise the level of 
protection  in  the  Community  as  a  whole.  This  corresponds  to  the  principle  of 
subsidiarity established in  Article 3b of  the Treaty and further reinforced in a protocol 
to the new Amsterd.am Treaty. 
After 20 years of practical operation the Directive has generally proven effective in 
relation to the objective on internal market. It has been possible to meet the need to 
introduce  Community  wide  harmonised  restrictions  when· Member  States  have 
planned to unilaterally introduce national restrictions that would have disrupted the 
internal market. In recent years,  all proposals for harmonised restrictions have been 
adopted without any Member State voting against. 
However, in three cases certain Member States have used the possibility under Article 
1  OOa  §4  to  request  derogations  from  the  Community  legislation  to  keep  stricter 
national  legislation in  force  providing a higher level of protection of man and  the 
environment. The requests  concern the provisions on PCP, cadmium  and  creosote. 
Two requests for derogations from the provisions on PCP have been confirmed whilst 
a thirdjs pending, as is the requests concerning cadmium and creosote, mostly due to 
lack  of scientific  evidence  of the  necessity  to  keep  stricter  legislation  given  the 
already high level of  protection provided by the Community legislation. 
The Amsterdam Treaty facilitates for Member States to request derogation from  the 
provisions in the Directive and  apply stricter national legislation to  further  protect 
health and the environment. The new Treaty also provides for a stricter regime for the 
Commission to react to the requests for derogation. This presents a challenge both in 
terms of  potentially more numerous requests for derogation and in terms of  the shorter 
time available for the Commission to make a decision. 
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phase out the use of  dangerous substances threaten to fragment the internal market. It 
has .  been  shown  that  harmonised  provisions  thr~mgh out  the  Community  can  be 
provided  by  the  Directive  also  in  these  cases.  However,  the  question  about 
competence  to  ·negotiate  and  enter  into  international  agreements  has  not  been 
adequately clarified. Decisions taken in such organisations may still pose a problem 
with  respect  to  the  internal  market  especially  where  all  Member  States  are  not 
contracting parties to the organisation. One ·example that could be mentioned in this 
context is  a P  ARC OM  Decision to  phase out the  use of short chained chlorinated 
paraffins. 
3.2  Protection of health and the environment 
The Directive shall, according to  Article  IOOa of the Treaty, provide a high level of 
protection to man and the environment. 
The protection of the public and particular persons using dangerous substances a,nd 
preparations  is  stressed  in the  recitals  of the  Directive.  The vast majority of the 
provisions in the Directive aim at protection of  human health,. and is providing a high 
level of protection especially to  consumers and vulnerable  gro~ps as  children.  For 
example, more than 850 substances are  ~anned for consumer use and about 15% of 
the entri~s in the Directive are concerned with protection of  the health of  children. 
The need for timely adoption of provisions reducing unacceptable risks to health and 
the environment is  evident. Although the time for  adoption normally can be deemed  · 
as acceptable in relation  to  transposition  time,  transition  periods  etc,  the  date  for 
application of the provisions can be delayed e.g.  if there is a need to.  develop new 
testing methods for the enforcement of the provisions. One example is the Directive 
restri~ting the marketing and use of  nickel in cheap jewellery. The Directive is not to 
b~ applied before testing methods have been adopted by the European standardisation 
organisation  (CEN).  The  development  of testing  methods  for  nickel  has  taken 
unacceptably long time, partly due to the procedures of CEN. Another example of a 
long and difficult processes to  adopt a Directive is  the review of the provisions on · 
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_,/21. asbestos.  In this  case  unclear  science,  the  need  to  consider the  substitutes  and  a 
considerable economic impact  for  certain countries of the proposed measures  hav.e 
contributed to the longtime to find an acceptable solution. 
Adoption  of amendments  adding  further  substances  to  the  Directive  by  the  co-
decision procedure provides for the democratic principles being respected.  In most 
cases  amendments  can  be  adopted  and  enter  into  force  within  an  acceptable 
. timeframe, However, the time needed to introduce a ban by the co-decision procedure 
has  shown overly resource  intensive and  time  consuming in certain cases.  This  is 
evident especially when the over-all principle to  ban certain substances has already 
been established as  is the case when newly classified c/rn/r substances are added to 
the list of cancer causing substances banned for  consumer use in the  Annex to the 
Directive  and  where  the  Commission  is  obliged  to  submit  a proposal  within  six 
months., Another example of  the co-decision procedure being perceived as too slow is 
when actions have to be taken to reduce immediate health risks to children. Where the 
current procedure allows for adoption by the Committee procedure, as  was the case 
with the fourth adaptation to technical progress on lamp-oils posing an acute risk to 
the  health  of small  children,  a Directive  can  be  developed  and  adopted  within  a  . 
reasonable time~ If  the co-decision procedure is needed, as in the case of  phthalates in 
toys and child care articles, the time for adoption will take considerable longer time. 
Another factor with a potential to  cause delay in introducing protective measures is 
uncertainties  about  the  nature  and  degree  of the  risk.  This  can  under  certain 
circumstances make the introduction of  protective measures difficult and lengthy. It is 
often  difficult  to  estimate  the  exposure· to  substances  in  different ·parts  of the 
Comritunity, the  topography  and climate vary  widely  and  the  Member States  have 
different views of  what is the required level of  protection. If the science is not giving 
a clear answer and  the  proposed restrictions  on  marketing  and  use, have ·a  serious 
economic impact the process to negotiate a new Directive can t~e  considerable time. 
This has been the case in the review of  the provisions on asbestos and cadmium. 
Finally,  as  pointed  out  earlier,  provisions  aiming  purely  at  the  protection  of the 
environment  are  not  as  frequent  in  the  Directive  as  provisions  on  substances 
dangerous to health. This is certainly a consequence of the general perception· of  risk 
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,12-'r being more focussed on health risks during the early days of the Directive. Also the 
.  . 
. fact that the knowledge about environmental risks has only gradually increased during 
the  last  decade  contributes  to  that  relatively  fewer  substances  dangerous  to  the 
environment have been restricted. 
4..  IMPROVEMENTS 
Three  main  areas  for  improvement  have  b.een  highlighted  in  the  evaluation  of 
Directive 76/769/EEC. The first issue concerns the functioning of the Directive in 
relation to the objective on internal market and the cases where certain Member States 
have requested derogations under Article 1  OOa  §4.  The second main issue concerns 
the effectiveness of  the Directive in terms ofthe time needed to meet the requirements 
to  protect health  and  the  environment.  Finally,  certain difficulties  in the practical 
operation ofthe Directive have been highlighted for improvement. 
The internal market 
In the ·three  cases where Member States have requested derogations  under Article 
1  OOa §4 and the Directive has been unable to provide hapnonised rules for the whole 
Community, solutions respecting the objectives ofthe Directive are actively sought by 
the Commission. 
•  It is intended that an internal market in PCP be established by a review of the 
provisions on PCP raising the level of protection for the whole Community. It is 
also intended that the request for a ~erogation on cadmium a solution be provided 
by introducing a higher level of protection in the Directive.  These changes are 
foreseen in the near future in the context of the review of the PCP and cadmium 
. provisions for the new Member States. 
•  The Cornrilission also has planned to provide a solution in the cases of  creosote. A 
review of the provisions of creosote  is  planned  following  new information on 
health dangers that has recently been made available.  The review has .to  be co-
.  .  ' 
ordinat~d with  a  review  of the  classification  of creosote  under  the  Directive 
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and preparations. 
Protection of  health and the environment 
The effectiveness of the Directive to meet the requirements to protect health and the 
environment could be further improved. Certain factors have been identified causing 
delays in the adoption and application of  proposed provisions. 
•  The introduction ofhannonised testing methods.· 
The experiences, especially from the Directive on nickel in cheap jewellery, show that 
development of testing methods should be under the control of the Commission and 
Member States in order to  guarantee a result within a reasonable  time  frame.  The 
R&D  work  could  be  done  by  independent,  governmental  or  industry  research 
institutes. Validation of  the testing methods could be done by appropriate independent 
bodies, in particular the JRC, in collaboration with independent technical bodies in the 
Member States. The Working Group on restriction on marketing and use consisting of 
Member State experts and  stakeholders could function  as  steering committee.  That 
provides also for a transparent procedure that would facilitate the final adoption of  the 
testing methods. 
"  Procedure for adoption of  amendments 
The co-decision procedure is being perceived as  overly  r~source intensive and time  . 
consuming for adding S!lbstances newly classified as c/m/r (carcinogenic, mutagenic 
and toxic to reproduction) to the Annex of  the Directive. The general principle to ban 
c/m/r  substances  for  consumer  use  was  already  introduced  in  1994  by  the ·14th 
amendment to the Directive. Newly. classified substances could instead be added to 
the Annex by the Committee procedure adapting Directive 761769/EEC to technical 
progress.  As  mentioned  earlier,  the  14th  amendment  will  be  subject  to  review 
following the new information on creosote. A change of  procedure to make possible a 
more ·speedy up-dating of  the Annex with regard to .c/m/r substances will be raised in 
the context of  that review. Also in the cases where urgent actions are needed to meet 
immediate threats to  health or the  environment a simpler and  less time consuming 
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-1lh procedure should be possible. Transparent procedures are ensured by the operation of 
' 
the i:nodus vivendi between the three Community Institutions and by the commitment 
ofthe Commission vis-a-vis the European Parliament on transparency  .. 
•  -Different views of  Member States on preferred/appropriate level of  protection. 
A clear picture of  the risks posed by the substance of  concern and of  the consequences 
of  the proposal is a of  utmost importance for the possibility to build consensus about a 
proposal. It will facilitate  the  introduction of restrictions that have  earlier  showed 
difficult  and  time-consuming  e.g.  on  substances  dangerous  to  the  environment. 
Although the methodology for targeted risk assessments and cost benefit analyses in 
the  frame  of Directive  761769  is  still  under development  these tools  have proven 
successful. Since 1995, when the concept was introduced, no Member State has voted 
against the Commission's proposals on restrictions on marketing and use. 
However, in some on-going work, e.g. the revision of the provisions on asbestos and 
cadmium, the process to  find  commonly acceptable solutions has taken many years 
and has been difficult. 
Further efforts have to  be made to  develop methodologies for c'ost benefit analyses 
and targeted risk assessments that provide  ~ sufficiently good basis for the proposals 
within a reasonable time frame.  The efforts to  develop an appropriate methodology 
for targeted risk assessments and especially for cost benefit analysis in the frame of 
Directive 76/769/EEC will continue. To improve cost benefit analyses there is a need 
- -
to  agree  overall  Community  principles  and  also  to  find  a  way  to  performing 
independent peer review  of cost  benefit  studies.  Two  seminars  have  already been . 
organised  with- a  broad  representation  of Member  State  experts,  stakeholders, 
academia etc. A report on risk management in the context of  restrictions on marketing 
and  use has  been prepared  and  a third  seminar to  further  develop  the  concept  is 
planned. 
Proposals should be  based· on  work  carried out by independent scientific expertise 
.  \ 
involving  the  Scientific  Committee  on  Toxity,  Ecotoxity  and  t~e Environment  in 
order to ensure that independant, good quality and transparent scientific bases have 
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been  taken  into  consideration. ·This  will  not  only  facilitate  the  adoption  of new 
' 
restrictions  but will also  remove· much of the  incentive  for  the  Member States  to 
request  derogations  under  Article  1  OOa.  The concept  should  also  be  promoted  in 
international  organisations  like  the  Marine  Conventions.  A  uniform  approach  to 
restrictions  on marketing  and  use will  decease  the  effects  on  the  internal market. 
· Efforts to develop internatiomilly harmonised methods for risk assessments and cost 
benefit analyses are being made in the frame of OECD and the transatlantic business 
dialogue (T  ABD). 
However, in many cases science can not provide a full answer. Knowledge about e.g. 
long term effects of chemicals on health and the environment may be missing or the 
exposure  is  difficult  to  estimate.  Nevertheless,  in  most  situations  the  information 
available is  sufficient to  provide a sufficient basis  for  a decision.  It is possible to 
justify the introduction of  restrictions on marketing and use and to make sure that the 
proposals are proportionate. 
In some  cases  the  science  is  unclear.  The  risk  assessment  shows ·  that  important 
scientific  knowledge  is  missing,  that  the  uncertainties  are  considerable  and  that 
serious  concerns  can  not  be  excluded.  According  to  the  Rio  Declaration  on 
Environment and Development the  lack of full  scientific certainty, where there  are 
threats of  serious or irreversible damage, shall not be used as a reason for postponing 
cost-effective measures. 
A precautionary approach in the Directive to introduce cost effective measures when 
there is a well founded suspicion of  unacceptable risk will improve ~e  Directive with 
regard to the objective on a high level of  protection of  the environment and to further 
decrease the  incentive  for  Member  States to  request  for  derogations  under Article 
1  OOa §4 to keep  stric~er national legislation. 
This approach has been l:aken in the review of the provisions on asbestos and of the · 
provisions from which the new Member States have derogations. The possibility to 
find  solutions acceptable to  the majority of Member States based on a transparent 
operation of  the principle as defined in th~ Rio Declaration is high. 
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The main weaknesses in the daily operation of the Directive are  concerned with the  .  . 
complexity of the Directive and  certain difficulties  to  interpret the Directive with 
regard to both the scope and the provisions. The Commission has included·in its wo~k 
programme  for  1999  a  propos3.1  to  recast  Directive. 76/769/EEC.  A  recast  will 
introduce a modernised and simplified approach pro~ding  for clear definitions, a well 
defined scope and a safe guard clause. 
•  Definitions 
In  a  modernised  Directive  necessary  definitions  could  be  introduced  and  the 
provisions drafted in a clear and easily understandable language. 
•  Scope 
The scope of  the Directive could by clarified particularly in relation to the area being 
harmonised by the Directive. Within the harmonised area the Member States can not 
introduce legislation deviating from the provisions of  the Directive. Another example 
were the scope could be further chirified is· in relation to  goods containing or being 
treated with dangerous substances (reference: Cqurtjudgement of  the 1.10.98 i~ affair 
C-127/97) 
•  Safeguard clause 
The functioning of  the Directive could be improved by the introduction of  a safeguard 
clause making it possible for the Member States to take temporary measures if  needed 
.  to protect health and the environment from immediate danger. 
•  Furthermore,  the  provisiOns  could  be  presented  in  the  new  Directive  in  a 
structured way facilitating the daily use of  the Directive. 
By proposing a new modemi.sed and improved Directive the Commission canput into 
practice the ~rinciple of simplify existing legislation and thus making this legislation 
more  easily  understandable  by  all  parties  involved.  A  simplified  legislation 
contributes to  a  more homogeneous  implementation by  the· ~ember States of the 
provisions at:J.d to a higher legal certainty. 
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